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SUMMARY 
iii 
The tuberculosis (TB) incidence has increased in Southern Africa and the situation 
isworsened by the emergence of drug-resistant Mycobacterium tuberculosis strains. 
Molecular biological techniques have been used to understand the disease dynamics of 
TB. In a series of studies we describe the use of these techniques to understand the 
disease dynamics of TB in Southern Africa. 
 
Using spoligotyping and IS6110-restriction fragment length polymorphism (RFLP) to 
characterize M. tuberculosis strains from TB patients in Zimbabwe, we identified a 
genotype causing a disproportionate number of TB cases. The genotype belonged to the 
Latin American Mediterranean (LAM) lineage and we named it the Southern Africa1 
(SAF1) family and later renamed it SAF1/RDRio, also reflecting its predominance in 
South America. To establish if this family of strains was predominant elsewhere in 
Southern Africa, genotypes were compared to those from Western Cape, South Africa 
and Zambia. The SAF1/RDRio strains were highly prevalent in Zambia but were only a 
minor fraction of the strains in South Africa. The geographical distribution of 
SAF1/RDRio strains was determined in Gweru, Zimbabwe, and was found to be spread in 
high incidence areas. From these two studies it was hypothesized that certain host and 
bacterial factors were associated with disease due to SAF1/RDRio.  
 
Subsequently potential risk factors and clinical outcomes of disease due to SAF1/RDRio 
strains were explored. An association was found with smoking and cavitary pulmonary 
disease suggesting that SAF1/RDRio caused a more severe and highly transmissible 
formof TB 
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Using IS6110-RFLP, principal genetic grouping, spoligotyping, IS6110 insertion-site 
mapping and variable-number tandem repeats (VNTR) typing, low IS6110 copy clade 
(LCC) identified in Zimbabwe were characterized and compared to the strains from Cape 
Town, South Africa and other regions. The LCC strains from Cape Town, South Africa, 
were found to have close evolutionary relationship with strains from Zimbabwe and other 
regions and were widely distributed suggesting they play an important role in the global 
TB epidemic. 
 
Observations from these studies and those from other studies led to the hypothesis that 
specific genotypes of M. tuberculosis predominate in regions of Southern Africa. To gain 
an insight on the population structure of M. tuberculosis strains in Southern Africa, 
spoligotyping and/or IS6110-RFLP data from eight countries were compared. This is the 
first study to describe the M. tuberculosis population structure in Southern Africa. 
Distinct genotypes were associated with specific geographic regions. These findings have 
important implications for TB diagnostics, anti-TB drug and vaccine development. 
 
The population structure of multidrug-resistant (MDR), pre-extensively drug-resistant 
(pre-XDR) and extensively drug-resistant (XDR) M. tuberculosis isolates from provinces 
in South Africa was also determined. This is again the first study to describe the 
population structure of drug-resistant M. tuberculosis in South Africa. The results also 
showed geographic localization of genotypes and an association with resistance class. 
However, decreasing strain diversity was observed as the isolates evolved from MDR-TB 
to XDR-TB suggesting selection for the specific genotypes. These findings highlight the 
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importance of identifying genetic markers in drug-resistant strains, to enhance early 
detection of those at risk of developing XDR-TB. 
OPSOMMING 
vi 
Die voorkoms van tuberkulose (TB) in Suider Afrika word vererger deur stamme van 
Mycobacterium tuberculosis wat weerstandig is teen die beskikbare anti-tuberkulose 
middels. Molekulêre tegnieke word gebruik om in hierdie reeks studies die dinamika van 
TB in Suider Afrika te ondersoek 
 
Deur spoligotipering en IS6110 restriksie fragment lengte polimorfisme (RFLP) tegnieke 
te gebruik om M. tuberculosis stamme van pasiente in Zimbabwe te beskryf, het ons ‘n 
genotipe gevind wat ‘n buitengewone aantal TB gevalle veroorsaak het. Hierdie genotipe 
is deel van die internasionaal beskryfde Latyns Amerikaase en Meditereense (LAM) stam 
familie. Ons het dit die Suider Afrikaanse Familie1 (SAF1) genoem, maar later hernoem 
na SAF1/RDRio, omdat dieselfde genotipe in ook volop is in Suid Amerika. Om vas te stel 
of hierdie familie ook oorheesend is in die res van Suider Afrika, is dit vergelyk met 
beskikbare databasisse van die Wes-Kaap, Suid-Afrika en Zambië. Alhoewel 
SAF1/RDRio in die Wes-Kaap gevind is, dra dit slegs tot ‘n mindere mate by tot die 
plaaslike TB epidemie. Aan die anderkant kom SAF1/RDRio baie algemeen in Zambië 
voor. ‘n Verdere studie wys ook dat die SAF1/RDRio familie eweredig en wyd verspreid 
voorkom in hoë insidensie gebiede in Gweru, Zimbabwe. Vanuit die bevindings van 
hierdie 2 studies, kan ons aflei dat sekere gasheer- en bakteriële eienskappe geassosieer is 
met SAF1/RDRio-TB-infeksie. 
 
Hierna is potensiële risiko faktore en kliniese uitkomste van siekte as gevolg van infeksie 
met SAF1/RDRio ondersoek. ‘n Assosiasie met rook en kaviterende pulmonale infeksie is 
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gevind,wat daarop dui dat SAF1/RDRio erger vorm van TB veroorsaak en hoogs 
oordraagbaar is. 
 
Deur gebruik te maak van IS6110- (RFLP), hoof groep groepering, spoligotipering, 
IS6110 invoegings kaartering en veranderlike getal tandem herhaling (VNTR) tipering 
kon lae IS6110 invoeginsgetal (LCC) stamme van Kaapstad, Zimbabwe en ander gebiede 
vergelyk word. Al die LCC stamme in die studie is evolusionêr naby verwant aan mekaar 
en is wyd verspreid, wat dui op hulle belangrike rol in die wêreldwye TB epidemie. 
 
Waarnemings in hierdie asook ander studies het tot die hipotese gely dat spesifieke 
genotipes van M. tuberculosis dominant is in verskillende gebiede van Suider Afrika. Om 
meer insig tot die populasie samestelling van M. tuberculosis stamme in Suider Afrika in 
te win is spoligotipes en RFLP-data van 8 lande vergelyk. Hierdie is die eerste studie om 
die populasie samestelling van M. tuberculosis in Suider Afrika te beskryf en is 
belangrike fir toekomstige ontwikkeling van nuwe TB diagnose tegnieke, anti-TB 
middels en TB entstowwe. 
 
Die populasie samestelling van multiweerstandige (MDR), pre-ekstreme weerstandige 
(pre-XDR) en ekstreme weerstandige (XDR) M. tuberculosis van verskillende provinsies 
in Suid-Afrika is ook bepaal. Hierdie studie is ook die eerste wat die populasie 
samestelling van weerstandige M. tuberculosis in Suid-Afrika beskryf. Die resultate wys 
geografiese lokalisering van genotipes en ‘n assosiasie met weerstandigheidsklas. ‘n 
Afname in stam diversiteit soos die isolate van MDR-TB tot XDR-TB ontwikkel, dui op 
Opsomming 
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seleksie van spesifieke genotipes. Hierdie bevinding lê die klem op die belangrikheid van 
die identifisering van genetiese merkers in weerstandige stamme om die risiko vir die 
ontwikkeling van XDR-TB te verminder deur vroë deteksie. 
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Abstract 
Over the past decade the incidence of tuberculosis in South Africa has increased. The 
situation has been worsened by human immunodeficiency virus (HIV) co-infection and 
the emergence of drug resistant strains. This places severe pressure on tuberculosis (TB) 
control efforts and has necessitated deviation from conventional epidemiological 
methods. Approaches to improve control efforts have included the use of molecular 
epidemiology techniques together with the conventional methods to better understand 
disease dynamics. The ability to distinguish between the different IS6110-restriction 
fragment length polymorphisms (-RFLP) of Mycobacterium tuberculosis isolates has 
greatly improved our understanding of TB epidemiology. In South Africa the use of 
molecular epidemiological techniques has enabled the definition of the population 
structure of both drug sensitive and resistant M. tuberculosis strains. Using both 
conventional and molecular epidemiological methods it has been possible to show that 
the TB epidemic in these settings has been attributed predominantly to ongoing 
transmission. IS6110-RFLP data from communities particularly in Cape Town shows that 
there are several distinct M. tuberculosis strain family groupings with characteristic 
IS6110-RFLP patterns and that a few of these families cause a disproportionately large 
number of both drug sensitive and drug resistant TB cases. Molecular techniques using 
IS6110-RFLP have also allowed documentation of exogenous reinfection and distinction 
between cases of TB drug resistance due to true acquisition and those due to reinfection 
with a drug resistant strain.  Growing evidence from the molecular epidemiology studies 
also suggests that individuals may be infected with multiple strains of M. tuberculosis. 
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Not only has the data been used to answer immediate epidemiological questions but is 
beginning to be used to understand the evolution of this species. 
1.0 Introduction 
1.1 Global tuberculosis problem 
Tuberculosis (TB) has plagued mankind for thousands of years.  Today, TB is the world’s 
second most common cause of death from infectious disease after HIV/AIDS. Despite 
significant scientific progress in understanding this disease, the global incidence of TB 
continues to increase. The estimated number of new cases of TB in the world has 
increased from 8.4 million in 1999 to 9.2 million in 2006 and 9.4 million in 2009(1-4).  
Of the new cases in 2006, 3-4 million cases were sputum smear positive at diagnosis (the 
most infectious form of tuberculosis (4).   
 
Over the past decade South Africa has reported a rapid increase in TB incidence with 
new cases rising from less than 301 per 100 000 population in 1990 to 576 per 100 000 
population in 2000 and continues to increase, with more than 900 per 100 000 from 2006 
to 2009 (4).  In terms of the estimated number of persons with active tuberculosis, South 
Africa is one of the five countries with the highest number of incident cases of TB (4) 
which is exacerbated by an increase in number of TB cases resistant to anti-TB drugs (5).  
Tuberculosis and human immunodeficiency virus (TB/HIV) co-infection is thought to be 
one of the main constraints to achieving TB control in the world.  In South Africa it is 
estimated that more than 5.3 million people are living with HIV/AIDS, the highest in the 
world (6).  Of the total 1.84 million deaths from tuberculosis worldwide in 2000, 246 000 
were attributable to HIV infection with 203 000 occurring in Africa (1). 
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Infection due to Mycobacterium tuberculosis is commonly acquired via airborne 
transmission of infectious droplets (aerosols).  Persons with pulmonary TB who are 
sputum smear positive, are thought to be the main sources of infection, but smear 
negative patients have also been shown to transmit M. tuberculosis (7).  When 
susceptible hosts inhale the aerosols, they may become infected and an estimated 10-20% 
develop TB at some time during their life but have about half the risk of doing so within 
two years of infection (known as recent transmission) (8,9). In a majority of the cases, the 
infection is controlled within 2-10 weeks due to adequate immunity (10) and may force 
the pathogen into a dormant state (latent TB) for life. These latently infected individuals 
carry a 2-23% lifetime risk of developing reactivation TB while in immuno-compromised 
individuals this risk increases to 5-10% per year and is highly age dependent (10).   
 
Because HIV suppresses the body’s immune system, HIV-infected individuals are at 
increased risk of activation of latent infection and rapid progression of recently acquired 
infection to clinically active tuberculosis (11).  The estimates made by Corbett et al (1) 
suggest a lifetime risk of developing TB of 30-40% for co-infected persons in Africa 
compared to a between 10% and 20% lifetime risk in individuals infected only with 
TB(8,9).  
1.2 Drug- resistant tuberculosis 
A further threat to TB control is the emergence of drug resistant TB.  Drug resistant TB is 
defined as the state when M. tuberculosis becomes resistant to anti-microbial agents at 
the levels attainable in blood and tissue.  New evidence suggests that drug resistant M. 
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tuberculosis strains are becoming more resistant and unresponsive to current treatment 
(12).  Multi-drug resistant TB (MDR-TB), defined as resistance to at least isoniazid 
(INH) and rifampin (RIF) is also a major concern as these two drugs are the main drugs 
in the TB treatment regimen. Such resistance can develop through transmission (primary 
resistance) or under selective pressure of anti-TB agents (acquired) (13). The primary 
goals of anti-TB treatment are to kill the tubercle bacilli rapidly and hence prevent 
emergence of drug resistance, and eliminate persistent bacilli to prevent relapse. To 
achieve this, combination therapy, using more than one anti-TB drugs must be taken for a 
sufficiently long time. This will reduce the emergence of drug resistance during treatment 
as naturally occurring resistant strains would be selected for (selective pressure). 
Traditionally, patients with drug resistant TB are classified as having acquired or primary 
drug resistance on the basis of a history of previous treatment.  Primary resistance is 
defined as the presence of drug resistant M. tuberculosis in a patient with no prior or less 
than one month of treatment (13).  This means that the resistance is less likely to develop 
due to selective pressure of anti-TB agents but more likely to have been transmitted.  In 
general, primary resistance reflects the transmission of drug resistant TB over the years 
and it gives an indication of the achievements of the TB control program in controlling 
transmission. However, primary resistance may be grossly underestimated in cases of 
recurrent tuberculosis due to reinfection with drug resistant strains, since these patients 
may have had previous treatment (13). Acquired resistance is defined as resistance to 
anti-tuberculous drugs where a patient has received at least one month of anti-TB drugs 
(13).  Thus acquired resistance can be used to evaluate TB treatment strategies and hence 
the performances of TB control programs.  However this clinical classification is often 
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misleading, as the term acquired drug resistance includes patients with strains that truly 
acquired drug resistance during treatment and patients who were initially infected with a 
drug resistant strain, which was not detected by culture based phenotypic methods or by 
reinfection with a drug resistant strain (14).     
Recent reports from the WHO Global Project on anti-TB drug resistance surveillance 
indicate that multidrug-resistant-TB (MDR-TB) is present in all regions of the world (5).  
In addition available data suggests that globally MDR-TB is not a problem of the same 
magnitude as drug resistance but is at critical levels in specific regions of the world (15).  
In the 27 high TB burden countries the proportion of MDR-TB among new cases ranged 
from 1.6 in Ethiopia to 22% in Azerbaijan (5). In the African region, the proportion of 
MDR-TB among TB patients is generally low with frequencies ranging from 0.5% - 
3.9% among new cases and 0.0% to 16.7% among previously treated cases. Though these 
rates may seem low, the caseload of MDR-TB is high because of the high incidence of 
TB. There are an estimated 13 000 MDR-TB cases among new cases of TB in South 
Africa and in addition a growing problem of extensively drug-resistant TB (XDR-TB) 
(5).   This places severe constraints on the health budget as the cost of treating each 
MDR-TB case is of the order of US$3400(5) excluding hospitalization costs.  
1.3 Approaches to tuberculosis control 
1.3.1 Classical Epidemiology:  
Due to the nature of transmission and acquisition of M. tuberculosis infections,  persons 
recently exposed to newly reported cases of TB (contacts) are at high risk of developing 
TB disease because they have been recently infected (16,17). Two or more cases are 
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considered linked if there is judged to be sufficient sharing of the environment for 
transmission to have occurred. Therefore the organism causing disease or infection in the 
contact is assumed to be the same strain that caused disease in the index cases.  
 
The priorities of TB prevention and control programs include the identification and 
treatment of all persons with active TB and secondly to find contacts exposed to 
infectious TB patients and evaluate and treat them for latent TB infection (LTBI) or 
active TB disease (18,19).  The identification of LTBI in contacts involves testing for 
reactivity to tuberculin by doing a tuberculin skin test (TST) where a positive TST 
indicates possible exposure to M. tuberculosis. Studies have shown that by the time 
contact investigation is done, some of the contacts exposed and infected by a source may 
already have progressed to active TB (19,20). However the majority will have latent TB 
infection (20,21).  HIV is a strong risk factor for TB in individuals with latent TB or 
newly acquired infection.  
 
To reduce morbidity and mortality from TB in people living with HIV infection, WHO 
now the recommends the provision of antiretroviral therapy (ART) and the Three I’s; 
intensified case finding, isoniazid preventive therapy and infection control (22).  It is 
therefore critical for TB control strategies to not only evaluate contacts in order to find 
new cases of active TB, but also to identify candidates with LTBI for preventive therapy 
with isoniazid. Daily administration of isoniazid for 6 months is recommended in people 
living with HIV who do not have TB including; children, pregnant women, individuals 
on ART and those who have just completed treatment for TB. (22).  Treatment of LTBI 
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will reduce the latter group’s risk of progression to TB, thereby minimizing further 
transmission of TB.   
 
Studies of contact investigation have focused on TB transmission and identification of 
active TB among contacts. Close contacts with active TB disease were identified for TB 
patients with highly sputum smear positive disease and cavitary disease(19), drug 
resistant TB (22,23) and MDR-TB (24,25).  More recently, observations suggest that 
more casual contact may in some instances be sufficient for the transmission of M. 
tuberculosis (26). 
 
Although contact investigation has been the mainstay of classical epidemiological 
methods, a clear distinction between routine contact investigation and epidemiological 
investigations was made by Onorato et al (26,27).  The former mainly involves the 
identification and evaluation of persons with either active TB or latent TB, while the 
latter is more directed toward identifying the dynamics of the disease and its 
transmission.  In most countries, even though active case finding and contact tracing is 
advocated, infection in the contacts may well have come from a source other than the 
index case and many of the contacts leading to infection may be casual (28,29).  
Therefore many of these additional contacts of brief exposure may be entirely missed 
(16). These links are important in elucidating disease and transmission dynamics in TB 
and their identification may therefore require deviation from the basic routine classical 
epidemiological methods.   
Chapter 1 
10 
1.3.2 Molecular epidemiology 
During the last decade, genome differences mediated by mycobacterial repetitive 
elements have been widely exploited in epidemiologic studies of TB (7,30-33).  Although 
the M. tuberculosis genome contains several repetitive elements, only a few are 
polymorphic and have been widely studied. The best characterized repetitive elements 
include IS6110 insertions (34), IS1081 (35), polymorphic guanine cytosine–rich 
repetitive sequences (PGRS)(36), direct repeats (DR) (37), the oligonucleotide (GTG)5 
sequence (38) and mycobacterial interspersed repetitive units (MIRUs) (39).   
 
Molecular epidemiology of TB is most frequently based on the analysis of the 
distribution of the insertion sequence IS6110 in different isolates using the internationally 
standardized IS6110 restriction fragment length polymorphism (RFLP) methods (40). 
The transposable element IS6110 may be repeated up to 25 times per M. tuberculosis 
genome (41,42), although strains with no IS6110 insertion have been described (42,43). 
The IS6110 copies are nearly identical in sequence but the number of insertions and 
location in the genome vary, thereby yielding distinct RFLP patterns. These are 
visualized as RFLP banding patterns, generated by restriction digestion of the whole 
genome with a restriction enzyme PvuII, Southern transfer and hybridization with a 
labeled IS6110 probe (40).  Strains with six or fewer IS6110 insertions are classified as 
low-copy-number strains, whereas those with more than six copies of IS6110, as high-
copy-number strains (44).  
 
Chapter 1 
11 
The accuracy of genotyping can also be enhanced by the use of additional probes or 
secondary typing methods such as spacer oligonucleotide typing (spoligotyping) (45) and 
the more recently introduced method MIRU-VNTR  typing (39) which determines the 
presence or absence of 43 direct variable repeat (DVR) sequences in the DR region and 
variable numbers tandem repeats, respectively. Data generated as such is stored in 
databases of IS6110-RFLP or spoligotype patterns of M. tuberculosis complex strains 
such as that at the National Institute of Public Health and Environment (RIVM) in 
Bilthoven, the Netherlands (46) and spoligotype database (SpolDB3) (47).  These 
databases allow inter-laboratory comparisons to be made.   
 
Sequence analysis of M. tuberculosis strains collected from different geographical 
settings has shown that the frequency of mutation in this organism is relatively low 
thereby demonstrating that the global population of M. tuberculosis is clonal (48). 
Therefore the transposition of the insertion sequences such as IS6110 is a fundamental 
process in generating genomic variation. In addition to the classification using IS6110-
RFLP within this clonal population of M. tuberculosis, strains can be assigned to one of 
three principal genetic groups according to single nucleotide polymorphisms (SNPs) in 
the katG and gyrA genes (48).  These groupings give a broad evolutionary scenario of M. 
tuberculosis strains (48).   
 
The advent of molecular epidemiology using bacterial genetics to track organisms in 
defined communities and worldwide has enabled researchers to challenge many of the 
prevailing dogmas about TB epidemiology. IS6110-RFLP has been widely used in 
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community settings to support outbreak investigations (26,49), to document nosocomial 
transmission of TB (50,50,51), as a tool for studying TB transmission dynamics 
(31,52,53), for studying the M. tuberculosis population structure (32,54,55), as well as 
other aspects of TB epidemiology.  It is envisaged that this data will form the foundation 
of future TB control strategies.  
 
IS6110-RFLPs of M. tuberculosis isolates from patients with epidemiologically unrelated 
TB generally show differences, whereas those from patients infected by a common 
source are identical. Therefore the basic premise of most molecular epidemiology studies 
has been that isolates with the identical IS6110-RFLPs (clusters) are assumed to be part 
of the same chain of recent transmission (30,41,42). Conversely, isolates with unique 
IS6110-RFLPs (non-clustered) are assumed to be a result of reactivation of remote 
(latent) infection or influx from distant communities or failure to identify the source case 
(30,41,42). The extent of genetic homogeneity among strains in a community reflects the 
relative contribution of recently transmitted versus reactivated disease. This can have 
wide-reaching implications both for understanding and controlling TB and therefore must 
be interpreted carefully. Data from IS6110-RFLP however must be interpreted together 
with epidemiologic information, which is usually obtained by interviewing patients when 
TB is diagnosed. 
2.0 Molecular epidemiology studies in South African communities 
Tuberculosis molecular epidemiology studies have been done in a number of different 
regions of Southern Africa (31-33,52-55).  However, in certain studies biases have made 
it difficult to accurately quantify the extent of recent transmission in different regions. 
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The amount of clustering seen will depend on the duration of the study, the 
comprehensiveness of sampling, and the heterogeneity of the M. tuberculosis strains in 
the particular region (56,57).  South Africa has by far the most comprehensive molecular 
epidemiological data in Southern Africa with most of the reports emanating from the 
Western Cape Province.  These studies have defined the population structure of both drug 
sensitive and drug resistant M. tuberculosis strains in communities (33,58,59), estimated 
the degree of clustering (31,33,52,53), established the risk factors for clustering 
(31,52,53), and helped document exogenous reinfection (60) and nosocomial 
transmission of TB (50,61). Furthermore, all these studies have provided information that 
could potentially be used to guide TB control efforts.  
 
3.0 Mycobacterium tuberculosis strain diversity in South Africa 
Initial attempts to characterize M. tuberculosis strains present in an epidemiological field 
site in Cape Town, South Africa, indicated that there was high level of strain diversity 
(33).  The field site occupies an area of 3.4km2 and has a population of 38 500. 
 
A longitudinal IS6110-RFLP database representing clinical isolates from patients 
presenting with TB in this site within the Cape Town metropolitan was established in 
July 1992 and data collection is still ongoing.  This database is maintained at the 
University of Stellenbosch’s Department of Medical Biochemistry. Data from 1992-1998 
shows that 1526 patients were reported with tuberculosis and that  1023 of these had 
culture positive TB (52,62). Based on IS6110-RFLP, approximately 100 different high 
and low copy number strains were identified per km2 and cluster analysis grouped these 
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strains according to similarities. These groupings were assigned arbitrary numbers and 
are termed strain families. A total of 32 high copy number (≥ 6 IS6110 bands) strain 
families, designated F1-F32 and one family designated the low-copy-number clade 
(strains with 1-6 IS6110 bands) were identified (table 1). Some isolates were grouped as 
strain family 0 (2.12%) had unique IS6110 fingerprints and did not have IS6110-RFLP 
similarities with any of the other strain families. 
 
Among the different strain families identified to date in these communities, strain 
families designated F11, F28, F29 and the low-copy-number clade represented the 
groupings that were causing a disproportionately large number of TB cases (Table 1). 
These strain families have established themselves in this community and clonal variants 
are being spread from person to person (clonal spread). Interestingly these same four 
strain families were also responsible for more than 70% of the drug-resistant epidemic in 
the rural regions of Boland-Overberg and Southern Cape-Karoo of the Western Cape 
Province in South Africa (58).  These findings may imply that within the communities 
studied, these M. tuberculosis strains are more effectively spread or alternatively these 
strains have been present in the community for longer periods.  
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Table 1:  The frequency of high-and low-copy-number M. tuberculosis strain families 
from the epidemiological study site in Cape Town (data collected from 1993-1998) 
Strain family Number of IS6110 inserts Cases n (%) 
F 0 
 F 1 
 F 2 
  F 3 
 F 4 
 F 5 
 F 6 
 F 7 
 F 8 
 F 9 
  F10 
  F11 
  F12 
  F13 
  F14 
  F15 
  F16 
  F17 
  F18 
  F19 
  F20 
  F21 
  F22 
  F23 
  F24 
  F25 
  F26 
  F27 
  F28 
  F29 
  F30 
  F31 
  F32 
  Low-copy- number clade 
 
1-24 
8-13 
9-15 
9-12 
10-13 
12-14 
14-16 
10-15 
7-24 
8-14 
14-17 
10-19 
2-8 
11-18 
9-18 
13-18 
10-13 
14-16 
13-19 
9-12 
18-21 
5-13 
9-11 
9-15 
9-18 
13-20 
11-24 
15-17 
8-16 
16-25 
8-9 
15 
12 
1-6 
  18 (2.3) 
   5 (0.6) 
  26 (3.3) 
   3 (0.4) 
  20 (2.5) 
   2 (0.3) 
   5 (0.6) 
  13 (1.6) 
   2 (0.3) 
  17 (2.1) 
   4 (0.5) 
 155 (19.4) 
   1 (0.1) 
 14 (1.8) 
  26 (3.3) 
  11 (1.4) 
  11 (1.4) 
   9 (1.1) 
  19 (2.4) 
   3 (0.4) 
   6 (0.8) 
  18 (2.3) 
   4 (0.5) 
   9 (1.1) 
  13 (1.6) 
  13 (1.6) 
  11 (1.4) 
   2 (0.3) 
  79 (9.9) 
 137 (17.2) 
   2 (0.3) 
   1 (0.1) 
   1 (0.1) 
  137 (17.2) 
Total    797 (100) 
 
Marked strain diversity was also found in rural communities of Hlabisa in Durban, South 
Africa, with IS6110-RFLP revealing 175 distinct patterns from 246 patient isolates (53).  
However no published data on the distribution of the strain families in this study 
community is available and therefore it was not possible to compare data from the two 
different field sites. 
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4.0 Characteristics of dominant M. tuberculosis strain families: 
4.1 Family 11:  
Among the four strain families, F11 is the most predominant strain family in the Cape 
Town community, being represented by approximately a fifth of the isolates in the 
database (Table 1). On average the F11 strains have 14 IS6110 inserts (range 11-19) and 
a characteristic banding pattern (Fig 1), being represented by 97 different IS6110 variants 
in a total of 29 clusters and 52 related unique strains.  These F11 strains belong to 
principal genetic group 2 (63). The spoligotype signature for this strain family is 
characterized by deletion of DVRs or spacers 9-11, 21-24 and 33-36 and a total of 14 
different spoligotypes were identified (63). Family 11 strains have also been reported 
from other parts of South Africa (unpublished data) and were also shown to have a global 
distribution (59). 
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Fig 1:  IS6110 –RFLP patterns of representative isolates of family 11 Mycobacterium tuberculosis strains isolated from 
tuberculosis patients from an epidemiological field site in Cape Town, South Africa (data retrieved from the local 
database maintained in the Dept of Medical Biochemistry at the University of Stellenbosch).  Strain family groupings 
were defined by isolates having an IS6110 similarity index of >65%. 
 
4.2 Family 28:  
Among the patients with TB from the urban communities in Cape Town, F28 strains 
cause disease in 9.7% of the cases. Similarly this family is highly clonal demonstrated by 
high similarity among the IS6110-RFLP patterns (Fig 2).  Isolates of the Family 28 clade 
Chapter 1 
18 
are represented by 41 characteristic IS6110-RFLP patterns (63) with the number of 
IS6110-RFLP hybridizing bands ranging from 8 to13. This strain family also shares a 
spoligotype signature characterized by deletion of DVRs 9-10 and 33-36 and belongs to 
principle genetic group 2 (Table 2) and variability in the spoligotype signature is also 
observed resulting in a total of 14 spoligotypes (63).  No reports of this strain family have 
been made from other parts of South Africa and other regions of Africa.  Although F28 
appears common in the Western Cape Province, comparison of the IS6110-RFLP and the 
spoligotypes with the international RIVM database suggests that this family may be more 
widespread globally than previously thought.  For instance Nguyen and colleagues 
(64,65) have identified strains harboring the same spoligotype signature and the same 
IS6110 insertion site in low incidence areas of Quebec, Canada but with some of these 
strains associated with pyrazinamide mono-resistance.    
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Fig 2:  IS6110–RFLP patterns of representative isolates of family 28 Mycobacterium tuberculosis strains isolated from tuberculosis 
patients from an epidemiological field site in Cape Town, South Africa (data retrieved from the local database maintained in the Dept 
of Medical Biochemistry at the University of Stellenbosch).  Strain family groupings were defined by isolates having an IS6110 
similarity index of >65% 
4.3 Family 29 (Beijing-like clade) 
During the period 1992-1998 F29 strains caused disease in approximately 17% of all TB 
cases in the epidemiological field site in Cape Town (62). Although these strains have a 
large array of IS6110-RFLP patterns characterized by having a high copy number (15-26 
bands, average 17) (Fig 3) they are genetically related as they all belong to principal 
genetic group 1 (63,66) and have the same spoligotype pattern (Table 2) demonstrated by 
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deletion of the first 34 consecutive spoligotype spacers and presence of spacers 35-
43(63). The Beijing strains, often associated with MDR-TB, have been reported to cause 
outbreaks in institutional settings(67), hospital environments (49) and have been 
implicated in ongoing community transmission (68-71), contributing to their endemic 
nature. The prevalence of the Beijing strains is remarkably high in countries in Asia 
(68,69,70, ,73). Their importance in South African communities has been reported, being 
associated with an outbreak of MDR-TB in Cape Town(73), and rural communities in the 
Western Cape Province(58).  Only recently have these strains been isolated from other 
regions in African such as Kenya (74)and Zimbabwe (unpublished data).  Although the 
frequency of Beijing strains in South Africa is not as high as reported elsewhere (68-71), 
the extensive clustering and high transmission rates suggest that this family of strains is 
highly transmissible and may represent an emerging clade in the Western Cape Province.   
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Fig 3: IS6110 –RFLP patterns of representative isolates of family 29 (Beijing-like clade) Mycobacterium tuberculosis 
strains isolated from tuberculosis patients from an epidemiological field site in Cape Town, South Africa (data 
retrieved from the local database maintained in the Dept of Medical Biochemistry at the University of Stellenbosch).  
Strain family groupings were defined by isolates having an IS6110 similarity index of 65% 
 
4.4 Low-copy-number clade 
The low-copy-number clade isolates are characterized by specific IS6110-RFLP 
genotypes and spoligotypes.  In the well studied community in Cape Town, South Africa, 
18.1% of the patients with TB during 1992-1998 were infected with low-copy-number 
strains(75).  These strains have ≤ 6 IS6110-RFLP hybridizing fragments with inherently 
limited polymorphism (Fig 4). The IS6110-RFLP patterns in low copy number strains are 
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often more stable than their spoligotype pattern resulting in inherently limited IS6110-
RFLP polymorphism and poor discriminatory power of IS6110-RFLP in these strains. 
This therefore necessitates the use of additional genotyping methods such as principle 
genetic grouping(48), spoligotyping(45), insertion site mapping (76-78), PGRS(36) and 
MIRU-VNTR(79), to characterize them.  
 
Evidence from SNPs in the katG and gyrA genes suggests that M. tuberculosis strains of 
the low copy number clade from Cape Town may belong to either principal genetic group 
one or 2 representing two independently evolving lineages. Low-copy-number strains 
belonging to principal genetic group 2 show a deletion of DVRs 33-36, while clones of 
this group with ≥ 2 and ≤ 6 IS6110 insertions also showed an additional deletion of DVR 
18.  Only one low-copy-number isolate belonging to principal genetic group 1 has been 
identified so far in the epidemiological field site in Cape Town and in this strain DVR 34 
is uniquely deleted (Warren, personal communication). Low copy number strains have 
also been isolated from Central (Free State) and  Northern (Gauteng and Mpumalanga) 
parts of South Africa (unpublished data), neighbouring countries such as Zimbabwe 
(unpublished data), Europe (76,79) and America (80).  
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Fig 4: Dendrogram showing the number of IS6110 bands of Mycobacterium tuberculosis isolates belonging to the low 
copy number clade, isolated from tuberculosis patients from the field site in Cape Town, South Africa.  Low-copy-
number isolates have 1-6 IS6110 inserts. 
 
Table 2:  Characteristics defining the four predominant strain families isolated from TB 
patients in an epidemiological field site in Cape Town, South Africa 
 
Strain Family IS6110-
3’  bands 
IS6110-3’ 
variants 
Principal 
Genetic 
group
a
 
Spoligotype in world wide 
database
47
 
No of 
spoligotypes  
F11 11-19  97 2 33 14 
F28   8-13  41 2 34 14 
Beijing 15-26  38 1 1 1 
Low-copy-number 
clade 
    1-6  15 1 or 2 18,53,70,92,119,137, 
336, 347,352,489,806 
19 
aPrincipal genetic group classified according to mutations in the katG and gyrA genes (ref).  Principle genetic group 1 
isolates have the allele combination of katG codon 463 GTG (Leu) and gyrA codon 95 ACC (Thr) whereas group 2 
isolates have katG codon 463 CGG (Arg) and gyrA codon 95 ACC (Thr) 
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5.0 Insights into the transmission of tuberculosis in the communities 
Strain typing of TB has not only provided insights into the number and the type of strains 
circulating in communities but has also been used as a tool to quantify the degree of TB 
transmission.  Depending on the specific epidemiological question being addressed, 
studies have varied in both design and the sampling methodologies.   
5.1 Recent transmission and reactivation 
In attempts to determine the number of people with disease due to recent transmission 
(clustered cases) as opposed to reactivated disease most studies have adopted the “n 
minus one method”, based on the assumption that one case per cluster was due to 
reactivation and this case gave rise to other cases in the cluster, hence allowing one 
source case per cluster (81,82).  The TB epidemic in urban areas of Cape Town has been 
attributed predominantly to ongoing transmission (52,83).  Using conventional and 
molecular epidemiological methods to group M. tuberculosis strains, 58% of the TB 
cases were attributable to ongoing transmission (52).  
 
This calculation was based on the assumption that the IS6110 is sufficiently stable to 
define ongoing transmission. However more recently molecular epidemiology data also 
shows that IS6110 may change in a subset of cases over time during the passage from an 
infected source case to a contact (chains of transmission) giving rise to variants with one 
or two band differences (84,85). Therefore traditional molecular epidemiology 
assumptions would exclude any change in IS6110 banding patterns associated with 
transmission and such isolates may be incorrectly classified. A study by Warren et al(85) 
Chapter 1 
25 
showed that over a period of 6.5 years genotypes are estimated to change by 
approximately 20% during transmission events.  Taking this into consideration van der 
Spuy et al (83) calculated the genetic distance (number of band differences) between 
strains circulating in the study site. Assuming that strains with a genetic distance of 1-4 
represent ongoing transmission the proportion of cases due to ongoing transmission was 
estimated to be between 66-94% (83).    
 
Not only has ongoing transmission been implicated in TB epidemic urban communities 
of Cape Town, it has also been implicated in other parts of South Africa, including 
communal settings with high cure rates of TB (31) and rural settings (53). In these 
communities where ongoing transmission rates were high (high degree of clustering), 
smear positivity and being a re-treatment case following default were the main risk 
factors for clustering (31,52).  The apparent lack of epidemiological links in some of the 
studies in South Africa (31,33,53) and elsewhere (30,86) may point to the possible role of 
casual contact in transmission of TB or simply that some source cases were missed. The 
high level of ongoing transmission, clearly points to TB control interventions that are 
unable to effectively reduce transmission of TB. Whether the DOTS strategy of passive 
case finding coupled with other elements including observed chemotherapy is adequate in 
these high incidence communities may be questioned. A need for more emphasis on early 
presentation, active case finding, rapid diagnosis and subsequent treatment of cases may 
yield better results.   
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5.2 Household transmission   
The assumption often made is close and prolonged contact and therefore transmission 
occurs amongst household members.  This would imply that if two or more people in one 
household have TB, M. tuberculosis isolates from their cultures would be identical.  
Consequently a household contact has always been thought to play a major role in the 
transmission of TB and identifying household contacts and implementation of 
chemoprophylaxis has been the key in contact investigations. In children, TB is usually 
due to recently acquired infection.  This infection is assumed to have been acquired from 
an adult within the same household who has active infectious form of TB.  
 
Using IS6110-RFLP to classify strains in the epidemiological field site in the Western 
Cape Province, it was possible to demonstrate that people in the same household who 
have TB do not always have the same M. tuberculosis strain (29) even if the presumed 
secondary case was a child (87).  Classen and colleagues demonstrated that in a majority 
of the households (55%) at least one patient had a strain different from other household 
members’ strains (29). Similarly, of the 35 children with TB only 19 household contacts 
were identified and of these only 12 had the same strain as the child. The former study 
further highlighted the importance of contact in social gatherings which may not 
necessarily be casual contact (29).  These findings imply that in high incidence settings, 
transmission of M. tuberculosis may occur equally in the community and household and 
these findings may have implications for overall quantification of disease and the 
traditionally used contact tracing strategies. 
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5.3 Transmission of drug resistant tuberculosis 
Tuberculosis control in high incidence communities may be problematical if the MDR-
TB scourge increases. The use of molecular techniques has helped establish the relative 
contribution of transmission vs. acquisition of drug resistant M. tuberculosis. Clustered 
drug resistant strains would imply recent transmission and genetically diverse and 
unrelated strains would suggest acquisition of drug resistance provided the possible 
source cases had been identified. 
 
Using IS6110-RFLP and/or spoligotyping, to study the molecular epidemiology of TB in 
rural and urban communities of the Western Cape (14,33,58) has revealed that 
transmission is an important mechanism in the spread of drug resistant TB , and 
particularly MDR-TB. Characterization of isolates by both genotypic and phenotypic 
methods showed that MDR-TB contributed to the drug resistant TB epidemic (58,88).  
The extent of the problem is clearly given in the rural regions of Boland-Overberg and 
Southern Cape Karoo where 40% of the drug resistant cases were MDR-TB (58).  
However 70% of this drug resistance epidemic was being driven by four strain families 
only (F11, F28, F29 and IS6110 low-copy-number clade), the most prevalent being the 
Beijing/W like and IS6110 low-copy-number clade (58). The IS6110-low-copy number 
strains are widespread throughout the region studied but a particular group with a 
characteristic spoligotype (spoligotype 115) was only isolated from one town, possibly 
implying  
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an outbreak of MDR-TB (58).  The Beijing strains have been associated with drug 
resistance and MDR-TB in other regions of the Western Cape (62,74) and also worldwide 
(49,73).   
 
Despite the limited amount of IS6110-RFLP data from KwaZulu-Natal Province of South 
Africa, it was suggested that recent transmission was not contributing significantly to the 
drug resistant TB problem (89).  A substantial increase in the rate of MDR-TB was 
reported from the same community and IS6110-RFLP analysis suggested that between 
38-67% of the MDR-TB cases were recently transmitted (88).  However there was no 
evidence of a dominant circulating strain. On the contrary, in the gold mining 
communities of South Africa, another community with very high rates of TB, MDR-TB 
isolates were less likely to be clustered than drug susceptible isolates, suggesting that 
MDR-TB isolates caused fewer secondary cases of TB than drug susceptible ones (31).   
 
Results from the study by van Rie and colleagues (14) further suggested that in an 
epidemic area, a large proportion of TB drug resistance traditionally classified as 
acquired may be due to recent transmission (14).  However in a setting with high rates of 
TB transmission and HIV-1 infection, Sonnenberg and colleagues (90)showed that the 
dominant mechanism of drug resistance while on treatment was acquisition rather than 
transmission. These findings would therefore imply that the term acquired drug resistance 
is often misleading, especially when relying only on history of previous treatment.  This 
is because cases classified as having acquired drug resistance, include cases with drug 
resistance due to true acquisition as well as those due to reinfection with a drug resistant 
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strain (transmission). This therefore results in the misclassification of the latter group as 
having acquired drug resistance when in fact they would have recently been reinfected 
with a drug resistant strain.  This misclassification may lead to incorrect treatment 
regimens being prescribed and these cases may remain infectious for long periods of 
time, thereby contributing to the pool of infectious cases resulting in increased 
transmission of drug resistant TB.   
5.4 Tuberculosis infection in individual cases 
Historically a repeat episode (recurrent) of TB was thought to be due to endogenous 
reactivation. However, as far back as 1978, exogenous reinfection was suspected to be a 
contributor to the burden of TB (91). Understanding these mechanisms and their 
contribution to recurrent disease has extremely important implications for 1) drug trials 2) 
patient management 3) vaccine development. Exogenous reinfection and relapse are 
clinically indistinguishable and identification of these causes of recurrence requires the 
ability to differentiate the strains involved in the first and the subsequent TB episode.   
 
By distinguishing between strains with the same IS6110-RFLP fingerprint from those 
with different fingerprints, molecular techniques using IS6110 have allowed 
documentation of exogenous reinfection and now provide us with the tools to determine 
the mechanisms leading to recurrence (60,92-97). A recurrence of TB is the development 
of a second episode of active TB in a previously infected individual who had been 
considered cured.  This therefore raises the question whether this represents a 
recrudescence of the initially infecting organism (endogenous reactivation/relapse) or 
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infection with a new strain of M. tuberculosis (exogenous reinfection) (98).  Relapse can 
occur when TB bacilli persist after treatment despite apparent cure (true relapse) mainly 
due to inadequate treatment regimen and treatment duration (99).  Exogenous reinfection 
on the other hand is reinfection with a second strain of M. tuberculosis after contact with 
an infectious case and this can occur after curative treatment and/or in individuals who 
are latently infected (98, 99). The risk of reinfection therefore depends on the background 
TB incidence in communities and the risk of it breaking down into a second episode of 
disease (99). 
5.5 Exogenous re-infection after curative treatment 
Molecular epidemiology has provided dramatic evidence for the mechanisms of 
recurrence.  Anecdotal evidence initially showed that immuno-compromised individuals 
may be reinfected with different strains after curative treatment (95).  Subsequently, data 
from a high TB incidence epidemiological field site in Cape Town South Africa showed 
that 75% of retreatment episodes in HIV negative individuals were due to reinfection 
(60).  From this study it was concluded that the initial episode of disease was unable to 
confer protection against subsequent infections and disease progression. Furthermore, 
this study highlighted the importance of limiting active transmission which places 
previously treated individuals at risk of reinfection. However, this observation is not 
unique to high incidence settings, as more recently, a number of reports have shown that 
both persistent cases and retreatment cases may result from exogenous reinfection 
(92,93,95-97)with drug sensitive and resistant strains.   
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Reinfection has now been equated to a paradigm shift in our understanding of TB 
pathogenesis. Interestingly the relative proportion of recurrent cases due to reinfection 
differs in different settings in South Africa. A lower percentage of recurrence due to 
exogenous reinfection was observed in the gold mines of South Africa (97).  By 
following up 326 South African mineworkers who had successfully completed treatment 
for pulmonary TB in 1995 and combining classic and molecular epidemiology 
techniques, it was shown that approximately 20% had a second episode of TB (97).  Of 
these recurrent TB cases, 64% were due to relapse and 36% due to exogenous reinfection. 
Human immunodeficiency virus was a risk factor for recurrence and HIV-1 was more 
strongly associated with reinfection but not with relapse (97). Due to immuno-
suppression associated with, HIV-1 infection, individuals who are HIV-1 positive may be 
at high risk of developing infection after exposure to M tuberculosis. Exposure to M 
tuberculosis bacilli in turn increases in areas with high TB incidence. Following exposure 
to M. tuberculosis, HIV-1 infected individuals rapidly progress to disease further 
lowering their immunity to subsequent infection.  The high recurrence rate seen in HIV-1 
related TB in Africa may be due to increased susceptibility to exogenous reinfection and 
not treatment failure (94). 
5.6 Exogenous reinfection in latently infected individuals 
Tuberculosis has always been and still is thought by many to result from a single strain of 
M. tuberculosis and that this infection would protect against subsequent infections. In 
areas with a high incidence of TB, exogenous reinfection might also be a cause of the 
first episode of post-primary TB, since the immunity that develops after primary infection 
followed by a period of latency cannot be expected to confer protection against 
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subsequent exogenous reinfection. The high TB incidence being experienced in several 
regions may imply that many individuals may be exposed more than once and therefore 
exogenous reinfection may be an extremely important mechanism driving secondary TB 
in latently infected individuals.  However this is only based on assumption because it is 
not possible to genotype the strains in latently infected individuals. Mathematical 
modelling supports this notion suggesting that as many as 35 % of adults  by the age of 
35 years will have been infected more than once assuming an annual risk of tuberculosis 
infection of 3.5 % (P. Uys, personal communication).  
 
Studies have shown that both HIV-negative and HIV-positive individuals can be infected 
with more than one strain during the same episode (multiple infections) (100,101) in 
different lesions (102) or during successive TB episodes (reinfection) (60,92,93,95-97). 
Analysis of lung lesions clearly demonstrated that individuals with TB may have been 
reinfected due to the high annual risk of infection prior to disease presentation(102). The 
central dogma that a patient can only be infected with one M. tuberculosis strain has been 
further challenged.  Warren and colleagues (103) published the first report of the use of a 
polymerase chain reaction (PCR)-based method to determine the extent of multiple M. 
tuberculosis infection in sputum specimens collected from both new and retreatment TB 
cases in a high TB incidence community. They demonstrated that 19% of all the patients 
were simultaneously infected with a Beijing and non Beijing strain. Multiple strains were 
demonstrated to occur more frequently in retreatment cases (23%) as compared to new 
cases (17%).  
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There is growing evidence which leads us to suspect that some individuals with TB, 
especially in the high incidence communities, are infected with multiple strains of M. 
tuberculosis, (100-103) which could either be drug sensitive or resistant. In such cases 
DST is complicated as only one strain may be detectable or different antibiograms in 
different specimens collected from the same patient, complicating the interpretation and 
management of patients. These mixed infections may be detected, especially where the 
bacterial load is high. As with exogenous reinfection it is conceivable that the chances of 
mixed infection occurring in individuals are directly related to the local TB incidence and 
rate of infection.   
 
The use of targets that are more specific to other strains may in future help to provide 
more evidence and the true frequency of mixed infection which has not yet been possible 
with the currently standardized molecular biology methods.  It is imperative to identify 
these mixed infections in molecular epidemiology because they may influence the 
interpretation of molecular epidemiology data.  Most importantly the study by Warren 
and colleagues (103), substantiates the argument that prior infection with a pathogenic 
form of TB does not confer complete protection in this population, questioning the 
efficacy of the currently used Mycobacterium bovis BCG vaccine.  
 
How mixed infections in TB could influence the epidemiology of the disease remains to 
be determined, although it has been suggested that reinfection may exacerbate disease 
progression and endogenous reactivation of primary infection (102). This would imply 
that primary infection is unable to confer protection against subsequent infection, thereby 
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even further questioning the efficacy of the currently used vaccines.  Furthermore these 
findings will have implications on the interpretation of findings from drug and vaccine 
trials.  It is not clear if patients with mixed infections differ in clinical presentation or 
response to treatment, which would imply different clinical management of patients.  
Even though it is conceivable that mixed infections would be low in low incidence 
communities, their frequency needs to be determined both in high and low incidence 
communities to allow for accurate inferences to be made from molecular epidemiologic 
studies.  
6.0 Lessons learnt 
Strain typing of M tuberculosis in our region has revolutionized the epidemiology of TB 
by providing information on the variety and number of strains circulating in our 
communities.  Within these communities the data has also been used to track the spread 
of both drug sensitive and drug resistant strains (including MDR strains), to investigate 
recurrent M. tuberculosis infections and to examine the existence of multiple infections.  
Not only has it provided information on disease dynamics, the data has potential use in 
determining the evolutionary mechanisms in this species.   
 
A better understanding of these evolutionary mechanisms modeling the genome will 
provide new insights for the interpretation of molecular epidemiology data. In addition, 
information from DNA fingerprinting of M. tuberculosis strains contributes to the 
development of new mathematical models used in the study of tuberculosis transmission. 
This increases the accuracy of the mathematical models in identifying factors that may 
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have an effect on transmission, which in turn increases the reliability of predictions and 
design of intervention strategies. 
7.0 Hypothesis and aim of the study 
We hypothesized that the application of molecular epidemiological tools such as IS6110, 
spoligotyping and VNTR will help us understand the disease dynamics M. tuberculosis in 
high TB incidence settings in Southern Africa. The general aim of this study is to apply 
IS6110, spoligotyping and other molecular techniques to study the following aspects of 
the TB epidemic: the diversity and population structure of drug sensitive and multidrug 
and extensively resistant tuberculosis, risk factors for disease due to predominant M. 
tuberculosis strains and the evolution of M. tuberculosis strains in regions of Southern 
Africa. 
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Summary 
Setting: Zimbabwe and Zambia  
Objective: To determine the genetic diversity of Mycobacterium tuberculosis strains 
isolated from tuberculosis (TB) patients in Zimbabwe and Zambia.  
Design: M. tuberculosis isolates cultured from TB patients presenting at referral hospitals 
in Zimbabwe and healthcare-clinics in Zambia were characterized by IS6110-genotyping 
and/or spoligotyping using internationally standardized methods.  Genotypic data was 
compared to that from Cape Town and SpolDB3.0 database. 
Results: A predominant group of strains could be identified among 116 of 246 (47.2%) 
Zimbabwean isolates, by their characteristic IS6110-banding pattern and unique 
spoligotype- signature, where spacers 21-24, 27-30 and 33-36 were deleted. Comparison 
with strains from Cape Town showed that they were closely related to a family of strains 
present in 2.3% of Cape Town patients. Comparison of the spoligotypes with those 
obtained from 114 isolates from Zambia showed that 74 (65%) of these isolates had the 
same spoligotype-signature. Spoligotypes on the SpolDB3.0 database showed that this 
group of strains was rarely isolated from other parts of the world but commonly isolated 
in Southern-Africa.  
Conclusion: A predominant group of strains infecting approximately half of the patients 
in the study are major contributors to the TB epidemic in this region. We have designated 
this group of strains the Southern Africa 1“SAF1” family. 
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Introduction 
In terms of its historical and current disease burden Mycobacterium tuberculosis, the 
etiological agent for tuberculosis (TB), is undeniably the most successful human 
pathogen. Approximately one third of the world’s population is infected by M. 
tuberculosis; however, less than 10% of these develop active TB during their lifetime.  
Sub-Saharan Africa has the highest annual TB incidence rates since the emergence of the 
human immunodeficiency virus (HIV) epidemic and most countries in this region belong 
to the group of 22 high burden countries that collectively account for 80% of cases 
worldwide (1).   
 
In Zimbabwe, the incidence of TB is estimated at 604 new cases per 100 000 population 
(2). The situation is exacerbated by co-infection with the HIV with approximately 60% of 
cases presenting with tuberculosis, also being co-infected with HIV (2).  Sputum smear 
microscopy is the mainstay for diagnosis of pulmonary TB where culture is not available. 
However it is well established that smear negative cases may be disproportionately higher 
in HIV positive than in HIV negative individuals(3;4)  and hence the true denominator of 
total cases is largely unknown. Although countries in Southern Africa have by far the 
largest TB disease burden, very little is known about the disease dynamics and 
characteristics of the bacterial populations circulating in these communities.  
 
Approaches to understanding the disease dynamics of TB have included the use of 
molecular methods together with conventional TB epidemiology (5-7). Molecular 
epidemiology techniques have enabled differentiation of clinical isolates of M. 
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tuberculosis into distinct genotypes which may be important in understanding bacterial 
pathogenesis.  The most commonly used methods being IS6110-genotyping (8). The use 
of additional markers such as spoligotyping (9) and mycobacterial interspersed repetitive 
units(MIRUs) (10, 11) has greatly enhanced the accuracy in differentiating M. 
tuberculosis strains. 
 
The lack of comprehensive molecular epidemiological data from most countries in 
Africa, such as Zimbabwe and Zambia, has limited the understanding of TB disease 
dynamics in these areas.  A molecular epidemiology study conducted in Harare reported a 
high level of strain clustering (12).  However no comprehensive studies have been done 
in Zimbabwe to describe the degree of genetic heterogeneity of M. tuberculosis isolates 
circulating in this region. Earlier attempts to characterize M. tuberculosis strains from 
Zimbabwe using spoligotyping, were limited by small sample size, use of one marker, 
and study period (13).  In the absence of such information it is possible that the molecular 
epidemiology data may have been misinterpreted.  
 
In this study we have used the internationally standardized IS6110-genotyping method 
together with spoligotyping to determine the genetic diversity of M. tuberculosis strains 
isolated from TB patients in Harare and Gweru, Zimbabwe. Analysis of this data 
identified a predominant strain family contributing to the high TB incidence rates.  In 
order to gain an insight into the global significance of this strain family, genotypic data 
from Zimbabwe was compared to that from other countries in the Southern Africa region, 
thereby allowing an assessment of how molecular epidemiology could be used to 
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determine the dynamics of the current TB epidemic, such as transmission of the disease 
between communities, regions and countries.  
 
MATERIALS AND METHODS   
Recruitment of patients 
The M. tuberculosis strains were cultured from patients presenting with pulmonary TB in 
two cities in Zimbabwe.  During the period October to December 2001 sputum samples 
were collected from a total of 120 consecutive smear-positive pulmonary tuberculosis 
patients presenting at the Beatrice Road Infectious Diseases Hospital (BRIDH), (the main 
referral centre for infectious diseases in Harare, Zimbabwe). During the period 
September 2000 to September 2001 sputum samples were collected from 300 consecutive 
smear-positive or smear- negative pulmonary TB patients presenting at the Gweru 
Provincial Hospital (GPH).  
 
The Zambian isolates were collected as part of a national drug resistance surveillance 
study and were obtained from new smear positive patients presenting at various medical 
centres in different provinces of Zambia.  
 
This study was approved by the Medical Research Council of Zimbabwe (MRCZ/A/895, 
MRCZ/A/967) and the Stellenbosch University Faculty of Health Sciences (2003/022/N). 
 
Bacterial strains 
The sputum samples from BRIDH were sent to Biomedical Research and Training 
Institute (BRTI) in Harare, for sputum microscopy and subsequent culture on Lowenstein 
Chapter 2 
56 
Jensen (LJ) slants using conventional methods. Sputum samples from GPH were also 
sent to BRTI for sputum microscopy and culture on MGIT (14). All positive cultures 
were sub-cultured onto LJ slants and allowed to grow at 37ºC until confluent growth was 
observed to ensure adequate DNA for subsequent IS6110-genotyping. Only one culture 
from each patient was used for IS6110-genotyping and interpretation of the data.  
 
The samples from Zambia were cultured on LJ slants at the Chest Diseases Laboratory 
(CDL) in Zambia using conventional culture methods. All culture positive isolates 
confirmed as MTB were sent to the Tropical Disease Research Centre (TDRC) for DNA 
extraction.  A total of 114 isolates had DNA that could be used for genotyping. 
 
IS6110-genotyping 
DNA was extracted from M. tuberculosis cultures from Zimbabwe and Cape Town as 
previously described (15). IS6110–genotyping was performed using the international 
standard typing method for M. tuberculosis (8). Briefly Genomic DNA was digested with 
the restriction endonuclease PvuII and subjected to electrophoresis in a 0.8% agarose gel.  
Each lane on the gel included an internal marker (Marker X; Boehringer Mannheim, 
Germany) to enable normalization between lanes, while each gel included two external 
marker lanes (MTB 14323) to ensure inter-gel comparisons. The DNA fragments on the 
gel were Southern-blotted to Hybond N + (Amersham Pharmacia-Biotec) and IS6110-
containing fragment were visualized after hybridization with Enhanced 
Chemiluminescence (ECL)-labelled probes IS6110-3’ and Marker X DNA (Boehringer 
Mannheim, Germany). Each probe was stripped from the membrane by denaturation 
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before hybridization with the subsequent probe. Each DNA genotype was normalised and 
analysed using Gelcompar (Version 4.0, Applied Maths, BVBA, Kortrijk, Belgium) and 
entered into a database. The IS6110-genotype patterns were aligned by use of the 
GelCompar program with tolerance parameters allowing a 6% shift in each pattern as a 
whole and a 0.4% variance in individual band positions.  Cluster analysis was done using 
the Unweighted Pair Group Method with Arithmetic mean (UPGMA), based on Dice 
Coefficient. The isolates were classified into strain families according to the similarity of 
the IS6110-genotype patterns. Strain families were defined according to a similarity 
index of ≥ 70% (16). Isolates within strain families were classified into clusters of 
identical strains (strains sharing an identical IS6110-genotype pattern) or uniques (strains 
with a unique IS6110-genotype pattern). The IS6110-genotype database for Zimbabwe 
was compared to the IS6110-genotype database of isolates from the epidemiological 
study site in Cape Town (maintained at Stellenbosch University) (15, 17, 18) to identify 
similarities in IS6110-genotype patterns. 
 
IS6110-genotyping could not be done for the isolates from Zambia as there was 
insufficient DNA.   
 
Spoligotyping 
Isolates from Zimbabwe, Cape Town and Zambia were spoligotyped according to a 
standardized protocol (9) to detect DNA polymorphism in the direct repeat (DR) region.  
Spoligotyping was done at the Stellenbosch University, Department of Medical 
Biochemistry and the resultant autoradiographs were analysed manually and information 
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entered into a Microsoft Excel database to allow comparisons between isolates from the 
different regions.  
 
To determine the global distribution of the spoligotypes identified in this study, the 
spoligotypes were compared with the spoligotypes deposited in the SpolDB-3.0 
worldwide database (19). 
 
RESULTS 
IS6110-genotype patterns of M. tuberculosis strains isolated in Zimbabwe and Cape 
Town. 
Sputum cultures were available for genotyping from 246 different patients resident in 
Harare (n = 62) and Gweru (n = 184). Among these isolates, 220 (89.4%) harboured 
more than six IS6110 copies (high copy number strains), 24 (9.8%) had six or fewer 
IS6110 copies (low copy number strains) and the remaining two isolates had poor 
IS6110-genotype patterns due to poor quality DNA. Strains lacking IS6110 were not 
identified in either of the study sites. 
  
Cluster analysis based on the UPGMA and Dice coefficient grouped the isolates into a 
number of defined strain families (according to a similarity index of ›70%).  A total of 15 
strain families were identified among the Zimbabwean isolates (Figure 1).  However 116 
of the 246 isolates (47.2%) belonged to a group of strains sharing a similarity of ›80%.  
These 116 isolates were characterised by 8-17 IS6110 hybridizing fragments (Figure 2).  
The majority of these isolates shared six IS6110-PvuII fragments of 0.9, 1.67, 2.43, 2.60, 
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2.7, 4.16 and 4.6 Kb (Figure 2). The IS6110-genotyping analysis revealed 73 different 
patterns among these 116 isolates. Sixty-three isolates belonged to 20 clusters each 
containing between 2-8 isolates. The remaining 53 IS6110-genotype patterns were 
unique. Smear microscopy data was available for 75 isolates from this strain family and 
51 of these (68%) were smear positive whereas 24 (32%) were smear negative.  
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Figure 1: IS6110-genotype and spoligotype patterns of the M. tuberculosis isolates from Zimbabwe. 
Cluster analysis of M. tuberculosis isolates from Harare and Gweru in Zimbabwe. The analysis was based 
on UPGMA and Dice Coefficient. The resulting dendrogram shows the IS6110 similarity index on the left 
and the IS6110-genotype banding patterns in the middle. Strain families were assigned according to IS6110 
similarity index of ≥ 70% (16). On the extreme right are the corresponding DNA polymorphisms in the DR 
region (spoligotype patterns).   
  
Chapter 2 
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Figure 2: IS6110-genotype and spoligotype patterns of the “SAF1” Family isolates from Zimbabwe.  
IS6110-genotype banding patterns of isolates from Zimbabwe showed a similarity of ≥70%.  All isolates 
shared a common banding pattern of six IS6110-PvuII fragments, 0.9, 1.67, 2.43, 2.60, 2.7, 4.16 and 4.6 
Kb, respectively.  In addition, a spoligotype “signature” lacking spacers 21-24, 27-30 and 33-36 was 
observed among the isolates. The two isolates with no IS6110-RFLP due to poor DNA also had this 
characteristic spoligotype pattern. 
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Analysis of M. tuberculosis strains with spoligotyping. 
To confirm that the isolates belonged to a closely related group, representing clonal 
expansion, the 116 isolates were further characterized by analysis of the DR region using 
spoligotyping.  One hundred and fifteen isolates shared a characteristic spoligotype 
signature lacking spacers 21-24, 27-30 and 33-36(Figure 2).  One isolate only lacked 
spacers 21-24 and 33-36, but had the characteristic IS6110-genotype pattern possibly 
representing a more ancestral strain.  A total of 27 distinct spoligotypes were identified 
among these 116 isolates.  Twelve of the isolates each had a unique spoligotype pattern 
and the remaining 104 (89.7%) belonged to 15 clusters (Figure 3).  
 
Comparison of isolates belonging to the major family grouping with other 
databases. 
Comparison of the IS6110-genotype patterns from the Zimbabwean isolates with those 
from the Cape Town IS6110-genotype database showed ›70% similarity to19 Cape Town 
isolates (representing 2.3% of TB patients in that study setting)(16). Four different 
IS6110-genotype patterns were shared between isolates from Cape Town and from 
Zimbabwe.  Eighteen of the Cape Town isolates had the characteristic spoligotype 
signature, lacking spacers 21-24, 27-30 and 33-36 and one isolate had the ancestral 
spoligotype (Figure 3). Three spoligotype patterns (811, 815 and 59) were shared among 
isolates from Zimbabwe and Cape Town (Figure 3).   
 
We compared the characteristic spoligotype patterns with spoligotype patterns from 114 
Zambian isolates. Seventy-two of these isolates (63.2%) showed the characteristic 
spoligotype pattern; while a further 2 isolates showed the ancestral spoligotype (Figure 
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3). Restricted strain diversity was observed among the Zambian isolates with a total of 17 
spoligotype patterns being identified among the 74 isolates.  Of the 17 different patterns, 
4 patterns were shared among 61 isolates and 13 were unique (Figure 3). Five 
spoligotype patterns were shared among isolates from Zimbabwe and Zambia, while 3 
spoligotypes were shared between the Zambian and Cape Town isolates. Spoligotype 
pattern 59, formed the largest clusters in Zambia (44 isolates), Zimbabwe (36 isolates) 
and Cape Town (6 isolates). 
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Figure 3:  Schematic representation of spoligotype patterns obtained from Cape Town Zambia and 
Zimbabwe. The spoligotype nomenclature is according to the SpolDB3.0 database (19).  Orphan patterns 
Spoligo pattern Spoligotype Zimbabwe (n) Zambia (n) Cape Town (n) 
 orphan 0 2 0 
 816 3 0 0 
 orphan 0 1 0 
 orphan 0 3 0 
 412 1 0 0 
 orphan 0 0 1 
 753 1 0 0 
 orphan 0 0 1 
 orphan 2 0 0 
 orphan 0 1 0 
 orphan 0 1 3 
 20 0 1 0 
 orphan 1 0 0 
 orphan 0 1 0 
 orphan 0 1 0 
 orphan 2 0 0 
 orphan 1 0 0 
 orphan 1 1 0 
 orphan 0 0 1 
 orphan 0 1 0 
 orphan 2 0 0 
 orphan 1 0 0 
 orphan 1 0 0 
 orphan 2 0 0 
 orphan 1 0 0 
 orphan 4 0 0 
 84 1 0 0 
 orphan 0 0 3 
 orphan 2 0 0 
 orphan 1 0 0 
 orphan 5 0 0 
 orphan 1 0 0 
 orphan 2 0 0 
 811 14 0 2 
 orphan 0 1 0 
 813 3 1 0 
 814 1 1 0 
 815 20 12 1 
 orphan 2 1 0 
 orphan 5 0 0 
 59 36 44 6 
 42 0 1 1 
Total 42 116 74 19 
Chapter 2 
66 
did not have matches in the SpolDB3.0 database.  Spoligotypes 811, 813, 814 and 815 have been 
previously reported only from Zimbabwe (12;19). 
 
Dissemination of M. tuberculosis isolates of the identified major strain family 
grouping in other countries. 
The updated SpolDB3.0 database (19) was searched for isolates with the identical 
spoligotype signature as those found in Zimbabwe, Zambia and Cape Town.  Strains with 
similar spoligotype signatures have only been rarely isolated from other regions such as 
the Americas, Europe and Madagascar (19). With the exception of the isolates with 
spoligotype pattern 20, 42, 59, 412 and 753 this family of strains appears to be 
predominant in central regions of Southern Africa (Zimbabwe and Zambia) but not in 
Cape Town. Based on these findings we have now called this strain family Southern 
Africa Family 1“SAF1”. 
 
Discussion  
This study represents the first genetic study on M. tuberculosis, using IS6110-genotyping 
in combination with spoligotyping in Zimbabwe. This investigation has led to the 
identification of a predominant group of strains infecting approximately half of the 
patients in the study, and thereby are major contributors to the TB epidemic in this 
region.  The strains are characterised by a distinct IS6110-genotype pattern and a 
characteristic spoligotype signature suggesting clonal expansion from a common 
progenitor. This characteristic spoligotype signature was found not only among isolates 
from Zimbabwe but also predominantly from isolates from Zambia and in a minority of 
isolates from Cape Town, South Africa. We have named this strain family “SAF1”.  Only 
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rarely were “SAF1” spoligotypes identified in other regions of the world (19). Previous 
comparative genomic studies have shown that the “SAF1” genotype is a member of the 
LAM family20, which includes F11, F13, F14, F15 and F26 from Cape Town (21).  
IS6110 insertion site mapping suggests that these strain families form part of a group of 
strains that have originated from a common progenitor (21).  This would therefore imply 
that the SAF1 family is a branch within this super family of genotypes, where different 
branches appear to have different frequencies in different settings. The strain family F11 
occurs as the highest frequency strain family in Cape Town, South Africa, being isolated 
in 21.4% of the patients (22).  
  
We acknowledge that this study has certain limitations. Firstly, the isolates were collected 
from different settings and therefore the epidemiological relationships according to 
clustering were not appropriate to define transmission event.  Our data set could only be 
applied to demonstrate the broad distribution of closely related genotypes.  To gain 
further insight into the disease dynamics in Southern African future studies will need to 
comprehensively analyse isolates of M. tuberculosis over an extended period. Such 
studies must be able to establish whether the M. tuberculosis population structure is 
influenced by HIV co-infection or whether there is an association between clinical 
presentation and strain genotype. Secondly, the restricted time interval over which the 
isolates were collected has limited the application of this study to only determine the 
population structure of M. tuberculosis. However, we do not believe that this has 
introduced a significant bias given that specimens were cultured from patients from 
diverse geographical settings. Lastly, it is possible that the M. tuberculosis strain 
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population structure may differ between smear positive and smear negative cases. The 
isolation of Beijing strains in very low proportions may be because these strains have 
been recently introduction in this population. 
 
Despite these limitations, our results provide evidence that the burden of disease of 
tuberculosis in the central Southern African regions is largely due to a relatively small 
subset of actively circulating strains. The success of particular predominant clones related 
to high incidence of TB was also reported in earlier studies (18, 23-25). The identification 
of a predominant strain genotype in central parts of Southern Africa may reflect that this 
strain has either gained a higher degree of virulence, or that the strains in these high 
incidence countries may have originated from a few clones that expanded rapidly in the 
recent past. The reasons for the selection and dissemination of these strains are unknown.  
A recent study on the global genetic population structure for M. tuberculosis has 
suggested that the organism has adapted to specific human populations in different 
geographical settings (26). As postulated for other predominant strain families, the 
success of these strains may be a result of increased transmissibility or from expression of 
an as yet unidentified virulence factor (27). The reason for high frequency of Beijing 
strains has been related to virulence and mutator phenotypes and this may explain a better 
adaptability to stress conditions and hostile intracellular conditions (28). 
  
This study may have important implications for the interpretation of molecular 
epidemiology data. In molecular epidemiological analysis the predominance of closely 
related strains implies restricted genetic diversity, which may be interpreted as 
transmission. This may hinder the quantification of the contribution of reactivation and 
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recent transmission to the epidemic. Furthermore, it may be difficult to define the 
mechanism leading to recurrent tuberculosis. However, the interpretation of genetic 
diversity will generally depend on the method of genotyping used, underscoring the need 
to develop molecular epidemiological tools appropriate to settings with low M. 
tuberculosis IS6110 genotypic diversity.  
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SUMMARY 
We analyzed the geographical distribution of adult pulmonary tuberculosis (PTB) cases 
that occurred in a well defined area in Gweru, Zimbabwe during the period September 
2000 to September 2001. Using data obtained though routine registration of TB patients 
the number of TB cases was linked to the population density of the respective districts 
where the cases originated. A subset of M. tuberculosis genotypes was plotted on a map 
using a geographical information system (GIS) to determine the distribution of the 
SAF1/RDRio strains genotypes in this city. The SAF1/RDRio strains were spread in the 
districts with high incidence of TB only, further supporting the earlier findings that these 
strains may be highly transmissible and that they play an important role in the TB 
epidemic in Zimbabwe. 
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Introduction 
Tuberculosis remains an important cause of premature death and efforts to control TB are 
undermined by the impact of HIV-associated TB. Among new adult TB cases in 
Zimbabwe, 67% are estimated to be co-infected with HIV (1). A steep rise in notification 
rates was observed from 1997 in cities in Zimbabwe suggesting that transmission was 
playing a major role in the epidemic.  
 
Molecular typing, particularly IS6110-restriction fragment length polymorphism and 
spoligotyping, have allowed strain differentiation of Mycobacterium tuberculosis and this 
has helped in understanding strain diversity, transmission patterns and distribution of 
strains in specific areas to be studied (2, 3, 4). Ever since Lord Snow discovered the 
association between water supply and cholera, epidemiologists have used maps when 
analyzing associations between location, environment and disease (5). Since the 1970s 
Geographic information systems (GIS) have added a powerful tool for the analysis of 
these associations because of its spatial analysis and display capabilities (6). A recent 
application of this is the mapping of M. tuberculosis DNA fingerprints. This has led to a 
better understanding of the transmission dynamics of tuberculosis (2, 3, 7, 8).  
 
Gweru is an industrial mining town with 141 210 inhabitants (2002 population census) 
and is situated on the central plateau of Zimbabwe and is in the Midlands province. The 
Gweru provincial hospital is the referral centre for the population of the Midlands 
province but also acts as a district hospital for Gweru District. The population for the 
district was 303 938 in 2001 as extrapolated from the 2002 census and that of Gweru City 
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is 141 210. The TB notification rate for the province was 412 per 100 000 population in 
2001, 66.7 % were pulmonary TB (PTB), and of these 51.5 % had a positive smear (9). 
We set out to determine the geographic distribution of PTB cases notified over a period 
of one year in Gweru and to describe the distribution of M. tuberculosis genotypes, which 
were later described in a another study. (10).  
 
Methodology 
 
Setting 
Patients were recruited at Gweru Provincial Hospital, the referral centre for the 
population of Midlands Province. Gweru City has a business centre, low density (district 
1-3 and 5) and high density living areas (district 4, 6-9) and an extensive heavy industrial 
area (Figure 1). Besides the government provincial hospital, health services are provided 
in 11 health facilities (clinics) governed by the health department of the city council, and 
also in one private hospital. Patients suspected of TB in private facilities and clinics are 
referred to, and eventually diagnosed and registered in the provincial hospital. 
 
Participants  
Consecutive patients diagnosed with PTB and started on treatment at Gweru Provincial 
Hospital from September 2000 until September 2001. For this analysis only patients that 
were residing for at least one year in Gweru City, were included. Demographic data (age, 
gender) and residential addressed were abstracted for the government TB registers. 
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M. tuberculosis isolates  
For the genotypic analyses a convenient subset of 90 M. tuberculosis isolates with 
genotyping data were selected.  
 
Geographical database 
All available geographical data on communal services, public places, roads and rivers, 
open and industrial areas in Gweru were imported in a geographical information system 
(GIS) using ArcView 3.2 (Environmental Systems Research Institute, Redlands, USA). 
Coordinates of residences of TB-cases were measured using a hand held GPS-receiver or 
were introduced in the GIS on the basis of the patient’s address. 
 
To compare the spatial distribution of SAF1/RDRio strains, their distribution was 
compared to that of the other genotypes. TB cases in Gweru, the TB cases identified in 
the different districts of the city were also plotted to show the distribution of cases. This 
was based on the residential address of the patient as indicated in the TB notification 
register.  
 
  
Chapter 2a 
79 
 
Fig 1: Geographical map showing the city of Gweru showing the nine residential areas in 
the city (also referred to as districts). 
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Ethical considerations 
This study was approved by the Medical Research Council of Zimbabwe (MRCZ/A/895, 
MRCZ/A/967), the Provincial Medical Director of the Midlands Province, the Medical 
Superintendent of Gweru Provincial Hospital and the Stellenbosch University Faculty of 
Health Sciences (2003/022/N).  
 
Results  
M. tuberculosis genotypes identified from a subset of isolates 
The 90 M. tuberculosis isolates were grouped into 15 IS6110-RFLP families based on 
classification by Richardson and colleagues (11). Of the 90 isolates 35 (38.8%) belonged 
to the SAF1/RDRio strains and shared a characteristic IS6110-RFLP pattern and 
spoligotype signature as described previously (11). The remaining 55 isolates belonged to 
14 genotypes including other Latin American Mediterranean (LAM;n=18; 20.0%), X 
(n=7; 7.8%), unknown types (n=7; 7.8%), S (n=6; 6.7%), Beijing (n=5; 5.6%), Central 
Asian (CAS;n=5; 5.5%), T (n=4; 4.4%), and Haarlem (H) genotypes (n=3; 3.3%). 
 
Geographical distribution of PTB cases 
Figure 2 depicts the geographical distribution of the 204 PTB patients that were notified 
from September 2000-September 2001. There was a concentration of cases in district 6 
and 9 and these are densely populated townships at the western and north-western side of 
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the heavy industrial area. Incidence rates for the districts are shown in table 1 below. 
 
Figure 2: Geographical distribution of PTB cases identified in Gweru City over a period 
of one year. Each red dot represents one TB case 
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Table 1: The pulmonary TB incidence in each of the nine districts in Gweru during 
September 2000 –September 2001 
 
District Population No of new  
pulmonary 
TB cases 
Population 
density 
Inhabitants/k
m² 
Incidence 
(n/1000) 
1 8230 2 805 0.24 
2 11357 11 914 0.97 
3 6547 16 487 2.44 
4 8605 9 1629 1.04 
5 6525 9 4083 1.38 
6 7357 19 15792 2.58 
7 6992 16 5614 2.29 
8 6813 10 1554 1.47 
9 78784 112 8311 1.42 
Total 141210 204  1.44 
 
Geographical distribution of M. tuberculosis strains 
Figure 3 shows the distribution of M. tuberculosis strains in Gweru City.  As observed 
with the number of cases of PTB (Fig 2), the SAF1/RDRio strains were identified mainly 
in district 6, 7, 8 and 9. These districts also had a high number of TB cases notified. The 
SAF1/RDRio strains were predominantly isolated in district 9 (23/35; 65.7%) and were 
widely spread within this district. Though districts 6, 7 and 8 had high number of PTB 
cases the SAF1/RDRio strains were identified in lower proportions.  
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Figure 3: Geographical distribution of Mycobacterium tuberculosis genotypes (IS6110-
DNA fingerprint families assigned according to Richardson and colleagues [11]). 
Different coloured shapes represent different strain families and IS6110 DNA fingerprint 
family 9= SAF1/RDRio. The abbreviation H in red represents clinics. 
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Discussion 
TB is a disease that is closely associated with poverty and transmission occurs in settings 
where infected persons are in close contact with others. Using data collected over a year 
we looked at the distribution of TB cases in Gweru city and we then went further to look 
at the distribution of M. tuberculosis genotype. By plotting the distribution of M. 
tuberculosis genotypes in this high incidence setting, SAF1/RDRio strains were found to 
be spread out in high incidence districts in Gweru. This findings confirms those of an 
earlier study (10), showing that the SAF1/RDRio strains play an important role in the TB 
epidemic in Zimbabwe.  
 
The study had several limitations.  Gweru residents that were diagnosed outside the City, 
and were not transferred to the provincial hospital for further follow-up, were missed and 
the numbers were unknown. Therefore the number of TB cases included in this analysis 
may be lower than expected and we may underestimate the number of circulating strains. 
A majority of cases were from the high population density suburbs (district 6 and 9) but 
there were a substantial number of cases from the low population density districts 
(district 1-3 and 5). Not all genotypes from 184 isolates analysed as part of the previous 
study (chapter 2) were included in this analysis but only a subset with available 
genotyping data at the time of this analysis. Therefore the proportions of strains may have 
been under-represented.  
 
The findings of the RFLP analyses showed low strain diversity and SAF1/RDRio 
predominated. The SAF1/RDRio strains were more likely to be identified in high TB 
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incidence districts such as district 6, 8 and 9 and because of the small sample size this 
could have occurred by chance. Transmission as defined by identical M. tuberculosis 
strains, in this case SAF1/RDRio strains seemed to occur more commonly in these high 
TB incidence settings. However none were identified in district 3, another high TB 
incidence setting, and this could possibly be explained by the low number if isolates 
included in this analysis. Earlier studies in Harare also found a trend in association 
towards clustering and certain districts in Harare and that the incidence of TB was 
influenced by a small subset of actively circulating strains (12). Similarly, in high 
incidence settings in Cape Town, South Africa, some extremely large clusters could be 
identified that represented a disproportionate number of TB cases (13). It therefore seems 
reasonable that the SAF1/RDRio isolates identified in this study would be spread in high 
incidence settings which may imply that they play an important role in driving the TB 
epidemic.   
 
In conclusion, the distribution of SAF1/RDRio strains in Gweru is widespread and the 
majority of cases were found in a densely populated township. Though conclusions 
cannot be drawn from this cross sectional study, there was no evidence of transmission 
within households. Further studies will need to be done to confirm or refute these initial 
observations. The M. tuberculosis SAF1/RDRio strains were not clustered within the 
districts but were widespread in the city, implying that they play an important role in the 
TB epidemic in Gweru.  
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Abstract 
Background 
Whether the clinical spectrum of disease is dependent on Mycobacterium tuberculosis 
strains and whether specific factors predispose to infection with specific strains is 
unclear.  
Objectives 
To characterize M. tuberculosis strains from tuberculosis (TB) patients in Harare, 
Zimbabwe and to analyze the relationship between genotype, demographic characteristics 
and clinical consequences.  
Methods 
M. tuberculosis isolates from patients presenting with chronic cough, were genotyped 
using IS6110-restriction fragment length polymorphism (RFLP) and spacer-
oligonucleotide typing (spoligotyping). Demographic and clinical information collected 
at enrolment, were used to identify potential risk factors for disease and clinical 
consequences associated with disease due to the predominant genotype. 
Results 
Southern Africa Family 1/RDRio (SAF1/RDRio) strains were identified from 69/134 
(51.5%) isolates. Among HIV co-infected TB patients smoking was associated with 
disease due to SAF1/RDRio strains (adjusted OR (aOR) 3.50, 95% CI 1.20-10.20; 
p=0.02), but not with cavitary disease. However considering all TB cases, regardless of 
HIV status, smoking was associated with disease due to SAF1/RDRio(aOR 3.33, 95% CI 
1.25-8.83; p=0.02) and so was cavitary disease (aOR 2.11, 95% CI 1.00-4.51; p=0.05). 
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Though not significant, HIV negative patients were more likely to present with cavitary 
disease.  
Conclusion 
The SAF1/RDRio M. tuberculosis strains predominate in this population in Harare, 
Zimbabwe. Smoking may increase the chances of getting disease due to SAF1/RDRio. 
The observation that cavitary disease was common among HIV negative TB patients 
presenting with disease due to SAF1/RDRio, suggests a more severe disease that is easily 
transmissible in this population. Early diagnosis and treatment are critical in curbing 
transmission of TB in this community. 
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Background 
Tuberculosis (TB) an infectious disease caused by Mycobacterium tuberculosis remains 
one of the world’s leading cause of mortality. The World Health Organization estimates 
that one-third of the world’s population is currently infected with M. tuberculosis of 
which 5-10% will become sick or infectious at sometime in their life (1). The risk of 
developing disease increases to 10% per year in those infected with both M. tuberculosis 
and HIV (1).  
 
The chances of exposure to infection with M. tuberculosis is largely dependent on 
prevailing risk factors which may include the number of incident infectious cases in a 
community, duration of infectiousness, nature of interactions between a case and a 
susceptible contact, age and gender (2). The HIV pandemic is one of the most important 
challenges facing TB control. Immune suppression increases the risk of reactivation of 
latent TB infection and rapid progression to active TB disease and TB also speeds 
progression of HIV/AIDS (3, 4, 5). The incidence of TB remains high in Zimbabwe 
increasing from 604 to 782 per 100 000 population in 2000 and 2007 respectively (6, 7).  
 
Molecular typing based on genetic markers allows the rapid identification of 
mycobacteria within the M. tuberculosis complex as well as providing tools for 
examining the transmission and evolution of these microorganisms. DNA fingerprinting 
has enabled the accurate classification of M. tuberculosis strains allowing them to be 
classified according to genotypic similarity (8). Isolates can be classified into identical 
clones (strains) and also into anciently related major global genotypes (lineages/clades) 
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and each of these classifications address different questions thereby providing insights 
into TB disease dynamics in host populations (9, 10, 11, 12). Efforts to characterize the 
strains present within populations have led to an increasing understanding of their 
transmission and global distribution. These studies have shown that in certain areas a 
small number of strains cause a disproportionate number of TB cases  (13, 14, 15, 16). 
This may be a result of some strains being more inherently transmissible than others 
either because; firstly, they cause sputum smear positive disease that is more likely to be 
transmitted; secondly, infection with these strains results in delayed onset of symptoms in 
patients, making them more infectious for longer; or thirdly, these strains are more 
virulent than others. 
 
The Beijing genotype, the best characterized strain family has been confirmed as an 
emerging pathogen in several areas and a predominant endemic strain in others (13); it is 
frequently associated with young age suggesting an increased tendency to spread in East 
Asian countries (17,18,19) and also with MDR in Estonia, United States and 
Russia(20,21,22). Studies in Cape Town suggest that the rapid emergence of a 
predominant Beijing genotype demonstrated adaptations to conditions within the study 
community and is likely to reflect enhanced pathogenicity rather than transmissibility 
(12). Recently Gagneaux et al reported on the phylogenetic structure of M. tuberculosis 
genotypes and provided data that supported the hypothesis that certain genotypes are 
preferentially adapted to particular human populations (23). 
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In an earlier study we described a predominant group of strains, the Southern Africa 
Family 1 (SAF1/RDRio), identified in 47.2% of the M. tuberculosis isolates from TB 
patients in Harare and Gweru in Zimbabwe (15). The SAF1/RDRio isolates were 
characterized by 8-17 IS6110 hybridizing fragments and the majority of the isolates 
shared six IS6110-PvuII fragments of 0.9; 1.67; 1.43; 2.60; 2.7; 4.16 and 4.6 Kb. 
Spoligotype analysis revealed a characteristic spoligotype signature lacking spacers 21-
24; 27-30 and 33-36. By comparing the spoligotype patterns with what is available in the 
SpolDB4 database it was established that the SAF1/RDRio strains belonged to the Latin 
American-Mediterranean (LAM) genotype and were found to fall into the South African 
F9 family and also similar to the RDRio which have been found to be the a significant 
cause of TB worldwide (24, 25).  
 
The LAM genotype is the most prevalent M. tuberculosis genotype globally accounting 
for approximately 15% of the global TB burden. These strains were implicated in earlier 
studies in Zimbabwe as causing high rates of clustering (26,27). M. tuberculosis strains of 
the SAF1/RDRio genotype belong to the LAM family which is found within the principal 
genetic group 2 (PGG2), in phylogenetic cluster VI (28, 29), have a deletion in the region 
of difference (RD) TbD1 and a genotype specific large sequence polymorphism (LSP) 
(23). 
 
This genotype has been associated with disease outbreaks and MDR-TB including a 
recent description of the LAM4 subfamily, a leading cause of extreme drug resistant 
(XDR) TB in KwaZulu Natal in South Africa (30). SAF1/RDRio strains have been 
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reported in similar proportions in Rio de Janeiro and Belo Horizonte in Brazil 
contributing 30% and 37% of total TB burden, respectively (16, 31). Despite its large 
contribution to TB, much less is known about clinical and demographic factors associated 
with infection with the LAM family strains.. Associations were found with haemoptysis, 
weight loss, higher bacillary load (16) and cavitary disease (31). In Harare, where these 
similar strains have been found to predominate, it is unknown if tuberculosis caused by 
these strains will present with a differential clinical spectrum. 
 
Despite the contribution of the SAF1/RDRio genotypes to TB burden in Zimbabwe, very 
little is known about its association with clinical and demographic factors. We 
hypothesize that specific host and pathogen characteristics exist in this population that 
may be associated with disease due to M. tuberculosis SAF1/RDRio strains.  
 
As part of a study investigating the causes of chronic cough in Harare (32) we undertook 
firstly; to genotype M. tuberculosis isolates from TB patients identified in the study, 
secondly; to analyze potential risk factors if any associated with these SAF1/RDRio strains 
and thirdly to look at clinical consequences of disease due to SAF1/RDRio strains that are 
disproportionately represented in this community.  
 
Methods 
Study design 
A prospective cohort of ambulatory patients was recruited from 2 primary health care 
clinics in Mbare, a high density suburb of Harare between April-September 2003. A 
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systematic approach was used where recruitment was limited to weekdays and to the first 
five patients with chronic cough for each clinic per day. This study was censored to 
include only patients enrolled in the first 5 months of the study because of inflation 
related costs of preparation and shipping of cultures. 
 
Study setting and population  
Mbare is a high-density, southern suburb of Harare with an estimated population of 300 
000 people. Patients presenting with symptoms suggestive of pulmonary TB (cough ≥3 
weeks) are treated after diagnosis, according to the guidelines of the National TB control 
Programme (NTP). Though NTP activities have been fully integrated within primary 
health care, diagnostic facilities are only provided at the referral hospital Beatrice Road 
Infectious diseases hospital (BRIDH). In this study participants were investigated at 
primary health care clinics.  
 
Participants were enrolled to the study if they had had a cough for ≥3 weeks (regardless 
of other symptoms) and were ≥16 years. Only those individuals with culture confirmed 
tuberculosis were included in the study. Potential participants were excluded if they were 
receiving treatment for TB or required immediate admission to hospital, were unwilling 
to undergo confidential HIV testing or did not reside in Mbare suburb.  
 
Investigations 
All participants completed a questionnaire and provided a specimen for confidential HIV 
testing with written informed consent. Diagnostic evaluation followed a preset algorithm 
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of first- and second-line management and physical examination (32). Following 
examination 3 sputum specimens were collected for TB microscopy and culture and send 
to the Biomedical Research and Training Institute (BRTI) in Harare for microscopy, 
culture and organism identification. Radiographs were obtained on the first day and if 
abnormal again on day 7 and were graded by 2 independent readers (33).  
 
Case definitions and clinical data 
During the study the diagnosis of TB was confirmed if two or more positive results of 
sputum smear or culture plus compatible symptoms were identified. Diagnosis of 
probable TB was made if one positive result of sputum smear and/or positive result of 
culture with compatible clinical or radiological illness, failure to respond to broad 
spectrum antibiotics and response to TB treatment by 1 month (32). Patients with a 
positive diagnosis were referred to the city health department for clinical management 
and follow up. Clinical data was collected using a questionnaire and this included gender, 
age, duration of cough, signs and symptoms, history of previous treatment for TB, 
household TB contact, smoking and exposure to heavy dust or other irritants.  
 
Laboratory methods 
HIV testing 
Confidential HIV testing was performed using the Determine test (Abbott). All positive 
results and 1 in 10 negative results were confirmed with Unigold (Trinity Biotech). 
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Bacterial strains 
Concentrated sputum specimens were stained with auramine and examined under 
fluorescent light and positive slides were confirmed with Ziehl-Nieelsen (ZN). 
Mycobacterial culture was performed with Lowenstein-Jensen (LJ) slopes and Kirchner’s 
media after decontamination with 4% sodium hydroxide. All positive LJ slants were 
shipped to Stellenbosch University. A fresh LJ was re-inoculated at Stellenbosch LJ 
cultures and were incubated at 37°C until there was confluent growth to ensure adequate 
DNA for subsequent IS6110 genotyping. Only one isolate per patient was included in the 
analysis. Cultures were also tested for sensitivity to isoniazid (H) and rifampicin (R), 
using BACTEC MGIT 460 at critical drug concentrations of 0.1 mg/ml for H and 2.0 
mg/ml for R respectively. Drug susceptibility testing for streptomycin (S) and ethambutol 
(E) at critical drug concentrations of 2.0 mg/ml and 2.5 mg/ml, respectively, were only 
done if there was any resistance to H or R. 
 
DNA extraction 
DNA was extracted from M. tuberculosis cultures using previously described methods 
(34). IS6110–genotyping was performed using the international standard typing method 
for M. tuberculosis (35).  
 
DNA fingerprints were analyzed using Gelcompar (Version 4.0, Applied Maths, BVBA, 
Kortrijk, Belgium) and entered into a database.  Cluster analysis was done using the 
Unweighted Pair Group Method with Arithmetic mean (UPGMA), based on Dice 
Coefficient.  The isolates were classified into strain families according to the similarity of 
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the IS6110-genotype patterns. Isolates with an IS6110 similarity index of ≥70% were 
grouped into the same strain family (35). Isolates within strain families were classified 
into clusters of identical strains (strains sharing an identical IS6110 genotype pattern 
therefore considered as clustered) or unique (strains with unique genotype patterns 
therefore assumed to be unique cases).  
 
To allow classification of the strains into known family groupings the Harare dataset for 
the Mbare community was compared initially to the IS6110 genotype database of isolates 
from the epidemiological study site in Cape Town and the previous database from Harare 
and Gweru, Zimbabwe (both databases are maintained at Stellenbosch University) (12, 
15), to identify similarities in IS6110 genotype patterns . 
 
Spoligotyping 
M. tuberculosis isolates were spoligotyped by amplifying the Direct Repeat (DR) of the 
M. tuberculosis genome using the internationally standardized PCR protocol (36). To 
determine the reproducibility of the spoligotyping method, M. tuberculosis H37Rv DNA 
was amplified and included on each blot as a reference strain. The amplified products 
were hybridized to a set of 43 immobilized oligonucleotides each corresponding to one of 
the spacer DNA sequences in the DR locus. Resultant autoradiographs were analyzed 
manually and the binary pattern was entered into Microsoft Excel database (Microsoft 
Corporation, Redmond WA USA). The spoligotypes were compared with the 
spoligotypes deposited in the SpolDB4 worldwide database of the Pasteur Institute of 
Guadeloupe (available at http://www.pasteurguadeloupe.fr:8081/SITVITDemo). 
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Statistical analysis  
Data management 
Statistical analyses were performed using STATA 10.0 (Statacorp, College Station, 
Texas USA). An initial analysis was done by merging the clinical database with the 
IS6110 and spoligotype datasets.  
 
Study outcomes  
For the primary outcome M. tuberculosis strains were categorized into two major groups, 
the SAF1/RDRio strains versus all other strains families.   
 
The clinical outcome of cavitary disease was considered together with secondary 
outcomes of smear status and presence of three or more TB symptoms. Patients were 
coded as having cavitary disease if this was detected on chest X-ray. Disease severity 
scored as 0-6 based on the American thoracic society system (33) were further 
categorized as 0=none, less severe (a disease score of 2-3) and more severe (a disease 
score of 4-6). 
 
Smear positive isolates were categorized as positive and all scanty and negative smear 
isolates categorized as negative. As all participants enrolled to the study had a cough for 
≥3 weeks they were asked if they had any other symptoms including fever, night sweats 
and weight loss in addition to the cough. In this analysis the number of symptoms present 
was used as a proxy to severity of disease.  
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Clustering was also considered as a binary outcome variable with strains categorized as 
clustered if more than one isolate had the same IS6110 pattern and unique if the IS6110 
pattern was not shared with any other isolate.  
 
Exposure variables considered 
To establish if specific exposures predisposed to infection with the predominant strain 
family, the following exposures were considered: gender, age, HIV status, prior history of 
TB, household contact, smoking and exposure to heavy dust or irritants. Participants 
reporting having shared a home with someone on TB treatment were considered to have 
had a household contact with someone with TB. 
 
In univariable analyses each exposure variable was cross tabulated with strain family for 
all cases. Unadjusted odds ratios (OR) and their 95% confidence intervals (CIs) were 
estimated using logistic regression. Stratification of the analysis by HIV status was 
limited by power due to the limited numbers in the HIV negative group.  Therefore we 
present here an analysis for all TB patients and a sub-analysis for the HIV positive group. 
 
For the clinical outcome, cavitary tuberculosis and other secondary outcomes, strain 
family was considered as an exposure variable alongside exposure variables above. Each 
variable was cross tabulated with the secondary outcome (smear status or TB symptoms 
reported) and odds ratios and 95% confidence intervals estimated using logistic 
regression.  
 
Chapter 3 
101 
 
 All variables with evidence of an association with the outcome (p-value<0.05) in the 
univariable analysis were included in the multivariable model and adjusted odds ratios 
(aOR) and their 95% CIs estimated. The likelihood ratio test (LRT) was used to assess 
the overall associations.   
 
Ethical consideration  
Written informed consent was provided by all participants. Approval for the study was 
granted by the Ethics committees of the Biomedical Research Institute, Harare 
Zimbabwe, The Medical Research Council of Zimbabwe, the London School of Hygiene 
and Tropical Medicine and the Ethics Committee (Institutional Review Board) of the 
Faculty of Health Sciences Stellenbosch University. Voluntary counseling and testing 
was provided to all participants wanting to know their status, with onward referral for 
HIV-positive participants. 
 
Results  
In the 5 month period between 2 April 2003-1 September 2003, a total of 336 patients 
presenting with a cough ≥3 weeks (regardless of other symptoms) and culture positive for 
TB were enrolled to the study. Of these 149 (44.3%) were confirmed as having TB (two 
or more positive results of sputum smears or culture plus compatible illness). Culture was 
positive for 134 of 149 (89.9%) TB patients and these were included in this study.  
 
Of the 134 TB patients included in the study 119 (88.8%) were HIV positive and 15 
(11.2%) were HIV negative. The majority of the participants were males (56.0%), median 
age of 30 years (inter-quartile range 27-38 years), 61.9% reported having a cough for 
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more than 5 weeks and 58.2% were smear positive (Table 1). 16.4% of the TB patients 
who reported having been previously on TB treatment were all HIV positive. Cavitary 
TB was reported in 31.3% of the participants (Table 1).  
Chapter 3 
103 
 
Table 1: Characteristics of TB patients with genotyped M. tuberculosis isolates  
Characteristics* All (n=134) HIV positive (n=119) HIV negative 
(n=15) 
 n (column %) n (column %) n (column %) 
Age (years) 
18-24 
25-29 
30-34 
35-39 
≥40 
**30(16-73)  
16 (12.0) 
41 (30.8) 
30 (22.6) 
16 (12.0) 
30 (22.6)  
**30(16-56)  
13 (10.9) 
38 (31.9) 
28 (23.5) 
13 (10.9 
27 (22.8) 
**30 (19-73)  
3 (21.4) 
3 (21.4) 
2 (14.3) 
3 (21.4) 
3 (21.4) 
Gender 
Female 
Male 
 
59 (44.0) 
75 (56.0) 
 
54 (45.38) 
65 (54.6) 
 
5 (33.3) 
10 (66.7) 
Smear status 
Positive 
Negative 
 
78 (58.2)  
56 (41.8) 
 
69 (58.0) 
50 (42.0) 
 
9 (60.0) 
6 (40.0) 
Duration of cough (weeks) 
3-4 
≥5 
 
51 (38.1) 
83 (61.9) 
 
45 (37.8) 
74 (62.2) 
 
6 (40.0) 
9 (60.0) 
Past TB treatment 
Yes 
No 
 
22 (16.4) 
112 (83.6) 
 
22 (18.5) 
97 (81.5) 
 
0 (0.0) 
15 (100.0) 
Symptoms and signs 
Purulent sputum 
Haemoptysis 
Felt Feverish 
Night sweats 
Loss of weight 
 
31 (23.1) 
27 (20.1) 
129 (96.3) 
123 (91.2)  
271 (71.7) 
 
27 (23.1) 
22 (18.6) 
117 (98.3) 
112 (94.1) 
117 (98.3) 
 
4 (26.7) 
5 (33.3) 
12 (80.0) 
11 (73.3) 
13 (86.7) 
Household TB contact 
Yes 
No 
 
94 (70.1) 
40 (29.9) 
 
83 (69.8) 
36 (30.2) 
 
11 (73.3)  
4 (26.7) 
Exposure to occupation heavy dust 
Yes 
No 
 
24(18.0) 
109(82.0) 
 
22(18.6) 
96(81.4) 
 
2(13.3) 
13(86.7) 
Smoking status 
Never smoked 
Current smoker 
Former smoker 
 
93 (69.0) 
13 (9.7) 
20 (14.9) 
 
82 (73.9) 
           11 (9.9) 
18 (16.2) 
 
11 (73.3) 
2 (13.3) 
2 (13.3) 
Cavitary tuberculosis 
Yes 
No 
 
42 (31.3) 
92 (68.7) 
 
34 (28.8) 
84 (71.2) 
 
8 (53.3) 
7 (46.7) 
Cavitation 
None 
mild 
severe 
 
92 (68.7) 
16 (11.9) 
26 (19.4) 
 
84 (71.2) 
13 (11.0) 
21 (17.8) 
 
7 (46.7) 
3 (20.0) 
5 (33.3) 
***Diseased lung zones 
None 
Less extensive 
More extensive 
 
 
45 (33.6) 
51 (38.1) 
38(28.4) 
 
41 (34.8) 
43 (36.1) 
34 (28.8) 
 
4 (26.7) 
7 (46.7) 
4 (26.7) 
Data missing for age (n=1), HIV status (n=2), duration of cough (n=1), symptoms and signs (n=5), household contact (n=2), exposure 
to occupational heavy dust (n=1), smoking status (n=8), **Median (Range) years; ***Diseased lung zones: none=score 0; less 
extensive=score≤3; more extensive=score≥4 
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IS6110 restriction fragment length polymorphism patterns 
A total of 134 isolates had both IS6110 RFLP and spoligotype pattern. Strains with more 
than six IS6110 bands (high copy number strains) were identified in 125 (93.3%). Using 
the classification by Richardson et al (35), a total of 18 IS6110 high copy number strain 
families could be identified and the most common were F9 (n=70), F13 (n=10), F11 
(n=6), F14 (n=6), F28 (n=5) and F29 (n=8). Low copy number strains were also 
identified from 9 (6.7%) patients. 
 
Seventy-nine (59.0%) isolates were clustered into 28 clusters with sizes ranging from 2-7 
isolates. The remaining 55 (41.0%) isolates had IS6110 RFLP patterns not shared with 
any other isolate in this cohort (unique).  
 
Genotypes identified by spoligotyping 
By comparing the spoligotype patterns with those deposited on the SpolDB4 database, 13 
genotypes were identified from the 134 isolates. Ten patterns from 20 isolates did not 
matched any of the 1939 shared types (STs) representing 39 295 strains posted on the 
SpolDB4 database. 
 
The five most prevalent genotypes were the LAM (54.5%), T genotypes (9.7%), the 
IS6110 low banding family X genotypes (6.7%), the Beijing genotypes (6.0%) and the 
Central Asian (CAS) genotypes (5.2%) (Figure 1), which included both CAS1_Dehli and 
CAS1_Kili genotypes. A large proportion of the isolates (14.9%) had spoligotype 
patterns that were not matched to any type on the SpolDB4 database and are referred to 
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as orphan strains in this study. One isolate was identified as F9 using IS6110 and as 
belonging to the T genotype using spoligotyping possibly pointing to a mixed infection.  
  
Figure 1: Mycobacterium tuberculosis spoligotypes identified from patients presenting 
with tuberculosis in Mbare Harare 
 
The SAF1/RD
rio
 genotype 
The SAF1/RDRio strains were identified among M. tuberculosis isolates from 69 (51.5%) 
patients, excluding the isolate with more than one genotype (mixed), 58(84.0%) of whom 
were HIV positive. Among the SAF1/RDRio strains 15 different spoligotype patterns were 
identified, 9 of which were not matched to any STs in the SpolDB4 database (Figure 2). 
Using IS6110 RFLP a total of 46 IS6110 RFLP patterns were observed among the 69 
isolates. Of these 37 (53.6%) isolates were clustered into 14 different IS6110 RFLP 
patterns with cluster size ranging from 2-7. The remaining 32 (46.4%) isolates were 
unique. On univariable analysis clustering was not associated with disease due to 
SAF1/RDRio strains (OR 0.78, 95% CI 0.39-1.56; p=0.49). 
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Genotype SpoliDB4 
code 
Number of 
isolates(n) 
Spoligotype pattern 
LAM11_ZWE 807 1  
LAM11_ZWE 84 1  
LAM11_ZWE 812 3  
LAM11_ZWE 813 3  
LAM11_ZWE 815 5  
LAM11_ZWE 59 24  
LAM4 811 18  
*#N/A #N/A 3  
#N/A #N/A 2  
#N/A #N/A 2  
#N/A #N/A 2  
#N/A #N/A 1  
#N/A #N/A 1  
#N/A #N/A 1  
#N/A #N/A 1  
#N/A #N/A 1  
Total  69 
 
 
Figure 2: Spoligotype patterns and genotypes of the SAF1/RDRio strains (n=69) as 
defined from SpolDB4 database 
*#N/A: These are spoligotype patterns that were not matched to any of those in the SpolDB4 database 
 
Risk factors for infection with SAF1/RD
Rio
 strains 
Among all TB cases, though not significant, there was a trend towards an association 
between those who were currently smoking or ever smoked with disease due to 
SAF1/RDRio strains (OR 2.01, 95% CI 0.94-4.29; p=0.06) and so was HIV status (OR 
2.89, 95% CI 0.87-9.59; p=0.06), with HIV negative TB patients more likely to present 
with disease due to SAF1/RDRio strains (Supplemental table 1).  These variables were 
included in a multivariable analysis together with gender and age as they are likely 
confounders of smoking.  After controlling for both gender and age, smoking was 
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associated with disease due to SAF1/RDRio strains (aOR 3.33, 95% CI 1.25-8.83; p=0.02) 
(Table 2). 
 
Table 2: Factors associated with disease due to Mycobacterium tuberculosis SAF1/RDRio 
strains among culture positive TB patients-multivariable analysis 
 
 Outcome: Mycobacterium tuberculosis SAF1/RD
Rio strains 
 *Unadjusted OR 
(95% CI) 
**P 
value 
***Adjusted OR 
(95% CI) 
**** P 
value 
All patients     
Age (years) 
18-24  
25-29 
30-34 
35-39 
≥40 
 
1 
0.71 (0.22-2.26) 
1.0 (0.30-3.37) 
3.0 (0.67-13.4) 
1.14 (0.34-3.84) 
 
0.24 
 
 
1 
0.65 (0.19-2.21) 
1.00 (0.28-3.58) 
2.93 (0.62-13.80) 
0.98 (0.27-3.55) 
 
0.25 
 
Gender 
Male  
Female 
 
1 
0. 95 (0.48-1.88) 
 
0.89 
 
1 
1.99 (0.81-4.88) 
 
0.13 
TB treatment history 
No 
Yes 
 
1 
0.93 (0.37-2.32) 
 
0.38 
  
HIV status 
Positive 
Negative 
 
1 
2.89 (0.87-9.59) 
 
0.06 
 
1 
3.06 (0.87-10.76) 
 
0.08 
Currently/ever smoked 
No 
Yes 
 
1 
2.01 (0.94-4.29) 
 
0.06 
 
1 
3.33 (1.25-8.83) 
 
0.02 
 
  *Overall P value for univariable association 
  **Adjusted Odds ratio from logistic regression representing the summary relative odds of having disease 
due to M. tuberculosis Southern Africa 1 (SAF1)/RDRio strains compared with other strains, adjusting for 
all factors listed; CI confidence interval; *** Overall P value for multivariable association 
 
 In the unadjusted analysis among HIV co-infected TB patients smoking was associated 
with disease due to SAF1/RDRio strains (OR 2.21, 95% CI 0.99-4.88; p=0.04) 
(Supplemental table 2). TB patients also co-infected with HIV, reporting having had 
contact with someone within their household who had TB were more likely to present 
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with disease due to SAF1/RDRio strains, though this was not significant (OR 2.09, 95% 
CI 0.94-4.69; p=0.07) similarly those exposed to heavy dust or irritants (OR 0.41, 95%CI 
0.15-1.10, p=0.07). These were included in a multivariable analysis together with gender 
and sex as they are likely confounders of smoking. Smoking remained strongly 
associated with disease due to SAF1/RDRio strains (aOR 3.50, 95% CI 1.20-10.20; 
p=0.02) (Table 3). 
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Table 3: Factors associated with disease due to Mycobacterium tuberculosis SAF1/RDRio 
strains, among HIV positive TB patients with culture positive disease-multivariable 
analysis 
*Overall P value for univariable association 
**Adjusted odds ratio from logistic regression representing the summary relative odds of having disease 
due to M. tuberculosis Southern Africa 1 (SAF1) /RDRio strains compared with other M. tuberculosis 
strains, adjusting for all factors listed; ***Overall P value for multivariable association; CI: confidence interval 
 
Clinical consequences of TB disease due to SAF1/RDRio strains 
Cavitary tuberculosis was reported among 42/134 (31.3%) TB patients, being more 
common among HIV negative (53.3%) compared to HIV positive (28.8%) patients 
(Table 1). In an unadjusted analysis, disease due to M. tuberculosis SAF1/RDRio was 
associated with a higher odds of cavitary tuberculosis (OR 2.20, 95% CI 1.03-4.67; 
 Outcome: Mycobacterium tuberculosis SAF1/RD
Rio  strains  
 
 Unadjusted OR 
(95% CI) 
*P value **Adjusted OR 
(95%CI) 
***P value 
HIV positive TB 
patients 
    
Age (years) 
18-24  
25-29 
30-34 
35-39 
≥40 
 
1 
0.85 (0.24-3.01) 
1.17 (0.31-4.35) 
2.63 (0.53-13.07) 
1.08 (0.29-4.08) 
 
 
0.56 
 
 
1 
0.94 (0.25-3.55) 
1.36 (0.34-5.48) 
2.48 (0.46-13.06) 
1.15 (0.28-4.75) 
 
0.70 
Gender 
Male  
Female 
 
1 
0.96 (0.47-1.97) 
 
0.90 
 
1 
1.82 (0.68-4.89) 
 
0.23 
Household TB contact 
No 
Yes 
 
 
1 
2.09 (0.94-4.69) 
 
 
0.07 
 
 
1 
1.87 (0.80-4.38) 
 
 
0.15 
Currently/ever 
smoked 
No 
Yes 
 
 
1 
2.21 (0.99-4.88) 
 
 
0.04 
 
 
1 
3.50 (1.20-10.20) 
 
 
0.02 
Exposure to dust or 
irritants 
No 
Yes 
 
 
1 
0.41 (0.15-1.10) 
 
 
0.07 
 
 
1 
0.38 (0.14-1.05) 
 
 
0.06 
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p=0.04) (Supplemental table 3). In the multivariable analysis this remained associated 
with cavitary tuberculosis (Table 4).  
 
Table 4: Factors associated with cavitary tuberculosis disease, among culture positive TB 
patients –multivariable analysis 
 
 Unadjusted OR 
(95% CI) 
*P value **Adjusted OR 
(95% CI) 
***P value 
All patients     
Age (years) 
18-24  
25-29 
30-34 
35-39 
≥40 
 
1 
0.20 (0.58-0.69) 
0.26 (0.07-0.92) 
0.20 (0.04-0.91) 
0.22 (0.06-0.80)  
 
0.09 
 
 
1 
0.23 (0.06-0.81) 
0.27 (0.07-1.00) 
0.15 (0.03-0.75) 
0.22 (0.06-0.85) 
 
0.09 
Strain family 
Other 
SAF1/RDRio 
 
1 
2.20 (1.03-4.67) 
 
0.04 
 
1 
2.29 (1.00-5.27) 
 
0.05 
Currently/ever 
smoked  
No 
Yes 
 
 
1 
0.76 (0.33-
1.71)  
 
 
0.50 
 
 
1 
0.81 (0.33-
1.96) 
 
 
0.64 
HIV status 
Positive 
Negative 
 
1 
2.82 (0.95-
8.40) 
 
0.06 
 
1 
2.03 (0.61-
6.76) 
 
0.25 
* Overall P value for univariable association;**Adjusted odds ratio from logistic regression representing the summary 
relative odds of having cavitary tuberculosis among culture positive TB patients, adjusting for all factors listed; 
***Adjusted odds ratio; ****Overall P value for multivariable association; CI confidence interval 
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Though not significant, HIV negative patients were more likely to present with cavitary 
tuberculosis than HIV positive patients (Supplemental table 3). Among TB patients co-
infected with HIV, cavitary tuberculosis was not associated with any of the factors 
explored (Supplemental table 4). 
 
Smear positive disease was relatively common being identified in 78/134 (58.2%) culture 
positive TB patients (Table 1).  In an unadjusted analysis, though not significant, TB 
patients with more extensive diseased lung zones were more likely to have smear positive 
disease (OR 1.64, 95% CI 0.65-4.11; p=0.06) (Table 5). Though not significant, TB 
patients with disease due to M. tuberculosis SAF1/RDRio strains were more likely to be 
smear positive (OR 1.81 95% CI 0.91-3.64; p=0.08) (Table 5), and similarly patients with 
cavitary tuberculosis were more likely to be smear positive (OR 1.99 95% CI 0.92-4.32; 
p=0.07) (Table 5). After adjusting for age, strain family and smoking, no trend in 
association between diseased lung zones and smear status was observed. 
 
Among 119 HIV positive patients 69 (58%) patients had smear positive disease (Table 1). 
Within this group disease due to M. tuberculosis SAF1/RDRio strains was not associated 
with being smear positive, however, HIV positive patients with cavitary disease were 
more likely to be smear positive than those without (OR 2.65, 95% 1.11-6.34; p=0.02). 
After adjusting for age the association was no longer significant. 
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Table 5: Factors associated with smear positive tuberculosis among culture positive TB patients 
  Outcome: Smear positive 
 Total (All 
cases)  
All TB cases 
(row %) 
*Unadjusted OR 
(95% CI) 
**P 
value 
***Adjusted OR 
(95% C1) 
****P value 
All patients n=134 n=78     
Age (years) 
18-24  
32-29 
30-34 
35-39 
≥40 
 
16 
41 
30 
16 
30 
 
10 (62.5) 
25 (61.0) 
15 (50.0) 
9 (56.3) 
18 (60.0) 
 
1 
0.93 (0.28-3.08) 
0.60 (0.17-2.07) 
0.78 (0.18-3.17) 
0.90 (0.26-3.13) 
 
0.89 
 
1 
1.34(0.36-4.97) 
0.81 (0.21-3.05) 
0.76 (0.17-3.54) 
1.13 (0.29-4.40) 
 
0.84 
Gender 
Male  
Female 
 
75 
59 
 
46 (61.3) 
32 (54.2) 
 
1 
0.75 (0.37-1.49) 
 
0.40 
  
Strain family 
Other 
SAF1/RDRio 
 
65 
69 
 
33 (50.8) 
45 (65.2) 
 
1 
1.81 (0.91-3.64) 
 
0.08 
 
 
1 
1.73 (0.82-3.65) 
 
0.15 
HIV status 
Positive 
Negative 
 
119 
15 
 
69 (58.0) 
9 (60.0) 
 
1 
1.08 (0.36-3.24) 
 
0.88 
  
Cavitary TB 
No 
Yes 
 
91 
42 
 
48 (52.8) 
29 (69.1) 
 
1 
1.99 (0.92-4.32) 
 
0.07 
 
1.73 (0.68-4.37) 
 
0.25 
*****Diseased lung zones 
None 
Less extensive 
More extensive  
 
45 
50 
38 
 
27 (60.0) 
23 (46.0) 
27 (71.0) 
 
1 
0.57 (0.25-1.28) 
1.64 (0.65-4.12) 
 
0.06 
 
1 
0.67 (0.19-1.13) 
1.23 (0.42-3.63) 
 
0.09 
*Unadjusted Odds ratio from logistic regression representing the summary relative odds of presenting with three or more symptoms compared with less among TB patients; CI 
confidence interval;**P value for univariable association 
***Adjusted Odds Ratio; CI confidence interval;****P value for multivariable association 
***** Diseased lung zones: none=score 0; less extensive=score≤3; more extensive=score≥4 
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At the time of presentation a majority of the TB patients (121/134; 90.3%) had three or 
more symptoms of TB in addition to a cough ≥3 weeks. Disease due to M. tuberculosis 
SAF1/RDRio strains was not associated with the presence of three or more symptoms. In 
the unadjusted analysis older age groups, male gender, HIV positive TB patients and 
patients without cavitary TB were more likely to present with three or more symptoms of 
TB (Table 6). Gender and HIV status remained associated with presence of three or more 
symptoms in the adjusted analysis (Table 6). 
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Table 6: Factors associated with presence of three or more symptoms, among TB patients with culture positive disease    
  Outcome: Presence of three or more symptoms 
 Total (All 
cases)  
All TB cases (row %) *Unadjusted OR 
(95% CI) 
**P value ***Adjusted OR 
(95% C1) 
****P value 
All patients n=134 n=134     
Age (years) 
18-24  
25-29 
30-34 
35+ 
 
16 
41 
30 
46 
 
13 (81.3) 
38 (92.7) 
24 (80.0) 
45 (97.8) 
 
1 
2.92 (0.52-16.3) 
0.92 (0.19-4.31) 
10.4 (0.99-108.42) 
 
0.04 
 
1 
0.80 (0.08-7.71) 
0.18 (0.02-1.75) 
14.1 (0.67-296.9) 
 
0.08 
Gender 
Male  
Female 
 
75 
59 
 
71 (94.7) 
50 (84.8) 
 
1 
0.31 (0.09-1.07) 
 
0.05 
 
1 
0.18 (0.01-0.99) 
 
0.05 
Strain family 
Other 
SAF1/RDRio 
 
65 
69 
 
59 (90.8) 
62 (89.9) 
 
1 
0.90 (0.29-2.83) 
 
0.85 
  
HIV status 
Positive 
Negative 
 
119 
15 
 
112 (94.1) 
    9 (60.0) 
 
1 
0.09 (0.03-0.34) 
 
<0.001 
 
1 
0.02 (0.002-0.16) 
 
<0.001 
Cavitary TB 
No 
Yes 
 
91 
42 
 
86 (94.5) 
34 (81.0) 
 
1 
0.25 (0.08-0.81) 
 
0.02 
 
1 
0.25 (0.06-1.18) 
 
0.08 
*****Diseased lung zones 
None 
Less extensive 
More extensive 
 
45 
50 
38 
 
44 (97.8) 
43 (86.0) 
33 (86.8) 
 
1 
0.14 (0.02-1.18) 
0.15 (0.02-1.35) 
 
0.07 
  
*Unadjusted Odds ratio from logistic regression representing the summary relative odds of presenting with three or more symptoms compared with less among TB patients; CI 
confidence interval;**P value for univariable association; ***Adjusted Odds ratio; CI confidence interval; ****P value for multivariable association ***** Diseased lung zones: 
none=score 0; less extensive=score≤3; more extensive=score≥4 
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Drug susceptibility testing 
Of the 104 M. tuberculosis isolates with drug susceptibility test results, 2(1.9%) were 
resistant to H and only one (0.96%) to R. Due to this low level of resistance the drug 
susceptibility testing results were not considered as a potential risk factor in the 
univariable analysis. 
 
Discussion 
This study confirms that the SAF1/RDRio M. tuberculosis strains which belong to the 
LAM genotype continue to cause disproportionate number of cases of TB in Harare, 
Zimbabwe. To begin to understand host factors in disease due to SAF1/RDRio strains the 
present study looked at the strain diversity, demographic and clinical consequences 
among TB patients presenting at peripheral clinics and not only at a referral hospital 
therefore more likely to be representative of the general community in this high density 
suburb. The SAF1/RDRio strains characterized as strains of the LAM genotypes were the 
cause of TB in 51.5% of the TB patients. Other genotypes were identified, including the 
globally emerging Beijing, CAS, well characterized X and the ill defined T genotypes, 
these but were identified in much lower proportions.  
 
Prevalent among the SAF1/RDRio genotype were the LAM11_ZWE strains which have 
been reported as predominant from this community in Zimbabwe over 13 years (26, 27). 
The reasons for the predominance of the SAF1/RDRio genotype and how this M. 
tuberculosis population structure affects disease dynamic also remain unclear. The 
SAF1/RDRio strains displayed a rich diversity in IS6110 DNA fingerprint (79 patterns) 
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and spoligotype patterns (15 patterns). This rich diversity may point to endemic strains 
that have been circulating in this community for a long time and due to the several 
transmission events may have either lost or gained IS6110 bands hence generating the 
more fitter/successful strains that are well adapted to transmit and cause secondary cases 
in this specific population.  This finding is indicative but not full proof of host-pathogen 
associations. Additional support for this host pathogen association was provided in 
findings from other studies (16, 23, 37). Strains belonging to the LAM genotype, 
including these SAF1/RDRio strains have also been recognized as playing a role in the TB 
epidemic, accounting for approximately 15% of the strains submitted to the SpolDB4 
database (25) and have been associated with multidrug resistant (MDR)(38) and 
extremely drug resistant (XDR)TB (30). Studies by Gagneaux et al (23) looking at 
lineage specific secondary case rate were more indicative of M. tuberculosis genotypes 
that are adapted to specific populations.  
 
Our findings show that culture positive HIV negative, TB patients with disease due to 
SAF1/RDRio strains are twice more likely to have cavitary disease and that they were 
more likely to be smear positive. However risk factor analyses could not be done in this 
subgroup because the number of such individuals was very small. By looking at all the 
TB patients regardless of HIV status an association between cavitary disease and strain 
family was observed. Not surprising, in the sub group analysis that included only the HIV 
co-infected TB patients, there was no association of disease due to SAF1 and cavitary 
disease. 
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In a study in Belo Horizonte in Brazil where TB cases with clinical suspicion of 
multidrug resistance were studied, patients with disease due to RDRio were eight times 
more likely to have cavitary lung disease (31). However in this study 70/87 (80.5%) TB 
patients tested for HIV were HIV negative unlike the population in our study where a 
large proportion was HIV positive. However by looking at the TB patients, regardless of 
HIV status, both studies show an association with cavitary disease. The lack of 
association between positive smear status and cavitary disease was surprising and 
contradicted earlier studies which found an association between cavitary TB and high 
bacillary burden and transmissibility (39). Similar associations between other 
predominant genotypes and cavitary disease were found in Western India. However 
associations between cavitary pulmonary disease and smear status were not established in 
this (40).  
 
The finding of an association between M. tuberculosis genotype and cavitary disease 
highlights the importance of pathogen characteristics in the epidemic. This together with 
earlier findings of faster rate of growth in the LAM genotypes (41), may imply a fitness 
advantage.  
 
This study is the first to show an association between TB due to SAF1/RDRio and 
smoking. Smoking was reported in 31% of the participants and an association was 
observed with M. tuberculosis SAF1/RDRio genotype. Smoking has long been associated 
with TB and interacts with this disease by increasing disease susceptibility and worsening 
outcomes. Lung damage caused by smoking could enhance the risk of progression to 
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disease. A TB disease dynamics model using data from Zimbabwe showed that smoking 
enhanced transmission, progression to active disease and the number of active TB cases 
increased as number of smokers increased (42). It is not apparent, however, from our 
study how much of the transmission of SAF1/RDRio strains is attributable to smoking. 
 
Despite the lack of a strong association between smear status and main outcome 
measures, the proportion of smear positive disease was high (58.2%). In addition 
clustering was high (58% by IS6110 RFLP), clearly indicating that the epidemic is driven 
by transmission, possibly as a consequence of diagnostic delay and similarly cavitary 
disease. In earlier studies in the same population with high HIV prevalence, a substantial 
burden of undiagnosed smear positive TB disease (0.4%) was reported (43). Our findings 
underscore the need for early diagnosis and treatment of all TB cases in particular the 
infectious cases in this population with high prevalence of HIV.  
 
 Limitations include a potential inclusion bias of patients with disease due to SAF1/RDRio 
strains. The recruitment was restricted to week days, over 5 months and only the first 5 
participants with chronic cough at each clinic were included. Stratification of the analysis 
by HIV status was limited by power, because the numbers of TB patients that were HIV 
negative was very small. The finding of SAF1/RDRio as predominant strains was reported 
in a previous study though in current study the proportion of disease due to these strains 
is much higher.  
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In conclusion SAF1/RDRio M. tuberculosis strains are the most prevalent genotype 
causing TB in Harare Zimbabwe where 88% of the population were HIV positive. These 
strains are well adapted to this population. Specific host factors such as smoking and 
pathogen characteristics such as ability to cause smear positive and cavitary TB may play 
a significant role in the transmission, acquisition and outcome of disease. Early detection 
of cases and treatment of cases are fundamental in controlling the epidemic. 
 
Acknowledgements 
We would like to thank the Harare City Health Department staff, Mavis Mudzana and 
Vongai Madamombe for running the Project clinics. We thank Beauty Makamure, Julitta 
Magwenzi, Tafadzwa Mavhudzi and Mrs Mandisodza for their input in the study. We 
thank Beauty Makamure for arranging shipment of the isolates to Stellenbosch, Erica 
Engelke and Marian de Kok for assistance with laboratory sub culture and drug 
susceptibility testing.  
 
Financial support:  
This study was funded by Rockefeller Foundation; E L. Corbett is supported by a Career 
Development Fellowship from the Wellcome Trust. The molecular epidemiology 
component was funded through the Wellcome Trust Research Leave Fellowship Grant 
(01680/2/00/2 to V N. Chihota).   
  
Chapter 3 
120 
 
References  
1. World Health Organization (WHO). Global tuberculosis control: Short update to 
the 2009 report. WHO/HTM/TB/2009.426: WHO 2009 Geneva. Available from  
http://www.who.int/tb/publications/global_report/2009/update/en/index.html accessed 
19 January 2010 
 
2. Reider HL. Epidemiologic basis of tuberculosis control. First Edition 1999. 
International Union Against tuberculosis and Lung disease. 
 
3. Aaron L, Saadoun D, Calatroni I, Launay O, Mémain N, Vincent V, Marchal G, 
Dupont B, Bouchaud O, Valeyne D and Lortholary O. Tuberculosis in HIV-
infected patients: a comprehensive review. Clin Microbiol Infect 2004; 10: 388-398  
 
4. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr 
and Hopewell PC. An outbreak of tuberculosis with accelerated progression among 
persons infected with human immunodeficiency virus. An analysis using restriction 
fragment length polymorphism. N Engl J Med 1992; 326:231-5  
 
5. Shafer RW, Singh S, Larkin C and Small PM. Exogenous reinfection with 
multidrug resistant Mycobacterium tuberculosis in immunocompetent patients. 
Tubercle Lung Dis 1995; 76:573-577 
 
6. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC and 
Dye C. The growing burden of tuberculosis: Global trends and interactions with the 
HIV epidemic. Arch Intern Med 2003;163: 1009-1021 
 
7. WHO report 2009. Global tuberculosis control 
http://apps.who.int/globalatlas/predefinedReports/TB/PDF_Files/zwe.pd. Accessed 
13th February 2010 
 
8. Hermans PW, Messadi F, Guerbrexabher H, van Soolingen D, de Haas PE, 
Heersma H, de Neelin H, Ayoub A, Portaels F and Frommel D. Analysis of the 
population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia and the 
Chapter 3 
121 
 
Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect 
Dis 1995; 3:1055-1060. 
 
9. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC ,Scheter GF, 
Daley CL and Schoolink GK. The epidemiology of tuberculosis in San Francisco. A 
population-based study using conventional and molecular methods. N Engl J Med 
1994; 330:1703-1709 
 
10. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Ernason DA, Beyers N 
and van Helden PD. Exogenous reinfection as a cause of recurrent tuberculosis after 
curative treatment. N Engl J Med 1999; 341: 1174-1179  
 
11. Valway SE, Sanchez MP, Shinnick TF, Orme I, Agerton T, Hoy D, Jones J S, 
Westmoreland H and Onorato IM. An outbreak involving extensive transmission 
of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1998; 338:633-639 
 
12. Van de Spuy GD, Kremer K, Ndabambi SL, Beyers N, Dunbar R, Marais BJ, 
van Helden PD and Warren RM. Changing Mycobacterium tuberculosis population 
highlights clade specific pathogenic characteristics. Tuberculosis 2009; 89: 120-125 
 
13. European concerted Action on New Generation Genetic Markers and Techniques 
for the Epidemiology and control of tuberculosis. Beijing /W Genotype 
Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006;12:736-742 
 
14. Glynn JR, Crampin AC, Traore H, Chaguluka S, Mwafulirwa DT, Alghamdi S, 
Ngwira B.M, Yates M.D, Drobniweski FD and Fine PE. Determinants of cluster 
size in large population-based molecular epidemiology of tuberculosis Northern 
Malawi. Emerg Infect Dis; 2008: 14:1060-1066. 
 
15. Chihota V, Apers L, Mungofa S, Kasongo W, Nyoni IW, Tembwe R, Mbulo G, 
Tembo M., Streicher EM, van der Spuy GD, Victor T, van Helden P and 
Warren RM. Predominance of a single genotype of Mycobacterium tuberculosis in 
regions of Southern Africa. Int J Tuberc Lung Dis; 11:311-318 
Chapter 3 
122 
 
16. Lazzarrini LC, Huard RC, Boechat NL, Gomes HM, Oelemann MC, Kurepina 
N, Shashkina E, Mello F.C.Q,  Gibson A., Virginio MJ, Marsico AG, Butler R, 
Kreiswirth B.N., Suffys PN, Silva JRL and Ho JL. Discovery of a novel 
Mycobacterium tuberculosis lineage that is a major cause of tuberculosis in Rio de 
Janeiro, Brazil. J Clin Microbiol 2007; 3891-3902 
 
17. Anh DD, Borgdorff MW, Van LT, van Gorkom T, Kremer K and van Soolingen 
D. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect 
Dis 2000; 6:302-305. 
 
18. Jou R, Chiang CY, and Huang WL. Distribution of the Beijing family genotypes of 
Mycobacterium tuberculosis in Taiwan. J Clin Microbiol 2005; 43:95-100. 
 
19. Buu TN, Huyen MN, Lan NTN, Quy HT, Hen NV, Zignol M, Borgdorff MW, 
Cobelens FGJ and van Soolingen D. The Beijing genotype is associated with young 
age and multidrug-resistant tuberculosis in rural Vietnam. Int J Tuberc Lung Dis 
2009; 13:900-906 
 
20. KrüüuerA, Hoffner SE, Sillastu H, Danilovits M, Levina K, Svenson SB, 
Ghebremicahel S, Koivula T and Kallenius G. Spread of drug resistant pulmonary 
tuberculosis in Estonia. J. Clin Microbiol 2001; 39:3339-3345 
 
21. Bifani PJ, Plitkaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey SL, Moghazeh 
W, Eisner W, Daniel TM, Kaplan MH, Crawford JT, Musser JM and 
Kreiswirth BN. Origin and interstate spread of a New York City multidrug resistant 
M. tuberculosis clone family. JAMA 1996;275:452-457 
 
22. Baranov AA, Mariandyshev AO, Mannsaker T, Dahle UR and Bjune GA. 
Molecular epidemiology and drug resistance of widespread genotypes of 
Mycobacterium tuberculosis in northwestern Russia. Int J Tuberc Lung Dis 
2009;13:1288-93 
 
Chapter 3 
123 
 
23. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, 
Nicol M., Niemann S, Kremer K, Gutierrez MC, Hilty M, Hopewell PC and 
Small P. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc 
Natl Acad Sci U S A 2006, 103(8):2869-2873. 
 
24. Gibson AL, Huard RC, Gey van Pittius NC, Lazzarini LCO, Driscoll J, 
Kurepina N, Zozio T, Sola C, Spindola SM, Kritski AL, Fitzgerald D, Kremer K, 
Mardassi H, Chitale P, Brinkworth J, Garcia de Viedma D, Gicquel B, Pape JW, 
van Soolingen D, Kreiswirth BN, Warren RM, van Helden PD, Rastogi N, Suffys 
PN, Lapa e Silva J, and Ho JL. Application of sensitive and specific molecular 
methods to uncover global dissemination of the major RDRio sublineage of the Latin 
American Meditteranean Mycobacterium tuberculosis spoligotype family. J Clin 
Microbiol 2008; 46: 1259-1267. 
 
25. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, 
Aristimuño L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, 
Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de 
Viedma D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, van 
Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, Kulkarni SP, 
Liens B, Lillebaek T, Ho ML, Martin C, Martin C, Mokrousov I, Narvskaïa O, 
Ngeow YF, Naumann L, Niemann S, Parwati I, Rahim Z, Rasolofo-
Razanamparany V, Rasolonavalona T, Rossetti ML, Rüsch-Gerdes S, Sajduda 
A, Samper S, Shemyakin IG, Singh UB, Somoskovi A, Skuce RA, van Soolingen 
D, Streicher EM, Suffys PN, Tortoli E, Tracevska T, Vincent V, Victor TC, 
Warren RM, Yap SF, Zaman K, Portaels F, Rastogi N, Sola C.  Mycobacterium, 
tuberculosis complex genetic diversity: mining the fourth international spoligotyping 
database (SpolDB4) for classification, population genetics and epidemiology. BMC 
Microbiology 2006;6:23 
 
26. Easterbrook PJ, Gibson A, Murad S, Lamprecht D, Ives N, Ferguson A, Lowe 
O, Mason P, Ndudzo, Taziwa A, Makombe R, Mbengeranwa L, Sola ., Rastogi N 
and Drobnisewski F. High rates of clustering of strains causing tuberculosis in 
Chapter 3 
124 
 
Harare Zimbabwe: A molecular epidemiological study. J. Clin Microbiol 2004; 
42:4536-4544 
 
27. Heydermann RS, Goyal M, Roberts P, Ushewokunze S, Zizhou S, Marshall BG, 
Makombe R, Vann Embden JDA, Mason PR and Shaw R.J. Pulmonary 
tuberculosis in Harare Zimbabwe: analysis by spoligotyping. Thorax 1998, 53:346-
350 
 
28. Gutacker MM, Mathema B, Soini H, SHashkina E, Kreiswirth BN, Graviss EA 
and Musser JM. Single nucleotide polymorphism based population genetic analysis 
of Mycobacterium tuberculosis strains from 4 geographic sites. J Infect Dis 2006; 
193:121-128 
 
29. Gutacker MM, Smoot JC, Migliaccio CA, Ricklefs SM, Hua S, Cousins DV, 
Graviss EA, Shashkina E, Kreiswirth BN and Musser JM. Genome-wide analysis 
of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis 
complex organisms: resolution of genetic relationships among closely related 
microbial strains. Genetics 2002; 162:1533-1543. 
 
30. Pillay M and Sturm AW. Evolution of the extensively drug resistant 
F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu Natal, South 
Africa. Clin Infect Dis 2007;45:1409–1414 
 
31. Lazzarini LCO, Spindola SM, Bang H, Gibson AL, Weisenberg S, da Silva 
Carvalho W, Augusto CJ, Huard RC, Kritski AL and Ho JL. RDrio 
Mycobacterium tuberculosis infection is associated with higher frequency of cavitary 
pulmonary disease. J Clin Microbiol 2008; 46:2175-2183 
 
32. Munyati SS, Dhoba T, Makanza ED, Mungofa S, Wellington M, Mutsvangwa J, 
Gwanzura L, Hakim J, Nyakabau M, Mason PR, Robertson V, Rusakaniko S, 
Butterworth AE and Corbett EL. Chronic cough in primary health care attendees, 
Harare, Zimbabwe: Diagnosis and impact of HIV infection. CIin Infect Dis 2008; 
40:1818-1827. 
Chapter 3 
125 
 
33. American Thoracic Society. Diagnosis and treatment of tuberculosis. Am J Resp 
Crit Care Med 1990; 142:725-735 
 
34. Richardson M, van Lill SW, van der Spuy GD, Munch Z, Booysen CN, Beyers 
N, van Helden PD and Warren RM. Historic and recent events contribute to the 
disease dynamics of Beijing-like Mycobacterium tuberculosis isolates in a high 
incidence region. Int J Tuberc Lung Dis 2002; 6(11):1001-1011. 
 
35. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach B, Hermans P, 
Martin C, McAdam R and Shinnick T. Strain identification of Mycobacterium 
tuberculosis by DNA fingerprinting: recommendations for a standardized 
methodology. J Clin Microbiol 1993; 31: 406-409. 
 
36. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, 
Bunschoten A, Molhuizen H, Shaw R, Goyal M and van Embden J. Simultaneous 
detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and 
epidemiology. J Clin Microbiol. 1997 Apr; 35(4):907-14. 
 
37. Baker L, Brown T, Maiden MC and Drobniewski F. Silent nucleotide 
polymorphism and a phylogeny of Mycobacterium tuberculosis. Emerg Infect Dis 
2004;10:1568-1577 
 
38. Ignatova A, Dubiley S, Stepanshina V and Shemyakin I. Predominance of 
multidrug-resistant LAM and Beijing family strains among Mycobacterium 
tuberculosis isolates recovered from prison inmates in Tula Region Russia. J. Med 
Microbiol. 2006; 55:1413-1418 
 
39. Driver CR, Macaraig W, McElroy PD, Clark C, Munsiff SS, Kreiswirth BN, 
Driscoll J and Zhao N. Which patients’ factors predict the rate of growth of 
Mycobacterium tuberculosis clusters in urban community? Am J Epidemiol 2006; 
164: 21-31 
 
Chapter 3 
126 
 
40. Chatterjee A, D’Souza D, Vira T, Bamne A, Ambe GT, Nicol MP, Wilkinson RJ 
and Mistry N. Strains of Mycobacterium tuberculosis from Western Maharshtra, 
India, exhibit a high degree of diversity and strain-specific associations with drug 
resistance, cavitary disease and treatment failure. J. Clin Microbiol 2010; 48:3593-
3599 
 
41. Von Groll A, Martin A, Felix C, Prata PFS, Honscha G, Portaels F, Van Dame 
P, Almelda da Silva PE and Palomino JC. Fitness study of the RDrio lineage and 
Latin American-Mediterranean family of Mycobacterium tuberculosis in the city of 
Rio Grande, Brazil. FEMS Immunl Med Microbiol 2010;58: 119-127 
 
42. Bhunu CP, Mushayabasa S and Tchuenche JM. A theoretical assessment of the 
effects of smoking on transmission dynamics of Tuberculosis. Bull Math Biol 2010; 
Aug 20. [Epub ahead of print] 
 
43. Corbett EL, Bandason T, Cheung YB, Makamure B, Dauya E, Munyati SS, 
Churchyard GJ, Williams BG, Butterworth AE, Mungofa S, Hayes RH and 
Mason P. Prevalent infectious tuberculosis in Harare, Zimbabwe: Burden, risk 
factors and implications for control. Int J Tuberc Lung Dis 2009;13:1231-1237 
 
Chapter 4 
127 
 
 
 
 
Clonal expansion of a globally disseminated lineage of 
Mycobacterium tuberculosis with low IS6110 copy numbers
5
. 
 
 
 
R.M Warren, Victor T, Streicher EM, Richardson M, GD van der Spuy, Johnson R, 
Chihota VN, Locht C, Supply P and PD van Helden
                                                 
4Published as an original article: R.M Warren, Victor T, Streicher EM, Richardson M, GD van 
der Spuy, Johnson R, Chihota VN, Locht C, Supply P and PD van Helden (2004). Clonal 
expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 
copy numbers.  Journal of Clinical Microbiology 42 (12); 5774-5782. 
 
Chapter 4 
128 
 
 Abstract 
Knowledge of the clonal expansion of Mycobacterium tuberculosis and the accurate 
identification of predominant evolutionary lineages remain limited in this species, 
especially with regard to low-IS6110-copy-number strains.  In this study, 170 M. 
tuberculosis isolates with ≤ 6 IS6110 insertions, identified in Cape Town, South Africa, 
were characterized by principle genetic grouping, restriction fragment length 
polymorphism analysis, spoligotyping, IS6110 insertion site mapping and variable 
number tandem repeat (VNTR) typing.  This analysis indicates that all but one of the 
isolates analyzed were members of principal genetic group 2 and of the same low-
IS6110-copy-number lineage.  The remaining isolate was a member of principal genetic 
group 1 and a different low-IS6110-copy-number lineage.  Phylogenetic reconstruction 
suggests clonal expansion through sequential acquisition of additional IS6110 copies, 
expansion and contraction of VNTR sequences and the deletion of specific direct variable 
repeat sequences.  Furthermore, comparison of the genotypic data of 91 representative 
low-IS6110-copy-number isolates from Cape Town, other Southern African regions, 
Europe and America suggests that certain low-IS6110-copy-number strain spoligotypes 
and IS6110 fingerprints have been acquired in a distant past.  These clones have 
subsequently become widely disseminated and now play an important role in the global 
tuberculosis epidemic.  
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Introduction 
Sequence analysis of Mycobacterium tuberculosis strains collected from different 
geographical settings has shown that the frequency of mutation in this species is 
extremely low (31).  Single nucleotide polymorphism (SNP) and Variable Number 
Tandem Repeat-(VNTR) based analyses have consistently indicated that the global 
population of M. tuberculosis is highly clonal (1,15,34).  Within this clonal structure, 
strains can be assigned to one of three principal genetic groups according to SNP’s in the 
katG and gyrA genes (31).  Using an expanded array of synonymous single nucleotide 
polymorphisms (sSNP), these principal genetic groups have been further divided into 8 
main clusters to depict the evolution of M. tuberculosis (15).  Simulations have suggested 
that the branch points in the SNP derived trees are accurate (1).  However, subsequent 
clonal expansion occurring at each of these branch points remains largely unknown due 
to the lack of resolution of SNP-based analyses (1).   
 
Various combinations of more variable markers, primarily used for molecular 
epidemiological studies, have been utilized to identify genotype families which fall into 
the different clusters defined by SNP’s (15).  The most commonly used marker is IS6110, 
a transposable element used as a probe in restriction fragment length polymorphism 
(RFLP) analysis of clinical isolates (35).  Genetic relationships between strains have been 
inferred according to an IS6110-RFLP dice similarity index of > 65 % and the inheritance 
of other specific polymorphisms.  This data has been applied to depict clonal expansion 
in high-copy-number strains with > 6 IS6110 copies (5,37,40,42) and for their 
epidemiologic analysis on a global scale (4).   
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However, only a limited amount of evolutionary data exists for low-IS6110-copy-number 
strains with ≤ 6 IS6110 hybridizing bands, due to their intrinsically limited IS6110-RFLP 
polymorphism.  One report has presented evidence to show evolution of the IS6110 
banding pattern in the progeny of a low-IS6110-copy-number strain (22).  More recently 
a high degree of congruence was shown to exist between IS6110 banding patterns and 
other markers in strains with few IS6110 copies collected in London, United Kingdom 
(7).  Accordingly, these strains have been classified into three different groups (7).  One 
of these groups (Group II) includes the principal genetic group 2 clusters IV and V 
defined by sSNP analysis, representing strains with 1-3 and 4-6 IS6110 copies, 
respectively (15).  A second distinct group includes strains from principal genetic group 1 
(cluster I (15)), which have been associated with patients from East-Africa and Asia 
(6,30).  However, the process of clonal expansion within these groups of low-IS6110-
copy-number strains remains largely unresolved.  Moreover, the genetic relationships 
between strains within these groups from different geographical regions are poorly 
understood.  
 
In this study we have used RFLP (42), principal genetic grouping (31), IS6110 insertion 
site mapping (6), spoligotyping (19), and PCR analysis of Variable Number of Tandem 
Repeats (VNTRs) interspersed in multiple loci (14,23,24,33) to determine the genetic 
relationship between low-IS6110-copy-number strains collected in Cape Town, South 
Africa.  This data has been compared to available genotypic data from low-IS6110-copy-
number strains isolated from other geographical areas, in order to better define the 
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evolution of low-IS6110-copy-number strains and the impact of such evolution on the 
interpretation of molecular epidemiological data. 
 
Materials and methods 
Study Setting 
Between January 1992 and December 1998, Mycobacterium tuberculosis isolates were 
obtained from patients resident in two suburbs in Cape Town, South Africa (3) as well as 
a subset of patients resident in the adjoining suburbs.  The two suburbs have a population 
of 38500 residents within an area of 3.4 km2 and have two healthcare clinics.  In this 
setting the average annual incidence of new bacteriologically confirmed tuberculosis 
cases (culture and/or smear-positive) was 313/100,000 (38).  
 
DNA fingerprinting  
Genomic DNA from each isolate of M. tuberculosis was digested with either PvuII or 
HinfI, electrophoretically fractionated and Southern transferred to Hybond N+ 
(Amersham, United Kingdom).  The blots containing the PvuII-digested DNA were 
sequentially hybridized with ECL-labelled probes complementary to the 3' domain of the 
IS6110 element (IS-3') (35), the 5' domain of the IS6110 element (IS-5') (42), direct 
repeat (DR) (42) and Marker X (Roche, Germany).  Each probe was stripped by 
denaturation before the next probe was applied.  The HinfI Southern blots were 
hybridized with the 32P-labeled MTB484(1) probe complementary to the polymorphic 
G+C-rich repeat sequences (PGRS) (41).  The autoradiographs were normalized and the 
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IS-3', IS-5' and DR bands were assigned using GelCompar II software.  Cluster analysis 
was done using the UPGMA (unweighted pair group method with arithmetic mean) and 
Dice coefficient (17).  Mutations in the IS6110-flanking domains were determined as 
previously described (43).  The band corresponding to the IS6110 insertion in the DR 
region was identified by aligning the DR and IS-3' autoradiographs (42). The blots 
probed by MTB484(1) were visually analyzed by two independent persons (42).  
PCR amplification was used to determine the presence or absence of an IS6110 insertion 
in the genes Rv0403c, Rv1758, or Rv3018c according to the previously described method 
(6).  IS6110 insertion in the gene Rv2787c was determined using the primer set 5'-
TTCAACCATCGCCGCCTCTAC-3' and 5'-GGCCAAATCCAGCACGGTGAAC-3'. 
 
Mutation analysis 
The M. tuberculosis isolates were classified into three principle genetic groups according 
to polymorphisms in the katG and gyrA genes (31), using the dot blot hybridization 
method (39). 
 
SpoligotypingDNA polymorphism in the DR locus was detected in isolates with ≤ 6 
IS6110 insertion elements by spoligotyping according to a standardized protocol (19).   
 
 
MIRU-VNTR typing 
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M. tuberculosis isolates were genotyped by PCR amplification of the 12 loci containing 
VNTRs of elements called Mycobacterial Interspersed Repetitive Units (MIRUs) (33) 
and 9 loci containing VNTRs of other interspersed sequences (14,21,24,Supply et al., in 
preparation) using both manual (33) and automated techniques (32).  The primers against 
the MIRU-VNTR flanking regions were the same as previously described (33), except 
that hex labelling was replaced by Vic labelling. The primers against the other loci are 
described in Table 1.  The samples were subjected to electrophoresis using a 96-well ABI 
377 automated sequencer as previously described (32).  Sizing of the PCR fragments and 
assignment of the various VNTR alleles were done using the GeneScan and Genotyper 
software packages (PE Applied Biosystem), as previously described (32) and based on 
the data described in Table 1. Tables used for VNTR allele scoring are available at 
http://www.ibl.fr/mirus/mirus.html.  Allele assignments were identical between the 
manual and automated methods.  
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Table 1: Conditions for multiplex PCRs of nine VNTR loci 
Multiplex Conventional  
designation
a 
 
VNTR length 
(bp) 
MgCl2  
(mM) 
PCR primer pairs  
(5' to 3', with labeling indicated) 
Mix E VNTR 2347 57 1.5 GCCAGCCGCCGTGCATAAACCT (FAM) 
AGCCACCCGGTGTGCCTTGTATGAC 
 VNTR 2461 57  ATGGCCACCCGATACCGCTTCAGT (VIC) 
CGACGGGCCATCTTGGATCAGCTAC 
 VNTR 3171 54  GGTGCGCACCTGCTCCAGATAA (NED) 
GGCTCTCATTGCTGGAGGGTTGTAC 
Mix F VNTR 0424 51 1.5 CTTGGCCGGCATCAAGCGCATTATT 
GGCAGCAGAGCCCGGGATTCTTC (FAM) 
 VNTR 0577 58  CGAGAGTGGCAGTGGCGGTTATCT (VIC) 
AATGACTTGAACGCGCAAATTGTGA 
 VNTR 1895 57  GTGAGCAGGCCCAGCAGACT (NED) 
CCACGAAATGTTCAAACACCTCAAT 
Mix G VNTR 2401  58 3.0 CTTGAAGCCCCGGTCTCATCTGT (FAM) 
ACTTGAACCCCCACGCCCATTAGTA 
 VNTR 3690 58  CGGTGGAGGCGATGAACGTCTTC (VIC) 
TAGAGCGGCACGGGGGAAAGCTTAG 
 VNTR 4156 59  TGACCACGGATTGCTCTAGT 
GCCGGCGTCCATGTT (NED) 
aVNTR 0577, 2461, 4156, 1895 are described in (28), and correspond to ETRC, ETRB, QUB 4156 and 
1895, respectively (14,25). 
 
Global dissemination  
To determine the geographical spread of the low-IS6110-copy-number strains, M. 
tuberculosis isolates collected from Southern (Western Cape) (n = 47), Central (Free 
State) (n = 4) and Northern (Gauteng and Mpumalanga) (n = 4) regions in South Africa 
and from Harare and Gweru (n = 11) in Zimbabwe were subjected to spoligotyping, 
IS6110-RFLP and IS6110 insertion mapping (6).  This genotypic data was compared to 
previously published genotypic data (IS6110 banding patterns (visual comparison), 
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IS6110 insertion points and spoligotype patterns) on low-IS6110-copy-number strains 
from Europe (United Kingdom (n = 14) (7), Denmark  (n = 2) (2)) and America 
(Michigan (n = 70) (6) and CDC1551 (12)). 
 
Genetic relationship analysis  
The evolutionary state(s) for the RFLP data were assigned according to the presence 
(indicated by “1”) or the absence (indicated by “0”) of a hybridizing band.  Spoligotypes 
were assigned according to the presence or absence of spacer sequences, while the VNTR 
alleles were assigned according to the number of repeats present in the different loci.  The 
complete set of evolutionary states for the different markers were subjected to 
phylogenetic analysis using the neighbor joining algorithm (PAUP 4.0*; Phylogenetic 
Analysis Using Parsimony (*Other Methods) Version 4b10. Sinauer Associates, 
Sunderland, Massachusetts).  Bootstrapping was performed to establish a degree of 
statistical support for nodes within each phylogenetic reconstruction (10).  A consensus 
tree was generated using the program contree (PAUP 4.0*) in combination with the 
majority rule formula.  The resulting trees were rooted to the principal genetic group 1 
isolate (SA CT(67)).  Only branches which occurred in > 50 % of the bootstrap trees 
were included in the final tree and all branches with a zero branch length were collapsed.  
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Results 
Selection and molecular characterization of strains 
Between January 1992 and December 1998, Mycobacterium tuberculosis isolates were 
obtained from 1030 patients resident in the adjoining suburbs in Cape Town, South 
Africa.  IS6110-RFLP analysis established that 186 (18.1 %) of these patients were 
infected with a strain containing ≤ 6 IS6110 hybridizing bands.  No isolate lacking the 
IS6110 element was identified in this study setting.  Isolates were available from 170 (91 
%) of these patients for further genotypic analysis. 
 
Analysis of the katG and gyrA gene sequences classified 169 of these isolates in principal 
genetic group 2 , while only one isolate was classified as principal genetic group 1 (31).  
All isolates were then subjected to further analysis using Southern hybridization in 
combination with probes complementary to the 3' domain of the IS6110 element (IS-3') 
(35) (Figure 1), 5' domain of the IS6110 element (IS-5') (42), spoligotyping (19) (Table 
2) and VNTR allele typing based on 21 independent loci (14,21,25,32,33) and PGRS-
RFLP typing (41) (Table 3). This set included (alias designation in brackets) MIRU-
VNTR loci 2, 4 (ETR-D), 10, 16, 20, 23, 24, 26, 27, 31 (ETR-E), 39 and 40, and VNTR 
loci 424, 577 (ETR-C), 1895 (QUB-1895), 2347, 2401, 2461(ETR-B), 3171, 3690, 4156 
(QUB-4156). 
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Table 2: Spoligotype patterns of Cape Town M. tuberculosis isolates with ≤6 IS6110 
elements  
 
 
aSpoligotype type, arbitrary designation (see Table 3).  
bOctal Code according to (8).  
cClosed boxes infer the presence of DVR sequences, while open boxes infer the absence of DVR sequence.  
 
 
In addition, IS6110 insertion into the genes Rv0403c, Rv1758, Rv3018c and Rv2787c 
was determined by PCR amplification (Figure 1A).  Table 3 summarizes the genotypic 
data of the different isolates as defined by the combined markers.  For this data set, the 
number of principal genetic group 2 genotypes obtained with the different methods was 
ranked as follows: IS-3' (14 genotypes) < IS-5' (19 genotypes) < spoligotypes (20 
genotypes) < IS-3' & IS-5' (22 genotypes) < VNTR loci (38 genotypes) < PGRS (45 
genotypes).  In combination, these different genotyping methods identified a total of 66 
distinct principal genetic group 2 genotypes (Table 3). 
Spoligotype 
type
a
 
Octal code
b
 Spoligotype pattern
b
 
1 777777777760771                                            
2 777776777760601                                            
3 777736777760601                                            
4 677776777760601                                            
5 777776777760771                                            
6 777776777720601                                            
7 737776777760601                                            
8 767776777760601                                            
9 777776777760711                                            
10 743776777760601                                            
11 777776777760731                                            
12 700076777760771                                            
13 617776777760771                                            
14 777776777760740                                            
15 700076774360771                                            
16 700076777740371                                            
17 700076777760671                                            
18 777776777560771                                            
19 777776617560771                                            
20 757777777413731                                            
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Table 3: Genotypic classification of Cape Town M. tuberculosis isolates with ≤ 6 IS6110 
elements 
Name 
Principal 
genetic 
group  
IS6110 
Copy 
IS-3' 
type  
IS-5' 
type  
PGRS 
 type  
12 MIRU-VNTR type 
(allele combinationsa) 
9 VNTR  
 (allele 
combinationsb) 
Spoligotype   
 typee (Octal format c) 
SA CT(1) 2 1 1 1 1 1 (225125113322)  (144442353) 1 (777777777760771) 
SA CT(2) 2 2 2 2 2 2 (223325153323)  (142442383) 2 (777776777760601) 
SA CT(3) 2 2 2 2 3 3 (224325123422)  (242442343) 3 (777736777760601) 
SA CT(4) 2 2 2 2 3 3 (224325123422)  (242442343) 2 (777776777760601) 
SA CT(5) 2 2 2 2 4 4 (224325143223) Nd 3 (777736777760601) 
SA CT(6) 2 2 2 2 4 4 (224325143223)  (442442333) 2 (777776777760601) 
SA CT(7) 2 2 2 2 5 5 (224325143324)  (242442343) 4 (677776777760601) 
SA CT(8) 2 2 2 2 5 5 (224325143324)  (242442343) 3 (777736777760601) 
SA CT(9) 2 2 2 2 5 5 (224325143324)  (242442343) 2 (777776777760601) 
SA CT(10) 2 2 2 2 6 6 (224325153223)  (442442431) 2 (777776777760601) 
SA CT(11 - 12) 2 2 2 2 2, 7 7 (224325153323)  (142442383) 2 (777776777760601) 
SA CT(13) 2 2 2 2 2 7 (224325153323)  (142442383) 5 (777776777760771) 
SA CT(14) 2 3 3 3d 8 8 (223325143323)  (2424422?3) 6 (777776777720601) 
SA CT(15) 2 3 3 4 9 9 (224325133324)  (442442333) 7 (737776777760601) 
SA CT(16) 2 3 3 4 9 10 (224325153323)  (442442333) 7 (737776777760601) 
SA CT(17) 2 3 4 5 10 11 (223325163322)  (242442333) 8 (767776777760601) 
SA CT(18) 2 3 4 5 10 12 (224325163322)  (242442333) 8 (767776777760601) 
SA CT(19) 2 3 5 6 11 13 (224325153222)  (522442332) 9 (777776777760711) 
SA CT(20) 2 3 5 7 d 12 14 (224325153324) (252441343) 10 (743776777760601) 
SA CT(21) 2 3 6 d 5 13 15 (223325153223)  (442442333) 2 (777776777760601) 
SA CT(22) 2 3 6 d 5 14 10 (224325153323)  (442442333) 2 (777776777760601) 
SA CT(23) 2 3 6 d 5 14 16 (224325153323)  (452442333) 2 (777776777760601) 
SA CT(24) 2 3 7 8 15 17 (223325163433) Nd 2 (777776777760601) 
SA CT(25) 2 4 8 9 16 18 (223325143322)  (432442333) 5 (777776777760771) 
SA CT(26 - 30) 2 4 8 9 16, 17, 18, 
19, 20 
19 (223325143324)  (432442333) 5 (777776777760771) 
SA CT(31) 2 4 8 9 19 20 (223325143325)  (432442333) 5 (777776777760771) 
SA CT(32) 2 4 8 9 17 21 (223325153324)  (432442333) 11 (777776777760731) 
SA CT(33) 2 4 8 9 21 19 (223325143324) Nd 5 (777776777760771) 
SA CT(34) 2 4 8 9 22 21 (223325153324) (432442333) 5 (777776777760771) 
SA CT(35 - 36) 2 4 8 10 23, 24 22 (223325153224)  (332442343) 12 (700076777760771) 
SA CT(37) 2 4 8 10 23 23 (224325153322)  (432442343) 12 (700076777760771) 
SA CT(38 - 44) 2 4 8 10 23, 25, 26, 
27, 28, 29, 30 
24 (224325153324)  (432442343) 12 (700076777760771) 
SA CT(45) 2 4 8 10 31 24 (224325153324) Nd 5 (777776777760771) 
SA CT(46) 2 4 8 11 32 25 (224325153324) Nd 12 (700076777760771) 
SA CT(47) 2 4 8 11 33 25 (224325153324)  (332442331) 13 (617776777760771) 
SA CT(48) 2 4 9 12 d 34 26 (224325153324)  (432442333) 14 (777776777760740) 
SA CT(49 - 50) 2 4 9 9 34, 35 21 (223325153324)  (432442333) 14 (777776777760740) 
SA CT(51 - 52) 2 4 9 9 34, 35 27 (224325133324)  (432442333) 14 (777776777760740) 
SA CT(53) 2 4 9 9 34 28 (226325153324)  (432442333) 15 (777776777760740) 
SA CT(54) 2 4 9 10 36 24 (224325153324)  (432442343) 15 (700076774360771) 
SA CT(55) 2 4 9 10 37 29 (224325153325)  (432442343) 16 (700076777740371) 
SA CT(56) 2 4 10 13 38 30 (224325153434) Nd 2 (777776777760601) 
SA CT(57) 2 4 11 14 39 31 (224225164434) Nd 17 (700076777760671) 
SA CT(58) 2 5 12 15 d 40 32 (224325143324)  (432442334) 5 (777776777760771) 
SA CT(59) 2 5 12 16 41 33 (224325153322)  (432442333) 18 (777776777560771) 
SA CT(60) 2 5 12 16 42 33 (224325153322)  (432442333) 16 (777776777760771) 
SA CT(61) 2 5 12 16 41 34 (234325133323)  (432442333) 18 (777776777560771) 
SA CT(62) 2 5 12 16 41 35 (234325153323) Nd 5 (777776777760771) 
SA CT(63) 2 5 12 17 41 33 (224325153322)  (432442333) 19 (777776617560771) 
SA CT(64) 2 5 13 18 43 36 (224325153222)  (532442433) 12 (700076777760771) 
SA CT(65) 2 5 13 18 44 37 (224325153222)  (532442333) 12 (700076777760771) 
SA CT(66) 2 6 14 19 45 38 (224325164335) Nd 12 (700076777760771) 
SA CT(67) 1 5 15 20 46 39 (254316?34613) 
 
Nd 20 (757777777413731) 
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aMIRU-VNTR loci according to (33).  
bVNTR loci 424, 577, 1895, 2347, 2401, 2461, 3171, 3690, 4156 (see Table 1 and (14,24), Supply et al. in 
preparation).   
cSpoligotype nomenclature according to (8). 
dMutations in the IS6110-flanking domains other than in the DR region (43). 
eSpoligotype type: arbitrary designation to demonstrate genetic diversity.  
Nd not determined. ? missing VNTR allele.  
 
 
 
 
Clonal expansion of strains 
Combined analysis of the above different molecular markers strongly supported the close 
genetic relatedness of the principal genetic group 2 isolates and their clear distinctiveness 
from the single isolate from principal genetic group 1.  Six out of 21 VNTR loci (MIRU-
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Figure 1. Southern blot analysis of Cape Town M. tuberculosis isolates with ≤ 6 IS6110 i nsertions.  
Genomic DNA was restricted with PvuII, electrophoretically, fractionated on agarose gels and Southern 
hybridization was done with ECL-labeled IS-3' probe. 
A) IS6110 banding pattern of distinct principal genetic group 2 isolates from Cape Town, South Africa.  
Lanes are labeled according to the isolate names given in Table 3.  The band representing the IS6110
insertion in the DR repeat region and bands representing IS6110 insertions in genes Rv0403c, Rv1758, 
Rv2787c, and Rv3018c are indicated. 
B) IS6110 banding pattern of the principal genetic group 1 isolate from Cape Town, South Africa.  Lane 
labeled according to the isolate name given in Table 3.  Co-hybridization between the IS6110 and DR 
probes could not be de monstrated due to the presence of a PvuII site situated between the 3' domain of 
the IS6110 element and the flanking DR region
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VNTR loci: 2, 20, 23, 24, and VNTR 2347 and 2401) were fully identical within 
principal genetic group 2 isolates analysed (Table 3), while 7 other loci (MIRU-VNTR 
locus 4, 16, 27, 39, VNTR 1895, 2461, 3171) displayed at most 3 variations compared to 
the predominant alleles among these isolates.  PCR amplification of the Rv0403c region 
(Figure 1A), showed that only the principal genetic group 2 variants with ≥ 2 and ≤ 6 
IS6110 elements shared an IS6110 in the same position, suggesting that these isolates 
were derived from a common ancestor.  All principal genetic group 2 spoligotypes 
showed a deletion of direct variable repeat (DVR) sequences 33 to 36 (29), while isolates 
with ≥ 2 and ≤ 6 IS6110 insertions also all showed an additional DVR 18 deletion (Table 
2).  DVR 34 was deleted in the principal genetic group 1 isolate (Table 2).  
 
Phylogenetic analysis of the principle genetic group 2 isolates was done based on the 
whole set of markers, using the principle genetic group 1 member as an outgroup (SA 
CT(67)) (Figure 2).  The overall branching order of the tree suggests that the principal 
genetic group 2 isolates evolved from a common progenitor by sequential replicative 
transposition of IS6110 followed, in certain cases, by mutation in the regions flanking the 
IS6110 elements (Table 3).  According to this tree, these clones first evolved by 
replicative transposition of the IS6110 element into Rv0403c (Figure 1A) and by the 
deletion of DVR 18 to generate a strain with two IS6110 insertions (Figure 2).  These two 
genotypic characteristics, along with the six conserved VNTR loci, were subsequently 
inherited in all the progeny.  In different branches of this progeny, subsequent IS6110 
insertions were identified in Rv1758, Rv3018c and Rv2787c, to generate clonal variants 
with between three and six IS6110 insertions (Figure 2).  Along with these events 
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occurred the deletion of DVR's 39 to 42 and DVR's 4 to 12 (Table 2 and Figure 2).  
Broadly similar pictures of stepwise acquisition of IS6110 were obtained by phylogenetic 
analysis using either IS6110-RFLP, spoligotyping and PGRS or VNTR genotypes alone 
(data not shown). 
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Figure 2. Phylogenetic tree of Cape Town M. tuberculosis isolates with ≤ 6 IS6110 insertions.  Genetic data from five 
different genotyping methods were subjected to phylogenetic analysis using the bootstrapping and neighbor joining 
algorithm In methods. The tree was rooted to the principal genetic group 1 clone (isolate SA CT(67)).  Booststrap values are 
given at internal nodes.  IS6110 insertion in defined genes as well as DVR deletions are indicated at the nodes where they 
occurred.  All branches with a zero length were collapsed. Isolate names are the same as in Table 3.  Principle genetic 
groups 1 and 2 were assigned according to polymorphisms in the katG and gyrA genes (31). The scale indicates the number 
of steps per unit length 
Chapter 4 
143 
 
Geographical distribution of strains 
To determine the evolutionary relationships between the low-IS6110-copy-number 
strains in different geographical regions, the genotypic data from a representative set of 
the Cape Town isolates (n = 16) was compared with those of a representative set of low-
IS6110-copy-number isolates from other regions of Southern Africa (n= 17) (this study), 
Europe (London UK (n = 8) (7) and Denmark (n = 2) (2)), and America (Michigan (n = 
47) (6) and the CDC1551 reference strain (6)).  Phylogenetic analysis using these data 
indicated a close evolutionary relationship between the principal genetic group 2 isolates 
from these different geographical regions (Figure 3).  Many of the isolates between the 
different settings shared identical IS-3' banding patterns, IS6110 insertion points and 
spoligotypes, and only in rare instances were IS6110 transposition and DVR deletion 
events found to be unique to a specific geographic region (Figure 3, IS6110 insertion in 
Rv2787c of SA isolates).  These observations suggest that these genotype properties were 
acquired in a distant past and prior to the global dissemination of the lineage.  In contrast, 
comparison of MIRU-VNTR genotypes based on 12 loci, in common with those 
previously reported (6), failed to identify clones with identical IS-3', spoligotype and 
MIRU-VNTR genotypes between Cape Town and Michigan, indicating that the MIRU-
VNTR loci are evolving more rapidly.  A similar study could not be done for the PGRS 
genotypes as this methodology has not been internationally standardized. 
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Figure  3.  Phylo genetic tree of  M. tuberc ulos is iso lates with  ≤ 6  IS6110 insert ions  obtained fro m different geogra phica l re gio ns.   
Representative isolates (n  = 91) cul tured in  Cape Town , Southern Africa , Europe (2,7),  and the Uni ted Sta tes o f America (6,12)  were 
included.  Genetic  data  from  IS6110 banding  pat terns, IS6110 insertion  points  and spoligo typing were subjected to phylogene tic
analysis using the boo tstrapping and  neighbor jo ining algori thm  The tree was rooted  to  the  principal gene tic group 1  isolate  (SA
CT(67)).  Boos tstrap values are given  at  internal  nodes.  IS6110 insertion in  def ined genes as wel l as D VR dele tions are ind icated a t 
the nodes where they occurred.  All  branches with a  zero length  were collapsed.   The  Cape Town  isolate  names are  the  same as in 
Table 3,  while  the  isolates from o ther regions o f Southern  A frica are labeled  as follows: SA WC ( South  A frica Western Cape),  SA OF 
(South Africa  Free Sate),  SA G ( South  A frica Gauteng) , SA MP ( South  A frica Mpu malanga) and  ZIM (Zi mbabwe).  The  isolates from 
Europe are labeled  according to  (7) and (2),  while the isolates from the America are  labeled according to (6) and  (12)  Principal gene tic  
groups 1 and 2 were  ass igned according to poly morphisms in the ka tG and  gyrAgenes (31).   The scale indica tes the  number o f s teps 
per unit length . 
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Discussion 
This study provides evidence that nearly all M. tuberculosis isolates with ≤ 6 IS6110 
elements, collected in Cape Town, South Africa, are members of a lineage of the 
principal genetic group 2.  Evidence for this is based on the inheritance of defined 
polymorphisms, which include;  1) principal genetic group 2 classification according to 
mutations in the katG and gyrA genes (31), and concordant deletion of DVR's 33 to 36, 
known to be specific to principal genetic group 2 and 3 strains (29);  2) the identification 
of a conserved IS6110 insertion in Rv0403c (13) and the deletion of DVR 18 from the 
direct repeat region in principal genetic group 2 strains with ≥ 2 and ≤ 6 IS6110 
insertions;  3) the presence of six fully conserved VNTR loci.  Only one isolate from this 
setting was identified as being a member of a distinct low-IS6110-copy-number lineage 
of the principal genetic group 1, which corresponds to Cluster I (15) or Group I (7) and 
has been primarily associated with patients from East-Africa and Asia (6,30). 
 
The principal genetic group 2 lineage studied here encompasses the groups referred to as 
Group II and III (7) or clade X (27), and clusters IV and V defined by sSNP analysis (15).  
Our phylogenetic analysis based on fully independent markers in isolates from different 
geographical areas, supports the notion that strains in this principal genetic group 2 
lineage evolved from a common progenitor containing a single IS6110 element by 
sequential acquisition of up to five additional IS6110 copies, as well as by expansion and 
contraction of VNTR sequences and the deletion of specific DVRs. Sequential 
acquisition of additional IS6110 copies is consistent with the direct evolutionary 
relationship between the sSNP clusters IV and V, which include strains with 1-3 and 4-6 
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IS6110 copies, respectively (15).  Such congruence between phylogenies inferred from 
independent sets of markers (within our study or between our study and that of Guttacker 
et al., 2003) provides strong evidence for the robustness of the inferred phylogeny. 
Moreover, the deletion of DVRs suggested by our phylogenetical analysis (Figure 2 and 
3) is consistent with previous findings supporting that evolution of the DR region is 
driven by loss of DVR sequences rather than by their duplication (9,36,44). 
 
Interestingly, each IS6110 transposition event appeared to occur only once within the 
phylogenetic tree, suggesting divergent evolution.  This is in sharp contrast to previous 
suggestion that the IS6110 banding patterns of low-IS6110-copy-number strains could 
have evolved convergently due to the presence of preferential IS6110 integration sites 
(13).  The limited number of IS6110 variants identified may suggest that IS6110 
transposition is regulated in this lineage, raising the hypothesis of lineage-specific effects.  
Regulation in the number of transposable elements, referred to as taming, has been 
described in eukaryotic genomes, and might be a specific mechanism against mutagenic 
effects induced by these elements (18). 
 
The preservation of certain IS-3' banding patterns and spoligotypes in isolates from Cape 
Town, from other Southern African regions, from Europe and from America suggests that 
these markers have remained stable over a long period of time.  Therefore, we 
hypothesize that these genotypes represent distantly evolved clones that have become 
globally disseminated.  The examination of the SpolD database (11) indicates that 
principal genetic group 2 isolates with the characteristic DVR 33 to 36 and DVR 18 
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deletions have been isolated in 27 different countries.  By comparison, principal genetic 
group 1 clones with the characteristic DVR 34 deletion have been isolated in 26 
countries, with a high prevalence in South Asia.  Taken together, these findings suggest 
that in addition to other well-identified lineages like W-Beijing (4), the principal genetic 
group 1 and 2 low-IS6110-copy-number lineages also play an important role in the global 
tuberculosis epidemic.  
 
The inferred stability of the IS-3' banding patterns and of certain spoligotypes for 
extended periods of time is likely too high to be informative for tracking ongoing 
transmission between patients in settings where this lineage is predominant.  Conversely, 
comparison of our genotype data with those of Cowan et al. (6) failed to identify strains 
between Cape Town and Michigan in which the IS-3’ banding pattern, spoligotype and 
MIRU-VNTR types are identical.  Given the stability of MIRU-VNTR genotypes in 
epidemiologically-linked isolates (16,20,23,26) the absence of MIRU-VNTR matching 
between the two studies is in accordance with the above argument of distant relationships 
between shared IS-3' types and spoligotypes.  Moreover, it supports VNTR typing as a 
useful tool for epidemiologic tracking across various epidemiological settings and 
bacterial populations.  This is consistent with the contention that, as a multi-locus based 
method, VNTR typing is much less exposed to biases inherent to single loci or to copy 
numbers of a single genetic element, such as spoligotyping and IS6110-based typing, 
respectively. 
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Our study represents a step towards a better understanding of the evolutionary 
mechanisms modelling the genome in different M. tuberculosis lineages and of the 
different rates at which these events occur. This will provide new insights for the 
interpretation of molecular epidemiological data and enhance our understanding of how 
different strains contribute to the tuberculosis epidemic in specific regions and at a global 
scale. 
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Abstract 
Introduction 
Different Mycobacterium tuberculosis genotypes contributing to tuberculosis have been 
described in countries of Southern Africa. However a comprehensive assessment of the 
population structure of M. tuberculosis in this region has not been done. 
Aim 
To compare the population structure of M. tuberculosis in Southern Africa regions and to 
describe the regional population, as an entity. 
Methods 
Spoligotyping and/or IS6110-restriction fragment length polymorphism (RFLP) data 
were received from collaborating institutes in Mozambique, Tanzania, South Africa, 
Zambia and Zimbabwe. Additional spoligotyping data was extracted from the SpolDB4 
database and this was obtained for Madagascar, Malawi, Namibia and Zimbabwe, Further 
data from Tanzania was also obtained from published literature. Statistical analyses using 
X
2 test were performed to compare differences in proportions of the M. tuberculosis 
genotypes across these countries.  
Results 
A total of 5586 isolates from 8 countries in Southern Africa were included in this 
analysis, 53.2% of which were from South Africa. M. tuberculosis genotypes identified 
included Latin-American-Mediterranean (LAM) (34.2%), Beijing (16.1%), T (9.8%), 
Central Asian (CAS) (7.8%), X (6.9%) and East African Indian (EAI) (6.3%). LAM 
genotypes were predominantly isolated from Namibia (80% of isolates), 65% of isolates 
in both Zambia and Zimbabwe and 50% of isolates from Malawi. 88.3% of Beijing 
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genotypes identified were from South Africa. Other genotypes including T genotype were 
more prevalent in Madagascar, the CAS genotype in Tanzania, the EAI more prevalent in 
Mozambique (31.3%) and the S and X genotypes in South Africa (7.3%) and 11.2% 
respectively.  
Conclusion 
A large diversity of M. tuberculosis genotypes, with some genotypes localized within 
specific geographic regions was identified. These observations suggest that particular M. 
tuberculosis strains may be adapted to particular host populations in the region. This may 
have implications for development of diagnostic tools, vaccines and drugs.  
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Introduction  
Mycobacterium tuberculosis, an important human pathogen causing tuberculosis (TB), 
kills close to 2 million people each year and infects 2 billion people globally (1). The TB 
incidence in Southern Africa has increased due to the HIV epidemic, worsening the 
public health problem posed by TB. It is estimated that there are ≥500 new TB cases per 
100 000 population in each of the Southern African countries. The HIV prevalence in 
new TB cases is ≥50% and therefore TB remains the leading cause of death from an 
infectious disease (1,2).  
 
In recent years genetic loci in M. tuberculosis have been identified and molecular tools 
developed to better understand the epidemiology of TB (3). The Direct Repeat locus 
(DR) consisting of DRs and variable spacers has proved to be invaluable in assessing the 
genetic variability of tuberculosis (4). Spoligotyping is an easy, robust, cheap and highly 
reproducible molecular tool to assay this DR locus (4). Combining Spoligotyping with 
other molecular techniques such as variable number tandem repeat (VNTR) typing (5), 
Mycobacterial-interspersed-repetitive-units (MIRU) (6) or IS6110-restriction fragment 
length polymorphism (RFLP) (7) increases the precision in identifying the different M. 
tuberculosis clones. 
 
Different genotypes contributing to disease have been described globally with specific 
genotypes causing disproportionate disease in some populations (8).  The availability of 
genotypic data, including SpolDB4 (9), not only allows comparability analysis of the 
global phylogeographical population structure but regional structures as well, together 
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with TB transmission and underlying spatial and temporal evolution of strains of the 
different genotypes (9). These are important as they contribute to the development of new 
tuberculosis control tools. However a comprehensive assessment of the genetic 
variability of M. tuberculosis in Southern African regions has not been done despite the 
availability of some genetic diversity data from countries in this region. Thus our current 
knowledge of the genetic diversity is limited to a study by Gagneaux et al (10). Using 
comparative genomic and molecular epidemiological tools on a global sample of 875 
strains from 80 countries, the study defined six main lineages of M. tuberculosis that are 
highly geographically structured. 
 
Predominant clades have been reported from different countries in the Southern Africa 
region varying from Central Asia (CAS)_Kili strains making up 30% of the population in 
Northern Tanzania and Dar es Salaam (11, 12), Latin American- Mediterranean 
(LAM)strains in 47.2% and 65% of isolates from Zimbabwe and Zambia respectively 
(13) and five major clades Beijing, LAM, Low copy clade (LCC), Haarlem (H) and 
Quebec have been reported as making up 84% of the population structure in a community 
in Western Cape (14). Invariably some of these strains have been associated with drug 
resistance. Beijing genotype has been associated with multidrug-resistant (MDR) and 
extensively drug-resistant (XDR) TB in provinces of South Africa (15, 16, 17) and is 
overrepresented in children with drug resistant TB (18), LAM being associated with 
XDR in KwaZulu Natal (19) and LCC strains in the Boland/Overberg and Southern 
Cape/Karoo (BOKS) regions in Western Cape (20). 
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Early indications from these studies show that the M. tuberculosis population structure 
may be less homogenous within countries and across different countries than previously 
thought (9, 10). The distribution and heterogeneity could possibly reflect the different 
host population, migration patterns and colonization history across the region. These 
variations may have implications for TB prevention and control strategies. To better 
understand the population structure across this region the current study will collect data 
from different regions of Southern Africa with the aim of describing the clades of M. 
tuberculosis contributing to the TB problem and the spread these strains across the 
region. It is envisaged that by describing the distribution of strains at a regional level, the 
disease dynamics will be better understood. These data on M. tuberculosis population 
structure will help contribute towards understanding clinical presentation and in the 
development and design of vaccines, drugs and diagnostics. 
 
We hypothesize that specific genotypes of M. tuberculosis predominate in defined 
regions of Southern Africa and vary within and across different countries in this region.  
Such genotypes predominate and have a propensity to spread due specific bacterial and 
host population, migration and environmental factors. The aims of the study were to 
compare the population structure of M. tuberculosis in Southern Africa and to describe 
the regional population as an entity. 
 
Methods 
Study design 
Chapter 5 
160 
 
The study was a descriptive study using genotyping data available from countries that are 
part of Southern Africa to describe the population structure of M. tuberculosis complex. 
 
Study population 
The M. tuberculosis spoligotypes or IS6110 RFLP data included in the study were 
received from co-investigators and collaborating institutes from Southern Africa. IS6110 
DNA fingerprint patterns were assigned to genotypes (families) accordingly to previously 
described criteria (21, 22). Where spoligotyping data was not available from investigators 
or institutes, data was searched on the SpolDB4 database or on Pub Med for published 
literature reporting M. tuberculosis strain diversity and spoligotypes in regions of 
Southern Africa.  
 
All the spoligotyping data was entered in separate Microsoft Excel sheets and converted 
to STATA files using STATA 10 (Statacorp, College Station, Texas USA). 
 
Briefly, isolates contributing to this analysis were collected as follows: 
Mozambique 
Sputum samples were collected from 2007-2008 from pulmonary TB patients with no 
prior history of tuberculosis as part of a nationwide drug resistance surveillance (DRS) 
program. Patients included in the surveillance were 40 randomly selected districts in 
seven provinces of Mozambique including, Maputo City, Maputo, Gaza, Inhambane, 
Nampula, Cabo Delgado and Niass Provinces. Only tuberculosis patients aged 15 years 
or older were included in the study.  Sputum specimens were sent to the district 
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laboratories for smear microscopy and to National Reference Laboratory for culture and 
drug susceptibility testing. Heat killed cultures were sent to the Centre of Biotechnology 
of Eduardo Mondlane University, in Maputo city and to the Swedish Institute for 
Infectious Disease Control, in Solna, for genotyping.  
 
South Africa 
M. tuberculosis isolates included in this study were from three sites in Western Cape, as 
well as sites in Eastern Cape and KwaZulu Natal. 
 
In the first site in Western Cape, as part of a long term molecular epidemiological project 
started in 1992, M. tuberculosis isolates were collected from patients residing in and 
attending primary health care facilities in an epidemiological field site. In this community 
approximately 350 new bacteriologically confirmed adult tuberculosis cases are reported 
per 100 000 population annually. Each isolate was classified by IS6110 RFLP using 
internationally standardized protocol (7, 21). 
 
As part of a prospective study done in a second site in Cape Town from April 2002 to 31 
March 2004, patients presenting with symptoms of pulmonary TB were enrolled to the 
study. In addition, individuals identified as TB patients, from whom sputum samples 
were taken to determine whether or not they were infectious, were also enrolled in the 
study. Two sputum specimens were collected from each TB suspect and sent to the 
National Health Laboratory Services (NHLS) reference laboratory in Cape Town for 
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smear microscopy and culture. Positive Löwenstein-Jensen (LJ) slants were sent to the 
Stellenbosch University for IS6110 RFLP. 
 
Similarly, in the third suburb in Cape Town, South Africa, TB suspects having sputum 
taken for TB diagnosis and individuals identified as TB patients having sputum taken to 
determine whether or not they were infectious were enrolled to the study. Sputum 
samples were sent to the NHLS reference laboratory in Cape Town for smear microscopy 
and culture.  Positive LJ slants were sent to the Stellenbosch University for 
spoligotyping. 
 
Isolates from KwaZulu Natal were from sputum specimens collected from pulmonary TB 
patients hospitalized at two provincial hospitals in KwaZulu Natal from 2005-2006. Prior 
to 2006 specimens from patients in KwaZulu Natal were performed in 2 laboratories, one 
at Nelson R Mandela School of Medicine and at King George V Hospital in Durban. 
After February 2006, the samples were sent to NHLS for smear microscopy and culture. 
Positive LJ slants were sent to the University of KwaZulu Natal for genotyping using 
IS6110 -RFLP and spoligotyping. Only isolates sensitive to anti-TB drugs were included 
in this analysis. 
 
From July 2008-June 2009, tuberculosis cases that were suspected MDR-TB cases, as 
defined by clinical response to treatment, identified at primary health clinics in Eastern 
Cape Province were referred to the NHLS in Port Elizabeth for routine drug susceptibility 
testing. Only isolates sensitive to anti-TB drugs were included in this analysis. 
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Tanzania 
As part of a routine drug resistance surveillance programme from 2001-2007, sputum 
samples were collected from both new and retreatment TB cases identified at TB clinics 
in 26 regions of Tanzania. Smear microscopy was done at local facilities and specimens 
were sent for culture to one of the three tuberculosis reference laboratories in Tanzania 
namely; the Central Tuberculosis Reference Laboratory (CTRL), Dar es Salaam, the 
Bugando Medical Centre (BMC), Mwanza and the Kilimanjaro Christian Medical Centre 
(KCMC), Moshi. Positive cultures were heat killed and shipped to Norway for 
spoligotyping. 
 
Zambia 
The isolates from Zambia (n=114) were part of a national drug resistance surveillance 
study done between December 1999 and January 20001. Specimens were obtained from 
new smear positive patients who had not started tuberculosis treatment, presenting at 
various medical centres in different provinces. The samples were cultured on LJ slants at 
the Chest Diseases Laboratory (CDL) in Zambia. All culture positive isolates were sent to 
the Tropical Disease Research Centre (TDRC) for DNA extraction and the DNA shipped 
to Stellenbosch University, for spoligotyping.  
 
Zimbabwe 
The M. tuberculosis isolates included in this study were from studies done in Harare and 
Gweru in Zimbabwe. For the first study; sputum specimens were collected from patients 
presenting with pulmonary TB at Beatrice Road Infectious Diseases Hospital (BRIDH), 
Chapter 5 
164 
 
the main referral centre for infectious diseases in Harare, from October to December 
2001 (n=120). The second study included sputum specimens collected from pulmonary 
TB patients presenting at the Gweru Provincial Hospital, recruited from September 2000 
to September 2001 (n=300) as part of a study examining  the characteristics of different 
laboratory methods and the accuracy of diagnosis in routine circumstances and these 
results are described elsewhere (13, 23). In the third study sputum specimens were 
collected from patients presenting with chronic cough at primary health care clinics 
(n=134) (24) and from work place clinics in Harare (n=108). All sputum specimens 
collected in these studies were sent to the Biomedical Research and Training Institute 
(BRTI) in Harare for microscopy and culture. Positive cultures were sent to Stellenbosch 
University for spoligotyping and IS6110-RFLP. 
 
Statistical analysis 
To assess the population structure of M. tuberculosis in Southern Africa, individual 
databases for datasets from each data source were analyzed using STATA (Statacorp, 
College Station, Texas USA). After cleaning each dataset, the STATA files were merged 
by appending all the files. The Pearson’s chi-squared test was used for testing the 
difference in proportion of M. tuberculosis genotypes within provinces and also among 
the different provinces. A level of p<0.05 was considered statistically significant. 
 
Ethical considerations 
The current study was part of long-term molecular epidemiology study which has been 
approved by the ethics committee of the Faculty of Health Sciences, Stellenbosch 
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University Ethics Committee. Approvals were also sought from Ethics committees of 
represented countries and from individual investigators to collaborate in the study. 
Participants in the study were identified by a unique study number. No personal 
identifiers were included in the data sent to Stellenbosch University  
 
Results 
Spoligotyping and/or IS6110 RFLP data was received from co-authors in five countries 
including ten provinces of Mozambique (n=543), three provinces of South Africa 
including Western Cape Province (n=2648), KwaZulu Natal (n=119) and Eastern Cape 
(n=245); 20 regions of Tanzania (725), Zambia (n=114) and two provinces in Zimbabwe 
(Harare n=260, Midlands n=174). Additional spoligotyping data from Harare, Zimbabwe 
(n=245) was also extracted from SpolDB4 database together with data from Madagascar 
(n=323), Namibia (n=78) and Malawi (n=112). From the published literature additional 
data was obtained for Tanzania (Dar es Salaam n=146 and Northern Tanzania n=130) 
(11, 12). No data were available from Angola, Botswana, Democratic Republic of Congo 
(DRC), Lesotho and Swaziland. 
  
M. tuberculosis genotype identified in Southern African countries 
The regional distribution of M. tuberculosis genotypes was assessed within 8 of the 14 
(57.1%) countries in Southern Africa that are members of the Southern Africa 
Development Community (SADC). M. tuberculosis isolates from Western Cape Province 
were disproportionately represented and those from Namibia, Zambia and Malawi 
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underrepresented (Table 1). Of the 3012 isolates from South Africa, 2258 were 
genotyped using IS6110 RFLP and lineages inferred from this DNA fingerprinting data. 
 
Table 1: Number of M. tuberculosis isolates from the countries in Southern Africa  
Country M. tuberculosis Isolates (n) Percentage (%) 
Madagascar 323 5.8 
Malawi 112 2.0 
Mozambique 543 9.7 
Namibia 78 1.4 
South Africa 3012 53.9 
Tanzania 725 13.0 
Zambia 114 2.0 
Zimbabwe 679 12.2 
Total  5586 100.0 
 
Major M. tuberculosis genotypes identified in regions of Southern Africa 
The six most frequent genotypes identified among 5586 M. tuberculosis isolates from the 
eight Southern African countries were LAM (34.2%), Beijing (16.1%), T (9.8%), CAS 
(7.8%), X (6.9%) and East Asia India (EAI;6.3%),(Table 2).  
 
In six countries M. tuberculosis isolates belonging to the LAM genotype were identified 
in high proportions and these included Namibia (81%), Zambia and Zimbabwe in similar 
proportion (65%), Malawi (50%), Mozambique (34%) and South Africa (31%) (Figure 
1). A total of 68 shared types (STs) could be identified among these genotypes. Of the 78 
LAM strains identified in Namibia 62 (79%) were LAM 1 genotype, LAM 11_ZWE 
genotypes were common in isolates from Mozambique (32.6%), Zambia (79.7%) and 
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Zimbabwe (64.3). Of 125 LAM strains from South Africa that had sub lineage data 121 
were LAM 3 strains. 
 
M. tuberculosis genotypes of the Beijing family were isolated from 899 patients and a 
majority of these, 794 (88.3%) were from South Africa. These Beijing strains represented 
26.4% of the isolates from this country and a majority of these were typical Beijing 
strains (data not shown). 
 
The ill defined T genotypes were isolated in high proportion among isolates from 
Madagascar (31.6%). These were also identified among isolates from the other seven 
countries (Figure 1). A majority of the M. tuberculosis isolates identified as T genotypes 
were T1 strains. The T1 strains were prevalent among T genotypes identified in each of 
the eight countries; 76 (74.5%) in Madagascar, all 18 isolates in Malawi, 22 (37.9%) in 
Mozambique, all 9 isolates from Namibia, 67 (43.5%) in South Africa, 50 (57.5%) in 
Tanzania, 24 (85.7%) in Zambia and 78 (86.7%) in Zimbabwe.  
 
The CAS genotype which included the CAS1-Delhi and CAS1-Kilimanjaro (CAS1-
KILI) was predominantly isolated from M. tuberculosis isolates from Tanzania (41.2%) 
and Madagascar (12.1%) and in less than 10% of the isolates from each of the remaining 
six countries (Figure 1).  
 
The proportion of M. tuberculosis genotypes identified in the Southern African region 
(Table 2) differed significantly across the countries (p=<0.001).   
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Table 2: M. tuberculosis genotypes identified among isolates from eight countries in Southern Africa 
Genotype Madagascar Malawi Mozambique Namibia South Africa Tanzania Zambia Zimbabwe Total 
Beijing 2 (0.6) 0 (0.0) 33 (6.1) 0 (0.0) 794 (26.4) 47 (6.5) 1 (0.9) 22 (3.2) 899 (16.1) 
*CAS 39 (12.1) 8 (7.1) 12 (2.2) 0 (0.0) 39 (1.3) 299 (41.2) 4 (3.5) 33 (4.9) 434 (7.8) 
**EAI 49 (15.2) 18 (16.1) 170 (31.3) 1 (1.3) 3 (0.1) 90(12.4) 4 (3.5) 17 (2.5) 352 (6.3) 
***H/H like 28 (8.7) 0 (0.0) 15 (2.8) 0 (0.0) 220 (7.3) 10 (1.4) 1 (0.9) 16(2.4) 290 (5.2) 
****LAM 30 (9.3) 56 (50.0) 187 (34.4) 63 (80.8) 909 (30.2) 148 (20.4) 74 (64.9) 442 (65.1) 1909 (34.2) 
MANU 10 (3.1) 3 (2.7) 6 (1.1) 0 (0.0) 3 (0.1) 3 (0.4) 1 (0.9) 0 (0.0) 26 (0.5) 
S 4 (1.2) 1 (0.9) 10 (1.8) 0 (0.0) 204 (6.8) 6 (0.8) 0 (0.0) 4 (0.6) 229 (4.1) 
T 102 (31.6) 18 (16.1) 58 (10.7) 9 (11.5) 154 (5.1) 87 (12.0) 28 (24.6) 90 (13.3) 546 (9.8) 
U 48 (14.9) 0 (0.0) 0 (0.0) 2 (2.6) 2 (0.1) 8 (1.1) 0 (0.0) 1 (0.2) 61 (1.1) 
X 3 (0.9) 2 (1.8) 15 (2.8) 0 (0.0) 337 (11.2) 1 (0.1) 1 (0.9) 28 (4.1) 387 (6.9) 
orphan 0 (0.0) 0 (0.0) 37 (6.8) 0 (0.0) 75 (2.4) 17 (2.3) 0 (0.0) 18 (2.7) 147 (2.6) 
other 8 (2.5) 6 (5.4) 0 (0.0) 3 (3.9) 272 (9.0)) 9 (1.2) 0 (0.0) 8 (1.2) 306 (5.5) 
Total 323 (100.0) 112 (100.0) 543 (100.0) 78 (100.0) 3012(100.0) 725 (100.0) 114 (100.0) 679 (100.0) 
5586 
(100.0) 
*CAS: Central Asian; LAM:  
**Latin-American-Mediterranean;  
***EAI: East African Indian;  
****H/H-like: Haarlem/Haarlem-like 
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The well characterized IS6110 low-banding family, the X genotype family was identified 
among 387 of the 5586 isolates included in the study. This family was most prevalent in 
South Africa where 337 isolates were classified as X genotype. No isolates belonging to 
the X genotype were identified in Namibia but these were isolated in low proportions 
among isolates from the other six countries (Figure 1). 
 
 
Figure 1: Percentage of ten main spoligotyping-defined M. tuberculosis genotype families 
identified in eight Southern African countries. 
 
The EAI genotypes were identified among 352 isolates across all 8 countries but were 
isolated in high proportions from M. tuberculosis strains from Mozambique (31.3%), 
Madagascar (15.2%) and Tanzania (12.4%). The sub lineages were undefined in some 
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isolates characterized as EAI genotypes (n=16), but the rest included EAI5 (n=121), 
EAI1-Somalia (n=82), EAI8-Madagascar (n=46), EAI6-Bangladesh (n=38), EAI5/EAI3 
(n=34) and others (n=15). Among the three most common EAI sub lineages, EAI5 was 
isolated in high proportions from Mozambique (n=54) and Tanzania (n=34), whilst 
EAI_Somalia was prevalent in Mozambique (n=75) and EAI_Madagascar in Madagascar 
(n=46). 
 
The S genotype was more common in South Africa than in any of the other countries. 
The genotype was identified in 7.3% of the isolates from South Africa and ranging from 
very low proportions in five countries (0.6%-1.2%) to none in Zambia and Namibia. 
 
Distribution of genotypes in regions of Southern Africa 
Figure 2 is a pictorial map of Southern African countries showing the distribution of the 
main lineages identified in each of the eight countries. The LAM genotype was widely 
distributed across this region, most prevalent in the central parts of Southern Africa. The 
Beijing, X, Haarlem (H) and S genotypes were more likely to be isolated from South 
Africa than the other countries in Southern Africa. In addition the H genotype was also 
more likely to be identified in isolates from the island of Madagascar. The CAS genotype 
found mainly in India,the Indian subcontinent and Tanzania (9), was reconfirmed as 
being the most prevalent genotype in Tanzania.  The EAI genotypes were isolated at 
considerable frequency in Mozambique, Malawi Madagascar and Tanzania. 
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Figure 2: Distribution of Mycobacterium tuberculosis genotypes in Southern African countries 
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Discussion 
In this study we analyzed genotypes of M. tuberculosis isolated from patients presenting 
with pulmonary tuberculosis in eight Southern African countries that are part of the  
SADC region. To our knowledge this is this is the first collaborative effort to describe 
genotypes of M. tuberculosis as an entity, driving the tuberculosis epidemic in this region 
of high TB incidence and HIV prevalence. Using spoligotyping data submitted from 
different countries and the SpolDB4 to compare and extract additional data enabled 
uniform and accurate comparisons to be made across different countries. These data 
could also be compared to genotypes inferred from IS6110 RFLP data (22).  
 
The study used a combination of data sources; including unpublished data collected as 
part of studies from some countries and published data that is now available on the public 
domain. This was done to ensure that as much of the genotyping data that is available in 
the region from studies is included in the analysis in order to get a representative sample 
to infer the population structure in the region.  
 
The diversity of genotypes within this region seemed to be well structured along specific 
regional lines, but a few genotypes including LAM, Beijing, T, CAS, X and EAI were 
identified across most of the countries. Interestingly this comparison of the population 
structure in the different countries of Southern Africa demonstrates finer national 
differences in population structure, contrary to findings from earlier studies (10), where 
less evidence of phylogenetic structure was found in individual nations but more so in 
broader geographic regions. The observations that the LAM genotypes with a very rich 
Chapter 5 
173 
 
diversity were predominantly isolated from the Central parts of Southern Africa (Malawi, 
Namibia, Zimbabwe and Zambia) supports this notion. Similarly, EAI genotypes which 
have been linked to Asian countries (9) were predominantly found in countries on the 
Indian Ocean cost, including Madagascar, Mozambique and Tanzania. The prevalence of 
the EAI in Malawi may be explained by the fact that Malawi is a neighbouring country of 
both Mozambique and Tanzania and cross boarder migration may play a role in the 
spread of these strains. In part, this observation together with an observation of specific 
genotypes that are prevalent may reflect migratory and trade routes over the past 3 
decades. A study by Brudey et al (9), also supported our observations by demonstrating 
that the genetic diversity of M. tuberculosis is strongly linked to finer geographical scale. 
 
It was also interesting to note, however, that the Beijing genotype, which is known to be 
prevalent in Asia (Far East and Middle East Asia), emerging in other regions of the world 
and associated with drug resistance (25),was not prevalent in other countries on the 
Indian Ocean coast but more prevalent in South Africa. The Beijing genotypes which 
were primarily identified among isolates from Western Cape Province in South Africa 
were previously found to increase exponentially over time with a doubling time 4.86 
years, unlike other predominant genotypes in this province (14). This together with the 
relative fitness of Beijing strains may suggests that they may have a selective advantage 
associated with transmission in this community. This may explain in part the differences 
in prevalence of Beijing genotypes in South Africa and other countries on the Indian 
Ocean coast. We may also be drawn to speculate that the identification of Beijing 
genotypes in low proportions in other countries of Southern Africa including 
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Mozambique, Tanzania and Zimbabwe may represent an emerging genotype in the rest of 
Southern Africa.  
 
 Even though the same genotypes were identified across the eight countries, certain 
genotypes caused disproportionate numbers of tuberculosis cases, specifically the LAM 
genotype in Malawi, Zambia and Zimbabwe. One sub lineage LAM11_ZWE was the 
most prevalent in all three countries. These were designated SAF1/RDRio strains in earlier 
studies and have been shown in an earlier chapter in this thesis (Chapter 6) and in other 
studies to be associated with more severe forms of tuberculosis (26). Though in part we 
can speculate that it could be explained by cross boarder migration and environmental 
factors, the finer details remain unknown. One possible explanation is that the country 
specific population structures observed could have evolved by drift after a single entry 
and spread of the M. tuberculosis clone between countries or as the population of M. 
tuberculosis expanded in each country. Other factors like prevalence of HIV and host 
specific factors may also contribute to selection of these specific clones which may be 
more transmissible in these specific conditions. Our findings confirm those of early 
studies showing that M. tuberculosis strains are associated with specific host population 
(8, 10, 27). This in part could also explain the association seen between other prevalent 
genotypes identified in regions of Southern Africa including LAM, CAS, EAI, S, T and 
X. No demographic and clinical data was available in this study to better understand why 
in specific countries certain genotypes cause a disproportionate number of tuberculosis 
cases. However an earlier study looking at potential risk factors and clinical outcomes of 
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disease due to a sublineage of the LAM family suggested that disease due to these strains 
was more likely to cause cavitary disease (Chapter 2).   
 
Despite our attempt to get data from the region, it was still underrepresented in some of 
the countries (Namibia, Malawi) and completely absent in 6 of the 14 SADC countries. 
Consequently a clear picture of what is happening in the rest of the region is unknown 
and may be over represented for some countries such as South Africa which contributed 
53.2% of the data analyzed. Therefore our findings may not give a representative 
snapshot picture of the regional population structure of M. tuberculosis. Despite these 
limitations, stratification of data by country allowed us to define the main genotypes that 
constitute the population structure of M. tuberculosis in 57% of the SADC region.  
 
In conclusion, M. tuberculosis genotype data is increasingly becoming available from 
high burden countries including regions of Southern Africa. Our results suggest that the 
distinct genotypes are associated with specific countries and regions of Southern Africa 
with a geographical localization of some genotypes probably implying a complex 
interplay between geography, histories, host population migration and the TB epidemic. 
The observation that M. tuberculosis exhibits distinct phylogeographic population 
structure in these countries confirms that the epidemic in the region is a result of several 
outbreaks of specific genotypes requiring different approaches to diagnosis, treatment 
and prevention. As the different genotypes are likely to have different phenotypes this 
may affect the development of new diagnostics, vaccines and drugs. As more and more 
data becomes available it will be worthwhile repeating a similar study to increase the 
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resolution of the phylogeographical structure of M. tuberculosis in Southern Africa. Such 
information may help in influencing disease control efforts such as development of new 
diagnostic, drugs and vaccines. Within these regions this may influence the evolutionary 
order of the various genotypes, thereby underscoring the need for region specific 
approaches to controlling TB. 
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Abstract 
Background 
Drug-resistant tuberculosis (TB) and particularly multidrug-resistant (MDR) and 
extensively drug-resistant (XDR) TB, threaten TB control efforts throughout the world 
Aim 
To describe the population structure of M. tuberculosis strains isolated from patients with 
drug resistant TB in four provinces of South Africa 
Methods 
Multidrug-resistant (MDR), pre-extensively drug resistant (pre-XDR) TB and extensively 
drug-resistant (XDR) M. tuberculosis isolates were genotyped using spoligotyping and/or 
IS6110-restriction fragment length polymorphism (RFLP) using internationally 
standardized protocols. Differences in proportions of the M. tuberculosis genotypes 
among MDR-TB, pre-XDR-TB and XDR-TB in the four provinces were compared using 
Pearson’s chi-squared test. 
Results 
A total of 3795 drug resistant isolates from Western Cape (n=2489), Eastern Cape 
(n=307), KwaZulu Natal (n=234) and Gauteng (n=765) were included in the analysis. 
Beijing genotypes were the most prevalent genotypes identified from Eastern and 
Western Cape, 42.5% of MDR-TB isolates, 96.8% of pre-XDR-TB isolates and 92.5% of 
XDR-TB and 47.9% among MDR-TB, 68.0% among pre-XDR and 92.3% among XDR-
TB isolates respectively. Among 765 MDR-TB isolates from Gauteng the most prevalent 
genotypes were Latin American Mediterranean (LAM; 26.7%), Beijing (16.7%) and T 
(17.7%) genotypes. The S genotype (33.5%) and LAM genotype (24.9%) were the most 
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common genotypes identified from KwaZulu-Natal MDR-TB isolates. The proportion of 
LAM strains increased to 41.7% and 80% among PreXDR-TB and XDR-TB isolates 
respectively and were predominantly LAM4 genotype previously named 
F15/LAM4/KZN. The proportion of genotypes varied significantly across the three 
resistance classes and among the provinces (p<0.001).  
Conclusion 
In conclusion, the population structure of drug-resistant TB in South Africa is 
geographically localized. The diversity of M. tuberculosis genotypes decreased in all 
settings from MDR-TB to XDR-TB suggesting an increased ability of a limited number 
of strains to develop XDR-TB. These results support the need for identifying genetic 
markers in drug resistant M. tuberculosis which can aid in developing  diagnostic tests 
that  allow the identification of cases at high risk of developing XDR-TB. and  early 
initiation of adapted treatment regimens.  
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Introduction  
An estimated 440 000 cases of multidrug- resistant (MDR) tuberculosis (TB) occurred 
worldwide in 2008 of which 360 000 were likely due to transmission of an MDR strain 
and 94 000 were likely acquired resistance (1). In South Africa MDR has been reported 
in 1.8% new TB cases and 6.7% among previously treated cases. High levels of 
extensively drug-resistant (XDR) TB (10.5%) were reported from 5451 MDR cases 
tested for second line drugs (1). Drug resistant TB, including MDR- and XDR-TB, is a 
major challenge to the TB control because they have the most profound effects on patient 
treatment outcomes. The most effective antibiotics with the least side effects, isoniazid 
(INH) and rifampicin (RIF) must be replaced with less effective, more expensive and 
more toxic drugs in the treatment of MDR- and XDR-TB. 
 
As predicted by mathematical models the future of MDR-TB and XDR-TB will depend 
largely on the efficiency of their transmission (2, 3) and hence cannot be contained 
without specific efforts to limit transmission. Development of drug resistance in 
Mycobacteria is due to genomic events unlike in other infectious agents where exchange 
of genes plays a major role (4). Selection of resistant mutants therefore happens during 
treatment with anti-tuberculous drugs when patients are treated with inappropriate 
regimens or when patients do not adhere to treatment. Non adherence is worsened by the 
large number of drugs that should be taken, side effects and the long duration of 
treatment (six months in new TB cases, ≥9 months for retreatment cases and even longer 
for patients with drug resistant disease). Hence human behaviour is very important in the 
development of drug resistance in TB. 
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In recent years availability of culture, drug susceptibility testing of both first and second 
line drugs and genotyping has allowed strain diversity studies to be done to determine the 
disease dynamics of drug resistant strains. As such genotyping data is available to allow 
comparability analysis of regional phylogeographical population structure as well as 
transmission and underlying spatial and temporal evolution of drug resistant strains of the 
different genotypes (5, 6). These are important as they will help either confirm or refute 
predictions on the future of drug resistant tuberculosis made through mathematical 
modeling. These molecular epidemiology studies have also affirmed the role of human 
behavior in the transmission of drug resistant TB (5). More recently temporal analysis of 
drug resistant tuberculosis in communities in Western Cape Province showed that the 
genetic background of M. tuberculosis strains contributed to transmission and acquisition 
of drug resistant TB (6).   
 
Worldwide, molecular genotyping of M. tuberculosis strains has shown diverse lineages 
contributing to drug resistant TB worldwide. Specific genotypes have been suggested as 
being more successful than others in causing drug resistant TB, including Beijing (7, 8, 9, 
10) LAM (11) and strains belonging to the IS6110 low copy number clade (4). The 
Beijing strains can be grouped as modern (typical) or old (atypical) according to the 
presence or absence of an IS6110 insertion in the NTF locus of the M. tuberculosis 
genome (12). Characterization of strains using these molecular methods has enabled 
development of rapid tests to detect outbreak strains (13). Subsequently these strains have 
been hypothesized as having acquired unique properties that allow them to have a fitness 
advantage over other strains (14, 15, 16, 17). 
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Our current knowledge of the genetic diversity is limited to studies done in M. 
tuberculosis in general and not specific to drug resistant strains (18, 19). The studies 
show that the population structure of M. tuberculosis is highly structured along specific 
geographic lines and to a lesser extent in individual countries. To date paucity of studies 
looking at the occurrence of drug resistant strains within provinces and across provinces 
of South Africa has prevented comparative studies to be done. However, in recent years 
genotyping data has become available from other provinces including Gauteng and 
KwaZulu-Natal, but no comprehensive assessment of the genetic variability of drug 
resistant M. tuberculosis has been done. This information may be helpful in guiding TB 
control programmes (20).  
 
We hypothesize that specific lineages and therefore a distinct phylogeographic structure 
exists among drug resistant M. tuberculosis strains isolated from TB patients across the 
different provinces of South Africa. These genotypic differences exist because 
programmatic constraints and fitness of resistant M. tuberculosis strains that have now 
adapted to specific human populations.  
 
In this study we use recently collected data on drug resistant M. tuberculosis isolates 
from 4 provinces of South Africa, namely, the Eastern Cape, Gauteng, KwaZulu Natal 
and Western Cape. The aim of the study was to describe the population structure of M. 
tuberculosis strains isolated from patients with drug resistant TB in four provinces of 
South Africa 
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Methods 
Study design 
The study was a descriptive study which included M. tuberculosis isolates collected as 
part of studies done in four provinces in South Africa, including Western Cape, Eastern 
Cape, KwaZulu Natal and Gauteng.  
 
Study population 
Isolates from Western Cape were collected during the period August 2000 to January 
2010. Sputum specimens were routinely collected from all patients whose sputum failed 
to convert to smear negative after two months of intensive phase therapy for TB or at 
diagnosis for patients who had previously been treated with anti-tuberculous drugs 
(retreatment cases), attending primary health clinics in Cape Metropole, Boland, 
Overberg, Karoo and the Southern Cape regions of Western Cape. Sputum specimens 
were sent to the National Health Laboratory Services (NHLS) in the Western Cape 
Province or Stellenbosch University Laboratory.  
 
Following decontamination using sodium hydroxide-N-acetyl-L-cystein (NALC-NaOH), 
auramine stained slides were examined for acid fast bacilli and culture done on 
Mycobacterial Growth Indicator Tube (MGIT).  Using the indirect proportion method on 
Middlebrook 7H11 medium, drug susceptibility testing (DST) was done for isoniazid 
(INH) 0.2µg/ml; rifampicin (RIF) 1.0 µg/ml; ethambutol (EMB) 7.5µg/ml; streptomycin 
(SM) 2.0 µg/ml; kanamycin (KAN) 6.0µg/ml; ethionamide (ETH) 10.0 µg/ml; and 
ofloxacin (OFX) 2.0 0.2µg/ml (21).  Susceptibility testing for amikacin (AMK) was done 
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using BACTEC 960 using a concentration of 1.0 µg/ml as recommended for routine 
screening (22). Testing for second line drugs was only started from 2006 onwards. All 
drug resistant isolates were sent to Stellenbosch University for genotypic analyses. 
Spoligotyping was done on all isolates and IS6110 on a subset of isolates. 
 
From July 2008–June 2009, isolates of tuberculosis cases with a suspicion of MDR-TB as 
defined by lack of clinical response to treatment, identified at primary health clinics in 
Eastern Cape Province were referred to the NHLS in Eastern Cape Province for routine 
drug susceptibility testing (DST). The same laboratory procedures for testing were used 
as described above for Western Cape Province. 
 
In KwaZulu Natal sputum samples were collected from patients suspected of having 
MDR- and/or XDR-TB referred to a tertiary hospital and a provincial hospital in 
KwaZulu Natal. The two hospitals are referral hospitals for the KwaZulu Natal Province 
and data was collected during the period 2005-2006. Sputum samples were sent to either 
of two laboratories, one at the Nelson R Mandela School of Medicine and the other at 
King George V Hospital in Durban. After February 2006, the samples were sent to NHLS 
for smear microscopy, culture and DST. At the School of Medicine laboratory the 1% 
proportion method on Middlebrook 7H10 agar was used at the following concentrations; 
INH 0.2 mg/L and/or 1 mg/L; RIF 1 mg/L; EMB 7.5 mg/L, SM 2 and/or 10 mg/L.  For 
specimens sent to King George hospital, DST was done on LJ media at the following 
drug concentrations INH  0.2 mg/L and 1 mg/L; RIF 40mg/L; EMB 2 mg/L, SM 4 mg/L; 
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ETH, 20 mg/L; KAN 20 mg/L; OFX 2.5 mg/L.  Positive LJ slants were sent to University 
of KwaZulu-Natal for genotyping using IS6110 –RFLP and spoligotyping.  
 
During the period 2004-2007 isolates from suspected drug resistant TB cases were 
collected from the seven regions of Greater Johannesburg and sent to NHLS laboratories 
for drug susceptibility testing for four first line drugs including INH, RIF, SM and EMB. 
Drug susceptibility testing was done using the indirect proportion method on 
Middlebrook medium containing critical concentrations of 0.2 µg/ml INH and 30 µg/ml 
RIF. 
 
Definitions 
In this study drug-resistant strains were defined according to WHO definitions: MDR-TB 
isolates defined as M. tuberculosis isolates resistant to at least INH and RIF and XDR-TB 
strains as isolates that were resistant to at least INH, RIF, a fluoroquinolone such as OFX 
and one of three injectable second line drugs, either capreomycin (CPM), KAN or AMK 
(23). Pre-XDR-TB strains which are essentially one mutation away from becoming XDR-
TB were defined as MDR-TB isolates (i.e. at least resistant to both INH and RIF) and 
either a fluoroquinolone or a second-line injectable drug, but not both (24). In this 
analysis the MDR-TB population in the Eastern and Western Cape and KwaZulu Natal, 
excluded all identified pre-XDR-TB and XDR-TB isolates. 
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Genotypic classification 
M. tuberculosis isolates from patients were subcultured on LJ medium and genotypes 
were determined using spoligotyping (25) and/or IS6110 DNA fingerprinting (26) 
according to internationally standardized methods. 
 
Sub-classification of all the Beijing strains into typical and atypical strains, identified in 
Eastern Cape, a sample from Western Cape and another sample from Gauteng was done 
using a polymerase chain reaction (PCR) amplification method as previously described 
(27). None of the Beijing strains identified in KwaZulu Natal were further characterized.  
 
Comparison of isolates 
The spoligotype patterns were compared to spoligotype data deposited in the SpolDB4 
database maintained at the Pasteur Institute in Guadeloupe (28). Strains were grouped 
according to different clades/lineages as defined in the SpolDB4 database. Genotypes 
from IS6110-RFLP were assigned to families as previously described (29).  
 
Inclusion criteria 
Only the first M. tuberculosis isolate from each case was included in this analysis. 
Isolates were included in the analysis if they were MDR, pre-XDR or XDR and if the 
province where the patient resided was known.  
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Statistical analysis  
Statistical analyses were performed using STATA 10.0 (Statacorp, College Station, 
Texas USA). The Pearson’s chi-squared test was used for testing the difference in 
proportion of M. tuberculosis genotypes in the different resistance classes within 
provinces and also among the different provinces. A level of p<0.05 was considered 
statistically significant. 
 
Ethics considerations 
The current study was part of a long-term molecular epidemiology study which has been 
approved by the Ethics Committee (Institutional Review Board) of the Faculty of Health 
Sciences Stellenbosch University Ethics Committee. Approval was also sought from 
individual investigators to collaborate in the study. Participants in the study were 
identified by a unique study number and no personal identifiers were included.  
 
Results 
Mycobacterium tuberculosis isolates 
The number of isolates with spoligotyping data received from the provinces is shown in 
Supplemental table 5.  In this analysis spoligotyping data for MDR-TB, pre-XDR-TB and 
XDR-TB isolates (n=3795, received from 4 provinces in South Africa namely; Western 
Cape (n=2489), Eastern Cape (n=307), KwaZulu Natal (n=234) and Gauteng (n=765) 
were included (Supplemental table 5 column 3, 4 and 5).   
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M. tuberculosis genotypes identified among drug resistant isolates from all provinces 
Overall of the 3795 M. tuberculosis identified in this study as MDR Pre-XDR or XDR, 
1664 (43.9%) belonged to the Beijing genotype, 544 (14.3%) to the LAM genotype, 478 
(12.6) to the X genotype, 462 (12.2%) to the more modern T lineage, 189 (5.0%) to the S 
lineage, 57 (1.5%) to the U genotype and 28 (0.7%) to CAS. Other genotypes were 
identified among 260 isolates and these included mixed strains. A small proportion of 
isolates (n=113) had spoligotype patterns that were not matched to the SpolDB4.  
 
M. tuberculosis genotypes identified among drug resistant isolates from Eastern 
Cape  
Of the 307 M. tuberculosis isolates from Eastern Cape, 134 (43.6%) MDR-TB isolates 
were identified, 93 (30.3%) pre-XDR-TB and 80 (26.1%) XDR-TB isolates. The Beijing 
genotype was predominant among all drug resistant strains: MDR-TB isolates (57/134), 
pre-XDR-TB isolates (90/93) and XDR-TB isolates (74/80) (Figure 1). Of the 57 Beijing 
isolates that were MDR, 39 (68.4%) were atypical Beijing genotypes and 18 (31.6%) 
were typical Beijing genotypes (Figure 1). All Beijing isolates identified among pre-XDR 
isolates (n=90) and XDR isolates (n=74) were atypical Beijing genotypes (Figure 1).  
 
Close to two-thirds of isolates identified as LAM were MDR-TB isolates and the 
proportion of LAM strains decreased among pre-XDR-TB and XDR-TB isolates (Figure 
1). In total 39 LAM strains were identified and these were predominantly LAM 4 
genotypes (n=30; 76.9%).  M. tuberculosis isolates of the T genotype were isolated 
among 18 MDR strains and four sub lineages were identified, a majority (38.9%) 
belonged to the T1 sub lineage. The number of M. tuberculosis isolates belonging to 
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other genotypes decreased as we moved from MDR-TB to XDR-TB while that of Beijing 
genotypes increased, in particular the atypical Beijing genotype. The proportion of M. 
tuberculosis genotypes differed across the three resistance classes (p<0.001).  
 
 
Figure 1: M. tuberculosis genotypes associated with MDR-TB, Pre-XDR-TB and XDR-
TB in Eastern Cape Province, South Africa 
 
M. tuberculosis genotypes identified among drug resistant isolates from Gauteng 
Province  
All the M. tuberculosis isolates from Gauteng province (n=765) were classified as MDR-
TB isolates (Table 1). There was no data on second line testing, therefore inference to 
either pre-XDR or XDR could not be done. It is clear from Table 1 that the proportion of 
M. tuberculosis genotypes differed in this province. The most prevalent genotypes 
associated with MDR were LAM (26,7%), followed by T (17.7%) and Beijing (16.7%). 
Among the 204 MDR isolates identified as LAM, 129 (63.2%) belonged to the LAM4 
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lineage. One hundred and thirty-five isolates were identified as T genotypes and 87% of 
these belonged to the T1 sub lineage. 
 
Of the 128 Beijing strains, a sample (n=81) were sub-classified further as either typical or 
atypical Beijing strains. A majority 67 (82.7%) were typical Beijing and 14 (17.3%) were 
atypical Beijing strains (Figure 4). 
 
Table 1: Genotypes identified among M. tuberculosis MDR isolates 
 
Genotype 
Resistance class Percentage 
MDR 
LAM 204 26.7 
T 135 17.6 
Beijing 128 16.7 
H 106 13.9 
EAI 63 8.2 
S 54 7.1 
X 46 6.0 
Orphan 15 2.0 
CAS 12 1.6 
MANU 2 0.3 
Total 765 100.0 
 
M. tuberculosis genotypes identified among drug resistant isolates from KwaZulu 
Natal Province  
Of the 234 M. tuberculosis isolates from KwaZulu-Natal, 196 (74.8%) were MDR-TB 
isolates, 13 (5.0%) were preXDR-TB isolates and 25 (9.5%) were XDR-TB isolates.  
Among MDR-TB isolates, 66 (33.5%) were S genotype, 49 (24.9%) were LAM 
genotypes and 33 (16.8%) T genotypes (Figure 2). Of the 196 MDR-TB isolates only 15 
(7.6%) were Beijing strains and were not characterised further into typical or atypical 
Beijing lineages.  
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Four LAM sub lineages were identified and LAM 4 was the most prevalent being 
identified in 39 (79.6%) isolates. The proportion of LAM strains increased to 41.7% and 
80% among preXDR-TB and XDR-TB isolates respectively (Figure 2). LAM 4 
represented the majority of LAM strains within the pre-XDR and XDR groups, at 80% 
and 90% respectively. The proportion of other genotypes decreased and the Beijing 
genotype was not identified among pre-XDR-TB or XDR-TB isolates. The proportion of 
M. tuberculosis genotypes differed significantly among MDR-TB, preXDR-TB and 
MDR-TB isolates (p<0.001). 
 
 
Figure 2: M. tuberculosis genotypes associated with MDR-TB, pre-XDR-TB and XDR-
TB in KwaZulu Natal, South Africa 
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M. tuberculosis genotypes identified among drug resistant isolates from Western 
Cape Province  
Of the 2489 isolates identified from TB patients in Western Cape, 2091 (84.0%) were 
MDR-TB isolates, 281 (11.3%) preXDR-TB isolates and 117 (4.7%) were XDR-TB 
isolates. Strains belonging to the Beijing genotype were predominant among all the three 
drug resistant isolates (MDR-TB, pre-XDR-TB and XDR-TB isolates) (Figure 3).  
 
Beijing strains were identified from 1001 (47.9%) MDR-TB isolates, 191 (67.9%) pre-
XDR-TB isolates and 108 (92.3%) XDR-TB isolates (Figure 3). A subset of the isolates 
identified as Beijing genotype (312/1300) were sub-classified as either typical or atypical 
strains.  Typical Beijing strains were isolated in higher proportions from MDR isolates 
(159/189; 84.1%) and pre-XDR isolates (42/66; 63.6%), compared to XDR isolates 
(25/57; 43.8%) (Figure 4-6). On the contrary, atypical Beijing strains were isolated in 
lower proportions from MDR (30/189; 15.9%) and pre-XDR isolates (24/66; 36.4%) 
compared to XDR isolates (32/57; 56.1%).  
 
The X genotype (X1, X2 and X3) was identified in 413 isolates (16.6%) and the majority 
of these (93.5%) were identified from MDR-TB isolates.  
 
Across the three drug resistance classes, the proportion of M. tuberculosis genotypes was 
significantly different (p>0.001)  
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Figure 3: M. tuberculosis genotypes associated with MDR-TB pre-XDR-TB and XDR-TB in 
Western Cape Province, South Africa 
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Cape province, M. tuberculosis isolates belonging to the X genotype represented close to 
one-fifth of the MDR-TB isolates.   
 
In Gauteng M. tuberculosis isolates of the LAM genotype (26.7%) were predominantly 
isolated from MDR-TB isolates. This changed in KwaZulu Natal with M. tuberculosis 
isolates of the S genotype reported in a majority of the MDR isolates (33.5%) followed 
by LAM genotypes (25.0%). The distribution of MDR isolates across the provinces of 
South Africa is shown in Figure 4 below. 
 
Comparing across the provinces the genotypes associated with MDR-TB varied 
significantly (p<0.001) (Table 2). 
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Table 2: Comparison of M. tuberculosis genotypes identified among multi drug-resistant  
isolates from four provinces in South Africa 
 
M. tuberculosis 
genotype 
Province Total 
Eastern Cape Gauteng KwaZulu 
Natal 
n (%) 
WesternCape 
n (%) 
Beijing 57 (42.5) 128 (16.7) 15 (7.7) 1001 (47.9) 1201 (37.7) 
LAM 33 (24.6) 204 (26.7) 49 (25.0) 212 (10.1) 498 (15.6) 
T 18 (13.4) 135 (17.7) 33 (16.8) 250 (12.0) 436 (13.7) 
X 2 (1.5) 46 (6.0) 16 (8.1) 386 (18.5) 450 (14.1) 
S 8 (6.0) 54 (7.1) 66 (33.7) 49 (2.3) 177 (5.6) 
Other 16 (11.9) 198 (25.9) 17 (8.7) 193 (9.2) 424 (13.3) 
Total 134 (100.0) 765 (100.0) 196 (100.0) 2091 (100.0) 3186(100.0) 
 
 
Pre-XDR-TB  
M. tuberculosis isolates that were at least resistant to both INH and RIF and either a 
fluoroquinolone or an injectable second line anti-TB drug were identified in 386 isolates 
from Eastern Cape (n=93), KwaZulu Natal (n=12) and Western Cape (n=281). Of the 93 
Pre-XDR-TB isolates from Eastern Cape, 90 (96.8%) were Beijing strains, all of which 
were of the atypical Beijing genotype and 3 (3.2%) were LAM strains (Figure 5). Five 
genotypes could be identified among 12 pre-XDR isolates from KwaZulu Natal. Five of 
the 12 isolates (41.7%) were LAM genotypes and 4 (80%) of these were LAM4 sub 
lineage. Although a number of M. tuberculosis genotypes were identified from 281 pre-
XDR isolates from the Western Cape Province, the Beijing genotype was the most 
predominant genotype (n=191; 68.0%), and less frequently were the T (6.8%) and LAM 
genotypes (4.6%). Further characterization of a subset of the isolates (n=69), showed that 
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a majority of pre-XDR isolates that belonged to the Beijing genotype were typical 
Beijing strains (42/69). The distribution of the genotypes across the three provinces is 
shown in Figure 5. Genotypes identified among the pre-XDR isolates varied significantly 
across the three provinces (p<0.001). 
 
XDR-TB  
XDR-TB was identified in 222 isolates from the Eastern Cape (n=80), KwaZulu Natal 
(n=25) and the Western Cape (n=117) and none from Gauteng Province.  
 
Of the 80 XDR isolates from the Eastern Cape, all 74 (92.5%) isolates identified as 
Beijing were atypical Beijing strains, 3 (3.8%) LAM, 1 (1.3%) S type and 2 (2.5%) were 
other genotypes (Figure 6). M. tuberculosis isolates from KwaZulu Natal that were XDR 
were predominantly LAM genotypes (n=20; 80.0%). A majority of the LAM genotypes 
were of the LAM4 sub lineage (90%). The S and T genotypes were isolated in similar 
proportions (8.0%). As with the pre-XDR isolates identified in the Western Cape, the 
XDR-TB isolates belonged to a variety of M. tuberculosis genotypes (Figure 6), however, 
the Beijing genotype still predominated being represented in 92.3% of the XDR-TB 
isolates (Figure 6). Of the subset of isolates that could be characterized as typical or 
atypical (n=60), 32 (53.3%) were atypical Beijing genotype and 25 (41.6%) were typical 
Beijing types and 3 were mixed. The genotypes identified among the XDR-TB isolates 
were significantly associated with the origin of the isolates (p<0.001). 
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Figure 4: Distribution of Mycobacterium tuberculosis genotypes identified from MDR-TB isolates from Eastern Cape, Gauteng, KwaZulu-Natal and Western 
Cape provinces in South Africa. The blue and gray pie charts show the sub-classification of Beijing strains into typical Beijing strains and atypical Beijing strains 
respectively, for Eastern Cape (on all Beijing isolates n=57), Gauteng (on a subset of Beijing isolates n=81) and Western Cape (on a subset of Beijing isolates  
(n=189) 
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Figure 5: Distribution of Mycobacterium tuberculosis genotypes identified from Pre-XDR-TB isolates from Eastern Cape, KwaZulu-Natal and Western Cape 
provinces in South Africa. The blue and/or gray pie charts show the sub-classification of Beijing strains into typical Beijing strains and atypical Beijing strains 
respectively, from Western (on a subset of Beijing isolates n=66) and Eastern Cape (on all Beijing isolates n=90) into typical Beijing strains and atypical Beijing 
strains. 
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Figure 6: Distribution of Mycobacterium tuberculosis genotypes identified from XDR-TB isolates from Eastern Cape, KwaZulu-Natal and Western Cape 
provinces in South Africa. The blue and/or gray pie charts show the sub-classification of Beijing strains into typical Beijing strains and atypical Beijing strains 
respectively, from Eastern Cape (on all Beijing isolates n=74) and Western Cape (on a subset of Beijing isolates n=57) into typical Beijing and atypical Beijing 
strains. 
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Discussion 
We have used genotyping data from four provinces in South Africa including, Gauteng, 
KwaZulu Natal, Western and Eastern Cape to study the phylogeography of drug resistant 
M. tuberculosis, to test the hypothesis that specific lineages and therefore distinct 
phylogeographic structure exists across the different provinces. Our results show a within 
country geographically localized population of M. tuberculosis strains that are associated 
with MDR-TB, pre-XDR-TB or XDR-TB. The population structure was clearly different 
in Eastern and Western Cape and KwaZulu-Natal provinces, differing in both the type 
and frequency of occurrence of each genotype. Distinct genotypes were associated with 
each of the three resistance classes and the province from which the patients originated.   
 
The Beijing genotypes were predominantly associated with MDR-TB, pre-XDR-TB and 
XDR-TB in Eastern and Western Cape making up 72% and 52% respectively of all 
genotypes identified among the resistant isolates. The Beijing genotype could be 
classified further into the typical or atypical genotypes using a novel multiplex PCR 
method (13, 27). The results showed geographic localization at this level; with the 
atypical Beijing strains more likely to be isolated from MDR-TB, pre-XDR-TB and 
XDR-TB isolates from Eastern Cape than from the subset of isolates analyzed from 
Western Cape and Gauteng. We believe that the results from the subset from Western 
Cape and Gauteng were representative of the total isolates analyzed in this study. In an 
earlier study analyzing the genome structure M. tuberculosis Beijing isolates from rural 
and urban populations of Western Cape, an overabundance of the more recently evolving 
typical Beijing (sublineage 7) was observed (27). The typical Beijing sublineage 5, 6 and 
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7 were associated with MDR-TB, corroborating the findings among MDR-TB isolates 
from Western Cape in this study.  However, in our study we found a trend towards 
increasing proportion of atypical Beijing strains that was also seen as isolates evolved 
from MDR-TB to XDR-TB in Western Cape. This could imply migration from Eastern 
Cape to Western Cape. A similar analysis could not be done for the isolates from 
KwaZulu Natal as these were not further characterized.  
 
Previously typical Beijing strains have been defined as the more recently evolved strains 
that are well adapted to spread and cause disease given their frequency of occurrence 
when compared to the distantly evolved atypical Beijing strains (27, 30, 31). On the 
contrary, based on the frequency at which atypical Beijing strains occur in Eastern Cape 
Province, in this and other studies (14), the atypical Beijing genotypes could be well 
adapted to spread and cause disease in these communities. Further north in Gauteng 
province, though Beijing strains were also identified, the majority of strains identified 
among MDR-TB isolates belonged to the LAM genotype and these were predominantly 
LAM4 genotype. As with the Eastern and Western Cape, a variety of other genotypes 
were also identified from MDR-TB isolates in Gauteng but in lower proportions. 
Towards the North Eastern coast in KwaZulu-Natal a variety of genotypes were 
associated with MDR-TB but the S and LAM genotypes predominated and as in Gauteng 
the LAM4 was the predominant sublineage identified among the LAM strains. However, 
the proportions changed as the isolates evolved from MDR-TB to XDR-TB and the 
LAM4 genotypes predominated whereas the Beijing genotypes disappeared completely. 
From earlier studies the LAM4 genotype appeared to be unique to the KwaZulu Natal 
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Province and had a distinct spoligotype pattern and referred to as F15/LAM4/KZN (11). 
In this study however LAM4 strains were also identified from Gauteng among MDR-TB 
cases indicating that they may be more wide spread than initially thought. 
 
The possible explanation for the disappearance of the Beijing strains among XDR-TB 
isolates in this population could be that they have a relatively lower ability to acquire 
resistance to second-line drugs. Alternatively they may have been introduced in this 
setting recently and are therefore less frequently transmitted as drug resistant strains. As a 
result they are less likely to become XDR-TB strains and there is a selection bias for the 
LAM genotypes. The LAM genotypes appear to have adapted well in the KwaZulu Natal 
and Gauteng population. Transmission may be an important driver for the occurrence of 
MDR-TB in all settings and it seems reasonable to assume that transmitted MDR strains 
much more often become XDR-TB strains than initially pan sensitive or non-MDR 
strains. The data suggests that within each region, sub-populations of M. tuberculosis 
genotypes have been selected which have now gone to select pre-XDR-TB and XDR-TB 
population suggestive of outbreaks. The reasons for this are not apparent but the 
populations seem to be able to escape second-line treatment regimens. 
 
Our data shows that the genotypes and their frequency vary across the provinces. Within 
each province where we were able to describe genotypes among all three resistance 
classes, there was decreasing diversity of M. tuberculosis stains towards XDR-TB. The 
genotypes did not remain uniform but changed in proportion as isolated evolved to XDR-
TB.  
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On the contrary, the observation of a wider variety of genotypes among MDR–TB 
isolates possibly reflects the underlying M. tuberculosis population structure in each 
province that we may expect to see even among drug susceptible strains. In the previous 
chapter (Chapter 5) we showed a similar population structure among drug sensitive 
strains. In that study avariety of genotypes were identified from South Africa with LAM 
(30.2%), Beijing (26.4%), X (11.5%), H (7.4%) and S (6.8%), being the most prevalent. 
MDR strains evolving from such drug susceptible strains during exposure to first line 
treatment would be expected to show similar diversity of strains with a few 
predominating. This diversity decreases as we move towards XDR-TB indicating that 
there must be a very successful group of MDR-TB strains that are able to transmit 
efficiently, despite additional drug resistance.  
 
In this study we have shown that atypical Beijing and LAM 4 strains are more likely to 
be associated with XDR-TB in the Eastern/Western Cape and in KwaZulu-Nata, 
respectively. These strains may not necessarily transmit as XDR-TB strains but more 
likely as MDR. As second line drugs are added to the regimen, this results in acquisition 
of resistance to second line drugs. This notion is supported by the identification of 
different drug resistance mutations for second line drugs in the same clone (17).  
 
A few other genotypes were also identified among XDR-TB isolates but were represented 
in very low proportions varying from 1.0-13.0%, probably showing that these are less 
efficient in transmitting XDR-TB in these provinces. In addition, if there are other MDR-
TB strains that transmit in these settings they appear to be less efficient in acquiring 
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additional mutations and becoming XDR-TB strains than the atypical Beijing and LAM4 
clones that are specific to either Eastern and Western Cape and KwaZulu Natal. 
However, it seems quite reasonable that a well standardized drug regimen that still offers 
opportunities for strains to transmit eventually creates an ecological niche that strains will 
adapt to. 
 
Our study has some limitations. Data from the provinces was collected over different 
periods. The Western Cape Province dataset was collected over a period of 10 years 
(2000-2010) and DST to second-line drugs was only done from 2006 onwards. Therefore 
the population of XDR-TB isolates may be under-represented. In addition, the number of 
isolates contributed from the Western Cape was overrepresented when compared to 
Eastern Cape (2008-2009), Gauteng (2004-2007) and KwaZulu Natal (2005-2006). This 
together with the different levels of selection in the different provinces may have 
introduced a selection bias. The isolates from Gauteng were only tested for susceptibility 
to first-line drugs and MDR-TB isolates based on the definition used in this study may 
have been over-represented. A convenience sample of isolates was used to sub-classify 
Beijing strains from Western Cape and Gauteng; therefore we may have over or 
underestimated the proportions of atypical and typical Beijing strains. No data on this 
sub-classification was available from KwaZulu Natal and it was not possible to compare 
the Beijing strains from this province to those from other provinces.  
  
Despite these observations our results provide evidence of few successful clones that are 
driving M/XDR TB. In this study, the observation that atypical Beijing strains were the 
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most prevalent genotypes among XDR strains in the Eastern and Western Cape and 
LAM4 genotype in KwaZulu Natal strongly suggests that these are very effective M. 
tuberculosis clones. These very effective clones including atypical Beijing and LAM4 
genotypes have been shown to have an inhA promoter mutation (6, 14, 17). A significant 
association between the inhA promoter mutations and XDR-TB has been shown in two 
South African provinces, Eastern and Western Cape which were part of this study 
(Muller B, personal communications). In this study the proportion of isolates with an 
inhA promoter mutation also increased significantly from MDR-TB to XDR-TB (data not 
shown). These observations together with the observations made in our study on the 
population structure of XDR-TB isolates suggest a selective advantage of M. tuberculosis 
strains harbouring an inhA promoter mutation to become XDR-TB strains  
 
The predominance of certain genotypes could be due to geographical localization of 
genotypes before the implementation of standardized treatment regimens. The population 
that became effective in transmitting as drug-resistant strains, most likely, originated 
from the most prevalent drug sensitive group. However treatment practices in specific 
regions may also have contributed to the selection of specific lineages by suppressing 
wild type drug susceptible strains and selecting for these highly successful/adapted drug 
resistant clones. As soon as a group of strains has adapted to this new ecological niche, 
the frequencies were likely to change radically as the more adapted strains outcompeted 
less adapted strains and clustering of the adapted genotypes became more evident. 
Although other factors, such as HIV/AIDS may have contributed to the selection of 
specific lineages in the past two decades, the currently observed picture could possibly 
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also be explained without these other factors if we assume that geographical localization 
may have existed before the introduction of standardized regimens. The observation that 
certain drug-resistant genotypes can be present in high frequencies in specific populations 
despite having a heavy burden of drug resistant mutations may suggest that that they are 
more fit than initially presumed and may have specific but as yet unknown virulence 
factors. 
 
In conclusion the population structure of drug-resistant TB is geographically localized to 
different South African regions and the diversity of M. tuberculosis decreases as isolates 
move from MDR-TB to XDR-TB. These observations put emphasis on the need to 
identify prevalent cases though active screening including close contacts of such cases. 
The identification of genetic markers in drug resistant M. tuberculosis strains is important 
in identifying cases at risk of developing M(X)DR-TB. The tools for diagnosing such 
cases already exist, for example the Genotype® MTBDRplus assay which detects the 
principal mutation in the inhA promoter conferring INH resistance that are closely 
associated with these very successful strains and mutations conferring RIF resistance. 
The assay has been implemented in several countries including some provinces in South 
Africa to assist culture based DST. The results from the assay should allow for rapid 
detection of high risk patients and adjustment of treatment regimens. 
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Tuberculosis (TB) has affected mankind for thousands of years. Despite the noteworthy progress 
made in understanding the disease over the past 100 years, the global incidence of TB continues 
to increase especially in Southern Africa.  This is largely due to poor TB control programmes 
and the concurrent pandemic of HIV. Together these have gradually enabled the emergence of 
multidrug-resistant TB with the concomitant evolution of extensively drug-resistant strains of M. 
tuberculosis strains.   
 
In recent years the use of molecular biological techniques has confirmed that the genotypic and 
phenotypic characteristics of M. tuberculosis are associated with the epidemiology of TB. These 
findings have highlighted the need for the development of new tools for preventing, diagnosing 
and treating TB. Molecular epidemiological tools have recently been used in a number of 
different settings in Southern Africa.  
 
As discussed in Chapter 1, several lessons have been learnt from molecular epidemiology studies 
in South Africa. Major lessons include information on the diversity and frequency of occurrence 
of M. tuberculosis strains in these communities. Through this, some strain genotypes, including 
Beijing, LAM and LCC, have been shown to play a major role in the epidemic, both locally and 
globally, suggesting that these strain genotypes have evolved unique properties.  Not only have 
they allowed an understanding of strain diversity but also the spread of both drug sensitive and 
drug resistant strains.   
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In Chapter 2, using both spoligotyping and IS6110-RFLP, the diversity of M. tuberculosis strains 
in Zimbabwe has been described. To date only two manuscripts have reported molecular 
epidemiological data from this country. Our study identified a sub-group of LAM genotype 
strains which was over-represented in this region. This genotype was termed the SAF1 genotype. 
Subsequently, a study in Brazil confirmed the importance of this genotype in Rio de Janeiro.  We 
have recently renamed the strain SAF1/RDRio due to its characteristic region of difference. We 
also confirmed the occurrence of this family of strains further North in Zambia at relatively 
similar proportions. This study provided evidence that the burden of TB in central parts of 
Southern Africa is largely due to a small subset of actively circulating strains. The restricted 
strain diversity observed may be interpreted to reflect ongoing transmission or that this strain 
genotype is endemic as it was one of the first genotypes to be introduced into Southern Africa. If 
the latter is correct this could significantly restrict the utility of IS6110-RFLP in these regions.  
 
In chapter 2a we give a short description of the geographical distribution of TB cases in Gweru 
(one of the cities in Zimbabwe). A subset of M. tuberculosis isolates genotyped as part of the 
study in Chapter 2, were also studied to determine their geographic distribution. The 
predominant SAF1/RDRio strains were not clustered in one particular district in the city, further 
supporting their role in driving the TB epidemic in these settings. 
 
Interestingly, comparison of the strain population structure with other settings in South Africa 
clearly demonstrates regional differences, however risk factors for disease due to SAF1/RDRio 
strains are not known. We postulated host pathogen compatibility. In Chapter 3 potential risk 
factors for disease due to SAF1/RDRio strains were explored. Our study also showed an 
Conclusions 
219 
 
association with smoking. Smoking has long been associated with TB and interacts with this 
disease by increasing disease susceptibility and worsening outcomes. This study showed an 
association between disease due to SAF1/RDRio strains and cavitary pulmonary TB in all TB 
patients regardless of HIV status, but not among HIV co-infected patients. The association with 
cavitary disease suggested that this genotype induced a more severe form of disease in the 
Zimbabwean population. This confirms a previous finding which demonstrated a similar 
association in Brazil.A Further observation included a trend towards an association with smear 
positive disease, which suggests high levels of transmission and that early diagnosis and 
treatment are important in controlling TB in this community.  
 
In Chapter 4 we describe the genetic relationships among Low Copy Clade (LCC) strains 
identified in Cape Town in comparison to those from Zimbabwe and other regions using IS6110-
RFLP, principal genetic grouping, spoligotyping, IS6110 insertion site mapping and variable-
number tandem repeats (VNTR). At the time the LCC strains were a poorly defined genotype 
and it was not known whether LCC strains were genotypically related. Our analysis showed that 
LCC strains from Cape Town were evolutionary close to LCC strains from Zimbabwe and other 
regions. These findings showed that these strains were distributed on a wider scale, probably 
reflecting spread from a common source during colonization of the African continent. 
 
Specific M. tuberculosis genotypes have been associated with particular human populations. 
Molecular epidemiological data has clearly demonstrated regional differences, suggesting host 
pathogen compatibility (Chapter 2). In the past paucity of data from Southern Africa region has 
prevented such comparisons to be made regionally. In Chapter 5 we report the first study to 
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analyse the population structure of M. tuberculosis in 8 of the 14 countries in Southern Africa, 
using spoligotyping and/or IS6110-RFLP data. This study showed that distinct M. tuberculosis 
genotypes are associated with specific host populations, further supporting the notion of host 
pathogen compatibility. As the different genotypes are likely to have different phenotypes this 
may affect the development of new diagnostics, vaccines and drugs  
 
Realizing the importance of drug-resistant TB in Southern Africa, Chapter 6 builds on the 
findings in chapter 5 where we use a similar methodology to describe the distribution of drug-
resistant M. tuberculosis genotypes in provinces in South Africa. This is the first study to 
describe the population structure MDR-, pre-XDR- and XDR-TB on this scale. We showed that 
MDR-, pre-XDR- and XDR-TB genotypes were geographically localized across the four 
provinces. The Beijing genotype is particularly prevalent in the Western and Eastern Cape, with 
the typical Beijing genotype being predominantly associated with MDR-, pre-XDR-TB and 
XDR-TB in Western Cape, and atypical Beijing genotype with pre-XDR- and XDR-TB in the 
Eastern Cape. Further north in Gauteng and to the North East in KwaZulu Natal the LAM4 
genotypes were more prevalent and the proportion of these strains increased among XDR-TB 
strains in KwaZulu Natal.  
 
Our findings clearly demonstrate that MDR-TB is associated with a high number of genotypes 
probably reflecting both acquisition and transmission. Of significant importance is our 
observation that the diversity of XDR-TB genotypes is restricted in three of the four provinces. 
This suggests that there is a strong selection for certain genotypes to evolve to XDR-TB. Our 
present hypothesis is that these genotypes are at an advantage when exposed to second-line 
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treatment regimens.  These results support the need for identifying genetic markers in drug 
resistant M. tuberculosis which can aid in diagnostic tests. These tests should allow the simple 
identification of cases at high risk of developing XDR-TB.  
 
Collectively our findings show the importance of using standardized molecular biological 
techniques to study the epidemiology of TB in the Southern Africa region. Our findings show 
that different genotypes predominate in different geographic settings implying that these strains 
could be well adapted in these populations. The predominance of closely related strains implies 
that the bacterial population is fairly homogenous suggesting recent transmission of disease. 
These findings have major implications for the development of vaccines, new diagnostics and 
TB drugs. In vaccine and anti-TB drug design, different bacterial populations that are 
predominant in different geographic settings should be targeted and strain diversity should be 
considered in the development of diagnostic test. Genetic markers should be identified 
particularly among M(X) DR-TB strains to aid in identifying individuals at risk of developing 
drug resistant disease. 
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Supplemental table 1: Factors associated with disease due to Mycobacterium tuberculosis 
SAF1/RDRio strains among all culture positive TB patients: Univariable analysis  
 
 Total Outcome: Mycobacterium tuberculosis SAF1/RDRio strains  
 Total (All 
cases) 
All culture positive TB 
cases (row %) 
*Unadjusted OR 
(95% CI) 
**P value 
All patients n=134 n=69   
Age (years) 
18-24  
25-29 
30-34 
35-39 
≥40 
 
16 
41 
30 
16 
30 
 
  8(50.0) 
18(42.9) 
15(50.0) 
12(75.0) 
16(53.3) 
 
1 
0.71(0.22-2.26) 
1.0 (0.30-3.37) 
3.0 (0.67-13.4) 
1.14(0.34-3.84) 
 
0.24 
Gender 
Male  
Female 
 
75 
59 
 
 39 (52.0) 
 30 (50.9) 
 
1 
0. 95(0.48-1.88) 
 
0.89 
TB treatment history 
No 
Yes 
 
112 
22 
 
58(51.8) 
11(50.0) 
 
1 
0.93(0.37-2.32) 
 
0.38 
HIV status 
Positive 
Negative 
 
119 
15 
 
58(48.7) 
11(73.3) 
 
1 
2.89(0.87-9.59) 
 
0.06 
Household TB contact 
No 
Yes 
 
40 
94 
 
17(42.5) 
52(55.3) 
 
1 
1.67(0.79-3.54) 
 
0.17 
Currently/ever smoked 
No 
Yes 
 
93 
41 
 
43(46.2) 
26(63.4) 
 
1 
2.01(0.94-4.29) 
 
0.06 
Smoking 
No 
Currently smoking 
Ever smoked 
 
93 
13 
20 
 
43(46.2) 
8 (61.5) 
14(70.0) 
 
1 
1.86(0.57-6.11) 
2.71(0.96-7.67) 
 
0.11 
Exposure to dust or irritants 
No 
Yes 
 
 
109 
24 
 
 
60(55.1) 
9(37.5) 
 
 
1 
0.49(0.20-1.21 
 
 
0.12 
 
*Unadjusted Odds ratio from logistic regression representing the summary relative odds of having disease due to 
Mycobacterium tuberculosis Southern Africa 1 (SAF1/RDRio) strains compared with other Mycobacterium 
tuberculosis strains. 
 CI confidence interval; **P value for Univariable association 
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Supplemental table 2: Factors associated with disease due to Mycobacterium tuberculosis SAF1/RDRio 
strains, among HIV positive TB patients with culture positive disease-univariable analysis 
 
 Outcome: Mycobacterium tuberculosis SAF1/RDRio strains  
 HIV positive TB 
cases  
HIV positive 
n (row %) 
*Unadjusted OR 
(95% CI) 
**P value 
All patients n=119 n=58   
Age (years) 
18-24  
25-29 
30-34 
35-39 
≥40 
 
13 
38 
28 
13 
27 
 
6(46.2) 
16(42.1) 
14(50.0) 
9(69.2) 
13(48.2) 
 
1 
0.85(0.24-3.01) 
1.17(0.31-4.35) 
2.63(0.53-13.07) 
1.08(0.29-4.08) 
 
0.56 
Gender 
Male  
Female 
 
65 
54 
 
32(49.2) 
26(48.2) 
 
1 
0.96(0.47-1.97) 
 
0.90 
TB treatment history 
No 
Yes 
 
97 
22 
 
47(48.5) 
11(50.0) 
 
1 
1.06(0.42-2.68) 
 
0.90 
Household TB contact 
No 
Yes 
 
36 
83 
 
13(36.1) 
45(54.2) 
 
1 
2.09(0.94-4.69) 
 
0.07 
Currently/ever smoked 
No 
Yes 
 
82 
37 
 
35(42.7) 
23(62.2) 
 
1 
2.21(0.99-4.88) 
 
0.04 
Smoking 
No 
Currently smoking 
Ever smoked 
 
82 
11 
18 
 
35(42.7) 
7 (63.6) 
12(66.7) 
 
1 
2.35(0.64-8.66) 
2.69(0.92-7.86) 
 
0.10 
Exposure to dust or irritants 
No 
Yes 
 
96 
22 
 
51(53.1) 
7(31.8) 
 
1 
0.41(0.15-1.10) 
 
0.07 
*Unadjusted Odds ratio from logistic regression representing the summary relative odds of having disease due to 
Mycobacterium tuberculosis Southern Africa 1 (SAF1/RDRio strains compared with other Mycobacterium 
tuberculosis strains;  CI confidence interval; **P value for Univariable association 
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Supplemental table 3: Factors associated with cavitary tuberculosis disease among culture 
positive TB patients- Univariable analysis 
 
*Unadjusted odds ratio from logistic regression representing the summary relative odds of having cavitary 
tuberculosis; CI confidence interval; **P value for Univariable association 
  
 Total Outcome: Cavitary TB disease 
 Total (All 
cases) 
All culture positive 
TB cases (row %) 
Unadjusted OR 
(95% CI) 
P value 
All patients n=134 n=42   
Age (years) 
18-24  
25-29 
30-34 
35-39 
≥40 
 
16 
40 
30 
16 
30 
 
10(62.5) 
10(25.0) 
9(30.0) 
4(25.0) 
8(26.7) 
 
1 
0.20(0.58-0.69) 
0.26(0.07-0.92) 
0.20(0.04-0.91) 
0.22(0.06-0.80) 
 
0.09 
 
Gender 
Male  
Female 
 
74 
59 
 
20(27.0) 
22(37.3) 
 
 
1 
1.61(0.77-3.35) 
 
0.20 
Strain family 
Other 
SAF1/RDRio 
 
65 
68 
 
15(23.1) 
27(39.7) 
 
1 
2.20(1.03-4.67) 
 
0.04 
TB treatment history 
No 
Yes 
 
111 
22 
 
35(31.5) 
7 (31.8) 
 
1 
1.01(0.38-2.71) 
 
0.98 
HIV status 
Positive 
Negative 
 
118 
15 
 
34(28.8) 
8 (53.3) 
 
1 
2.82(0.95-8.40) 
 
0.06 
Household TB contact 
No 
Yes 
 
 
40 
93 
 
 
13(32.5) 
29(31.2) 
 
 
1 
0.94(0.42-2.08) 
 
 
0.88 
Currently/ever smoked 
No 
Yes 
 
93 
40 
 
31(33.3) 
11(27.5) 
 
1 
0.76(0.33-1.71) 
 
0.50 
Smoking 
No 
Currently smoking 
Ever smoked 
 
93 
13 
20 
 
31(33.3) 
3 (23.1) 
5 (25.0) 
 
1 
0.60(0.15-2.33) 
0.66(0.22-2.00) 
 
0.61 
Exposure to dust or irritants 
No 
Yes 
 
108 
24 
 
36(33.3) 
6 (25.0) 
 
1 
0.67(0.24-1.82) 
 
0.42 
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Supplemental table 4: Factors associated with cavitary tuberculosis disease, among HIV 
positive TB patients with culture positive disease –Univariable analysis 
 
*Unadjusted Odds ratio from logistic regression representing the summary relative odds of having  cavitary 
tuberculosis among HIV positive TB patients; CI confidence interval; **P value for Univariable association 
 
 
 Total Outcome: Cavitary TB disease 
 Total (All cases) HIV positive TB 
cases (row %) 
Unadjusted OR 
(95% CI) 
P value 
All patients n=134 n=134   
Age (years) 
18-24  
25-29 
30-34 
35-39 
≥40 
 
13 
37 
28 
13 
27 
 
 
8 (61.5) 
9 (24.3) 
8(28.6) 
3(23.1) 
6(22.2) 
 
1 
0.20(0.05-0.77) 
 
0.12 
 
Gender 
Male  
Female 
 
64 
54 
 
16(25.0) 
18(33.3) 
 
 
1 
1.50(0.67-3.33) 
 
0.31 
Strain family 
Other 
SAF1/RDRio 
 
61 
57 
 
15(24.6) 
19(33.3) 
 
1 
1.53(0.69-3.41) 
 
0.29 
TB treatment history 
No 
Yes 
 
96 
22 
 
27(28.1) 
7 (31.8) 
 
1 
1.19(0.44-3.25) 
 
0.73 
Household TB contact 
No 
Yes 
 
 
36 
82 
 
 
9 (25.0) 
25(30.5) 
 
 
1 
1.31(0.54-3.20) 
 
 
0.54 
Currently/ever smoked 
No 
Yes 
 
 
82 
36 
 
 
25(30.5) 
9 (25.0) 
 
 
1 
0.76(0.31-1.85) 
 
 
0.54 
Smoking 
No 
Currently smoking 
Ever smoked 
 
82 
11 
18 
 
25(30.5) 
2 (18.2) 
4 (22.2) 
 
1 
0.51(0.10-2.51) 
 
0.57 
Exposure to dust or irritants 
No 
Yes 
 
 
95 
22 
 
 
30(31.6) 
4 (18.2) 
 
 
1 
0.48(0.14-1.55) 
 
 
0.20 
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Supplemental table 5: Resistance profiles of M. tuberculosis isolates   
Province Resistance class  
InhMono 
n (%) 
RifMono 
n (%) 
MDR 
n (%) 
PreXDR 
n (%) 
XDR 
n (%) 
*Other 
n (%) 
Sensitive 
n(%) 
Unclassified 
n(%) 
Total 
Eastern Cape 0 (0.0) 0 (0.0) 134 (24.3) 93 (16.9) 80 (14.5) 0 (0.0) 245 (44.4) 0 (0.0) 552 (100.0) 
 
Gauteng 0 (0.0) 0 (0.0) 765 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 765 (100.0) 
 
KwaZulu 
Natal 
11 (2.8) 6 (1.6) 196 (50.5) 12 (3.1) 25 (6.4) 13 (3.3) 122 (31.4) 3(0.8) 388 (100.0) 
 
Western Cape 1433 (31.2) 424 (9.2) 2091 (45.6) 281 (6.1) 117 (2.6) 68 (1.5) 24 (0.5) 151 (3.3) 4589 
(100.0) 
 
**Other 28 (23.3) 8 (6.7) 68 (57.1) 7 (5.8) 3 (3.5) 1 (0.80 1 (0.8) 3 (2.5) 119 (100.0) 
 
Total  1472(23.0) 438 (6.8) 3255 (50.8) 393 (6.1) 225 (3.5) 82 (1.3) 392 (6.1) 157 (2.5) 6413 
(100.0) 
 
*Other- isolates in this drug resistant category were either mono resistant to other first line drugs or were poly resistant (streptomycin mono resistant (n=3); Ofloxacin mono 
resistant (n=1); Amikacin mono resistant (n=1); Poly resistant (n=81) 
**isolates from other provinces that were excluded from the analysis, Northern Cape (n=9); North West (n=17); Limpopo (n=1); Free State (n=1); Unknown (n=91)  
 
